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The leading causes of liver disease are Hepatitis C virus infection and chronic alcohol 
abuse. Alcohol accelerates liver disease in HCV but the mechanisms are poorly 
understood. The identification of molecular gene expression profiles on human liver 
tissue was performed using microarrays. Samples were obtained from alcoholic-cirrhotic, 
HCV-cirrhotic, HCV/alcohol-cirrhotic and control non-cirrhotic liver tissue. Probe set 
expression summaries were calculated using RMA. Probe set level linear models were fit 
where probe set expression was modeled by HCV status, alcohol status, and the 
interaction between HCV and Alcohol. HCV cirrhosis was associated with up-regulation 
of genes related to viral and immune response, apoptosis and inflammation.  There were 
down-regulation of genes in the ubiquititin-proteasome system in alcoholic cirrhosis. The 
interaction of HCV and alcohol revealed negative interaction for genes involved in 
apoptosis and immune response. There was a negative estimate for genes involved in 







Chronic Liver diseases of any etiology are the 9
th
 leading cause of death in the United 
States (1). The leading causes of liver disease are Alcoholic Liver Disease (ALD) and chronic 
Hepatitis C Virus (HCV) infection, either alone or in combination, as they account for close to two-
thirds of deaths from and patients with chronic liver diseases (1,2,3).  
The liver is vulnerable to sustained, chronic injury because the hepatocyte is the 
primary site of HCV replication as well as the metabolism of ethanol; thus it is intuitive that 
there is an interaction in the pathogenesis of HCV and alcohol (4). Despite clinical evidence of 
exacerbated injury, higher mortality rates and increased risk of hepatocellular carcinoma 
(HCC), liver disease mediated by the interaction of alcohol and HCV is complex and not 
completely understood. Pathogenesis of alcohol and HCV have similar effects of injury but 
arrive at those effects via different mechanisms as both etiologies manifest the four sequential 
hallmarks of liver disease: steatosis (fatty liver), steatohepatitis (inflamed fatty liver), fibrosis 










What is the Hepatitis C virus? 
 
 Hepatitis C is a single stranded positive sense RNA virus (6) that was discovered in 
1989. The virus is transmitted through bodily fluids, and most of those infected are intravenous 
drug users (7).  Over 170 million people worldwide are infected with the virus (8). The 
progression of the virus is slow, most people are not aware of their infection until presented 
with a compromised liver; the onset of chronic liver disease can take at least 20 to 30 years to 
develop (7,9). This progression is dependent on genetic and environmental factors and tends to 
proceed at a faster rate in males, in obese, in persons with diabetes, individuals with co-
infections such as Hepatitis B (HBV) and HIV, and in alcoholics (10). A small portion (15-
25%) of persons infected will spontaneously clear acute infections the virus, and of those that 
are chronically infected, only about half of them will respond to therapy such as pegylated 
interferon (IFN) with ribavirin (11,12).   
 The ssRNA (single-stranded RNA) of the virus is translated into a single polyprotein 
that is further processed by proteases belonging to both the cellular host and the virus in the 
endoplasmic reticulum of the host (13). The virus is composed of ten proteins: four structural 
(S) and six nonstructural (NS) proteins. The core protein(C), Envelope 1 and 2 (E1 and E2), 
and p7 protein are the four structural proteins, while the six NS proteins are NS2, NS3, NS4A, 
NS4B, NS5A, and NS5B (6,13,14). E1 and E2 form a heterodimer that is the glycoprotein 
envelope and the virus is unable to enter the host cell with out the envelope proteins (6). The 
core protein forms the nucleocapsid of the virus and binds RNA. Core protein has been 
associated with the interference of many cellular mechanisms such as cell signaling, viral 
response and induces oxidative stress through metabolism and apoptosis (6). The p7 protein 
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contains two transmembrane domains and separates the structural proteins from the NS 
proteins. The function of p7 has not been fully determined, although it is thought to be an ion 
channel (13). 
 The NS proteins consist of proteases and other enzymes involved with viral 
reproduction. The role of NS2 is to form the NS2/NS3 enzyme that cleaves the NS2/NS3 
junction (13).  Other than its viral assembly role in the NS2/NS3 protease complex, the 
functions NS2 protein has not been fully investigated (13). NS3 has two domains, a protease 
domain and a helicase/NTPase domain. Not only does it form a complex with NS2, NS4 is an 
important cofactor for NS3. The NS3/4A protease plays an important role because it is 
responsible for the downstream cleaving of the polypeptide, which consists of the rest of the 
NS proteins (15). Not much is known to date about protein NS4B besides its structure and that 
it is an integral trans-membrane protein that associated with both the lumen and cytosolic side 
of the ER (endoplasmic reticulum)and can alter intracellular membranes (12). NS5A is also 
involved in disrupting host cellular processes (6). NS5B is a RNA-dependent RNA polymerase 










Pathogenesis of Hepatitis C Virus Infection 
 
 There are many arguments that suggest HCV is not directly cytopathic to the hepatocyte 
and the main focus of pathology of HCV infection has been on inflammation from the immune 
response as the main contributor of reactive oxygen species (ROS) from macrophages and 
neutrophils (16). Recently more attention has been given to the role viral proteins play in 
oxidative stress because the serum and hepatic tissues of patients with HCV contain levels of 
markers for ROS (17). There is evidence of ROS production as levels of malondialdehyde 
(MDA)-adducts (18), and lipid peroxidation protein adducts (19) are higher and antioxidant 
markers such as GSH are reduced in those with the virus (20). The prevalence of hepatocellular 
carcinoma in HCV is also indicative of ROS production; increased levels of 8-hydroxy-
deoxyguanosine, a marker of DNA oxidative damage, have been found in circulating 
leukocytes of HCV patients (21). 
The most extensively studied protein in the proteome of HCV is the Core protein. Core 
induces cellular damage by oxidative stress, mitochondrial injuries, misfolded proteins, ER 
stress, and lipid peroxidation (22,23,24,25). Core’s association with the mitochondria causes a 
direct uptake of Ca
++
, inducing the electron transfer chain to increase production of ROS. 
NS5A can also increase ROS production, but through release of ER Ca
++
 which is then taken 
up by the mitochondria (20,22). NS3 contributes to ROS by up-regulating NADPH oxidase 
(NOX-2) in macrophages (17). The cytotoxicity of the viral proteins is somewhat controversial 
and more research is needed in this area. 
Another area under investigation is the suppression of T-lymphocytes. An early strong, 
sustained and virus specific CD4+ T-helper cell (Th) response and an early, broad CD8+ CTL 
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(cytotoxic T-cell) viral clearance is associated with acute viral clearance (7). In chronic carriers 
of the virus, the responses of T-lymphocytes are much weaker and impaired (15). The weak 
CD4+ T-cell mediated response is thought to be from T-cell exhaustion or impaired antigen 
presentation from dendritic cells (DC)(7,14). The impaired CTL viral clearance might be from 
an inefficient antigen presentation, hampered CD4+ cell mediated priming of CTLs, or viral 
escape through mutation (14,26). The lack of proofreading in the RdRp of viral protein NS5B 
and the hyper-variable region of E2 are thought to promote viral escape (6,15). 
 A virus, like any parasite, must be able to circumvent the host’s defense in response to 
foreign invaders. The host’s attempt to clear viruses and the virus’ need to persist have faced 
evolutionary selection pressures in this battle: Host cells have developed different strategies for 
clearance of viruses and to slow their entry and reproduction, while viruses have evolved 
methods of evading the immune system and counteracting antiviral pathways (12,15). The anti-
viral pathway in hepatic cells involves the induction of Type 1 IFN and ISGs (interferon 
stimulated genes). 
 Surveillance of pathogens by cell is by proteins that can recognize and bind pathogen-
associated molecular patterns (PAMP) (26). Viral PAMPs include single and double stranded 
RNA (dsRNA) and polyuridine nucleotide motifs. Hepatitis C is specifically recognized 
extracellularly by the Toll-like receptor (TLR)-3 and intracellularly by Retinoic-acid-inducible 
gene 1 (RIG-1) and by intracellular compartments containing TLR-3 (14). TLR-3 and RIG-1 
recognize and bind dsRNA, and even though HCV RNA is single stranded, there are secondary 
structural motifs that can be recognized by these receptors. Down stream signaling and 
transcription of IFN-β occurs through the transcription factors IRF (Interferon Regulatory 
factor)-3 and NF-κB (Nuclear Factor-kappa-B) (27) 
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HCV proteins NS3/4A will cleave adaptor proteins Toll/IL-1 receptor-domain-
containing adaptor inducing IFN-β (TRIF), of TLR-3 signaling , and Cardif, of RIG-1 
signaling, to attenuate the IFN-β transcription (27). Even if IFN-β is transcribed, HCV can also 
prevent the paracrine and autocrine effect of IFN signaling by inhibiting the JAK/STAT (Janus 
Kinase/ Signal Transducer and Activator of Transcription) pathway activated by IFN. 
ISG expression is activated through the Jak/STAT pathway, initiated by the binding of 
IFN to the IFN receptors. Jak proteins, JAK-1 and TYK (tyrosine kinase)-2 phosphorylate the 
STAT proteins STAT1 and STAT 2 (26). Core protein can block this pathway by inducing a 
negative regulator of the JAK/STAT pathway SOCS (suppresser of cytokine signaling)-3 (15). 















Mechanisms of Hepatic Cirrohosis 
 
Liver regeneration induces activation of a non-pathological inflammatory response 
during acute injury. Normal parenchymal cells are eventually replaced after resolution of the 
inflammatory response. However, during sustained, chronic injury the resulting deregulation of 
the wound healing response leads to liver cirrhosis, eventually compromising the structure and 
function of the organ. The progression of liver disease can take decades (28) and eventually 
lead to fibrosis, cirrhosis, liver failure, and ultimately hepatocellular carcinoma (29). Although 
some level of reversibility has been shown if the insult is removed, the only effective cure for 
advanced liver disease is orthotopic liver transplantation (OLT) (30,31). 
Fibrosis occurs in many different tissues and organs. The pathway of fibrogenesis can 
be stereotyped, as all types of tissue follow a common string of events. Persistent, repeated or 
chronic injury to tissue is followed by infiltration of immune cells due to the wound healing 
response, These release soluble cellular signals that activate myofibrogenic cells which start to 
proliferate and migrate to the injury site and begin synthesis of extracellular matrix proteins 
(ECM) (18,32,33). 
In the liver, the parenchymal cells are hepatocytes. When damaged, Kupffer cells (KC), 
the resident macrophage of the liver, are among the inflammatory infiltrate that migrate to the 
site of the injury releasing cytokines (34) that attract and promote the differentiation of hepatic 
stellate cells (HSC), the main source of ECM proteins (35). The continuation of this general 
cascade will result in the build up of ECM, mainly type I collagen, resulting in fibrosis (36,37).  
The hepatocytes can be damaged from viral, toxemia, metabolic disorders or iron overloads 
(38). Fibrogenic stimuli can vary depending on the etiology of the insult. Processing of cellular 
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toxins, such as ethanol, not only inflict cellular damage but also promote the generation of 
ROS, which can have a direct stimulatory affect on HSCs (33). In the case of a viral attack, 
infected hepatocytes are cleared by immune cells such as CTL and natural killer (NK) cells 
(39). When a cell is damaged beyond repair, the apoptotic bodies are released as signals during 
the death process and are important stimuli for macrophages that are constantly monitoring the 
organ (40). The death of hepatocytes used to be viewed as passive consequence of liver injury, 
however, apoptosis and necrosis of hepatocytes have been implicated as a stimulus to fibrosis 
as apoptotic bodies can be engulfed by KCs and HSCs. (41,42). Kupffer cells phagocytose 
damaged cells and apoptotic bodies and become activated. As a result they transcribe 

















Oxidative stress is central to both HCV and ALD pathogenesis and is proposed as a 
synergistic mechanism in liver disease mediated by the addition of alcohol to HCV.  Oxidative 
stress is defined as an imbalance between the generation of ROS and the antioxidant defense 
capacity of cell. ROS affects all cellular components including lipids, proteins, and DNA. As a 
result lipid and protein adducts can cause cytotoxicity, break autoimmunity and lead to cell 
death.  
Oxidative stress in ALD results from two main sources; the metabolism of ethanol itself 
and the inflammatory response from immune cells. Ethanol is metabolized by alcohol 
dehydrogenase (ADH) in the cytosol and Cytochrome P450 2E1 (CYP2E1) in microsomes. 
Both enzymes are inducible and reduce ethanol to acetaldehyde.  Considered a second 
messenger within the cell, generated ROS are important factors in the initiation of HSCs. 
Sources of ROS are recruited by neutrophils from the wound healing response, activated 
Kupffer cells, CYP2E1 and mitochondria (16,17). ROS can up-regulate the production of pro-
inflammatory cytokines through activation of the transcription factors NF-κB and c-Myb 
(43,44). 
Oxidative stress is directly related to the metabolism and break down of ethanol to 
acetaldehyde. ADH and CYP2E1 carry out this reaction through oxidation-reduction (45). The 
oxidation of ethanol to acetaldehyde by these enzymes results in the reduction of the cofactors 
NAD to NADH and NADP to NADPH respectively (45,46,47,48). The oxidation of NAD(P)H 
to NAD(P) takes place in the mitochondria by reducing oxygen to H2O via the electron transfer 
chain (46). Intermediate reactive oxygen species such as superoxide, the hydroxyl radical and 
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peroxide are formed during this process (49). Chronic ingestion of ethanol leads to a red-ox 
imbalance due to a high NAD(P)H/NAD(P) ratio and a generation of ROS that surpasses the 
anti-oxidant systems in cells. A high NAD(P)H/NAD(P) ratio promotes fatty acid synthesis 
(47) and ROS generation (49).  
Cytotoxicity is the result of oxidative stress from the build up of ROS intermediates 





















Both acute and chronic ethanol intake modulates the immune system (51,52). 
Alcoholics have a higher chance of post-surgical complications due to surgery and also exhibit 
decreased ability to clear bacterial and viral pathogens (51). Studies have shown a reduction of 
class I presentation partially due to inhibition of the proteasome which may hamper the ability 
of CTLs to recognize infected cells (53,54). The hepatitis C virus also exhibits its remarkable 
ability to evade host defenses by causing persistent infection in 75-80% of individuals 
acquiring the disease. Viral proteins have been shown to interfere with viral recognition and 
antiviral pathways such as NF- B and IFN signaling (55,56,57). In studies with chimpanzees 
and humans, successful clearance of the virus is associated with a strong, vigorous CD4+ T 
helper cell response and broad, multi-epitope specific CD8+ CTL response. Persistent infection 
is associated with weak narrowly focused T-cell response.  DC, the most potent APC (antigen 
presenting cell) for priming T-cells, are shown to be incapacitated in their ability to present and 










Alcohol and HCV 
 
Not all alcoholics will develop fibrosis and cirrhosis can take decades to develop in 
some hepatitis C infected individuals. The fibrogenic process is a very complex web and 
researchers have looked to environmental and genetic co-factors in the progression of liver 
fibrosis. Alcohol is considered an accelerant of fibrosis in individuals infected with HCV 
(10,42). There is a higher rate of HCV infection among alcoholics than the general population 
and there is a 40% increased odds of mortality in alcohol abusers with HCV (10). Additionally, 
the response rate of HCV therapy and compliance is much lower in alcoholics. 
There is a large body of evidence that alcohol exacerbates liver injury in patients with 
HCV. However, the mechanisms of synergism and/or additivity of the two etiologies are still 
unclear (60). There have also been conflicting findings in areas such as the effect of alcohol use 












Hypothesis and Aims 
 
The current study intends to identify molecular pathways affected by the addition of 
alcohol in HCV positive individuals. Gene expression profiling was modeled for the separate 
conditions (EtOH vs Normal and HCV vs Normal)as well as for their their interaction term 
(HCV*EtOH). 
Due to the impairment of the immune system from alcohol consumption, and HCV’s 
ability to evade and abrogate the immune response, our hypothesis is that the combination of 
chronic alcohol abuse and HCV infection may result in gene expression suggestive in 
immunomodulation, specifically in the activation of the adaptive immune response. 
Alcohol abuse may increase an individual’s susceptibility to infections. 
Although alcohol use and abuse is a major risk factor for cirrhosis in individuals 
infected with HCV, not much is known about the molecular mechanisms. There are practically 
no studies on gene expression in with concurrent alcohol use in HCV infection. We propose to: 
AIM 1: To identify characteristic molecular signatures individually associated with HCV 
cirrhosis and Alcoholic cirrhosis. 
AIM 2: To build molecular pathways associated with the direct effect of the interaction of 







Patients, Materials, and Methods 
 
 
Patients and Samples 
We used samples obtained from explanted liver from patients undergoing liver 
transplantation for ALD, end-stage hepatitis C, and combined hepatitis C and alcoholic 
cirrhosis at from the Hume-Lee Department of Transplantation at Virginia Commonwealth 
University. The study evaluated seventy-eight human liver tissues, including 23 (29.5%) from 
patients with HCV mediated cirrhosis, 13 (16.7%) from patients with ALD, 23 (29.5%) from 
patients with cirrhosis due to both HCV and alcohol, and 19 (24.4%) were non-cirrhotic, 
normal donor livers acquired from the United Network of Organ Sharing (UNOS) to be used 
for comparison analyses. Written informed consent was obtained from all patients prior to 
surgery. The institutional review board approved the research protocol. 
All normal liver donors were sero-negative for HCV Antibody and were shown to have 
normal liver function and histopathology. None of the HCV-infected patients were receiving 
anti-viral treatment at the time of surgery. Significant alcohol consumption was defined as > 
50g/day for a period of > 5 years or >80 g/day for a shorter time period. Alcohol intake was 
assessed by the attending physician prior to the transplant.  
 Liver tissue samples were obtained through Liver Tissue Cell Distribution system 





Sample Preparation.  
Samples from cirrhotic liver tissue were collected in liquid nitrogen or RNA later 
solution (Ambion, Inc., Austin, TX) and stored at -80 C until use. 
Sample preparation protocol follows the Affymetrix GeneChip Expression Analysis 
manual (Santa Clara, CA). Total RNA was extracted from liver tissue samples using TRIzol 
(Life Technologies, Rockville, MD). RNAs were purified using Rneasy kit (Qiagen, Valencia, 
CA). To facilitate hybridization to the U133A 2.0 GeneChip probe arrays, the purified RNA 
was reverse-transcribed using T7-polydT primer and then converted to double stranded cDNA 
by using Superscript Choice System (One-Cycle Target Labeling and Control Reagents, 
Affymetrix, Santa Clara, CA). The cDNA (complementary DNA)served as template to 
construct biotin-labeled antisense cRNA (complementary RNA) by way of an in vitro 
transcription reaction. The labeled cRNA was then chemically fragmented and made into a 
hybridization cocktail according to the Affymetrix GeneChip protocol, which was then 
hybridized to HG-U133A 2.0 GeneChip probe arrays (Affymetrix, Santa Clara, CA). The array 
image was generated by the high-resolution GeneChip
®
 Scanner 3000 by Affymetrix
®
 
(Affymetrix, Santa Clara, CA). After all chips passed quality control, the data were analyzed 
using Affymetrix Microarray Suite software, version 5.0 and Bioconductor packages 








Quality Assessment:  
RNA purity as measured by spectrophotometer was deemed sufficient, providing the 
ratios satisfied the criteria A260nm/A280nm >1.8 and A260nm/A270nm >1.3. Additionally, the RNA 
integrity, assessed by capillary electrophoresis using the Agilent Bioanalyzer, had to meet the 
criteria that the 28S/18S ratio ≥ 1.5, with an rRNA (ribosomal RNA)contribution greater than 



















Microarray Data Analysis: 
 Probe set expression summaries were calculated after image analysis using robust 
multiarray averaging (RMA). 
 Conducting an unsupervised analysis generated a dendrogram and associated heatmap. 
The data set was filtered by retaining the most variable probe sets (the probe sets having the top 
1% range was retained). Agglomerative hierarchical clustering using Ward’s method and using 
1-Pearson’s correlation as the dissimilarity measure was applied to the filtered data set. 
 For differential gene expression of HCV cirrhotic liver tissue vs normal liver tissue, 
each probe set was compared using a two-sample t-test with Satterwaites’s approximation to 
the degrees of freedom to account for unequal variances. Differential gene expression of 
alcohol cirrhotic liver tissue vs. normal liver tissue was compared in the same manner.  
 To examine the interaction of HCV and alcohol (HCV*EtOH), probe set level linear 
models were fit by modeling probe set expression by HCV status, EtOH status, and the 
interaction between HCV and Alcohol. The model is taken to be as 
yij = mj + b1jHCVi + b2jEtOHi +b3j (HCVi)(EtOHi) + eij 
where j represents a probe set and i represents an individual subject. HCVi and EtOHi are 
dichotomous variables representing the HCV or Alcohol status, respectively, for a given 
individual. b1j represents the effect due to HCV status on probe set j and b2j represents the 
effect due to alcohol status on probe set j, while b3j represents the effect of the interaction of 
HCV and alcohol on given probe set j.  yij represents the log2 intensity of probe set j for subject 
i and mj represents the baseline log2 intensity for probeset j. Random error term was represented 
by eij. Probe sets that were significant for the term b3i were of particular interest as this was an 
indication of the effect of the interaction of HCV and EtOH on gene expression being 
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synergistic or antagonistic, as opposed to being additive. A Bonferroni correction was used for 























Gene Annotation:  
 Gene ontology and gene interaction analyses for genes identified as differentially 
expressed were examined using Ingenuity Pathway Analysis (IPA) tools 7.0 
(http://www.ingenuity.com). 
In addition, an HTML page listing all significant probe sets with their associated Entrez 
ID, gene symbol, Unigene ID, chromosomal location, and gene name with appropriate hyper 


















Verification of Microarray Data:  
Reverse Transcriptase (RT) real time PCR Analysis. To validate our microarray results, 
we carried out a quantitative reverse transcriptase ―real time‖ PCR (QPCR) for genes selected 
for relevance and biological significance. We selected Caspase 1 (CASP1), interleukin 8 (IL8), 
interleukin 15 (IL15), platelet derived growth factor (PDGFC) myxovirus (influenza virus) 
resistance 1 (MX1) and transforming growth factor beta 1 (TGFB1). We used the same mRNA 
from the stock RNAs samples that were subjected to microarray study. Total RNA from each 
sample was subjected to reverse transcription using TaqMan® Reverse Transcription Reagents 
(Applied Biosystems, Foster City, CA) according to the manufacturer’s protocol. Real-time 
PCR reactions then were carried out in a 25µL reaction mixture in an ABI Prism 7700 
Sequence Detection System (Applied Biosystems, Foster City, CA), using TaqMan® Pre-
Developed Assay Reagents for Gene Expression (Applied Biosystems).  Each assay is a 20x 
mix of forward primer, reverse primer, and 6FAM™ dye - MGB labeled probe.  Data were 
analyzed according to the comparative cycle threshold (Ct) method and normalized by Beta 2-
microglobulin (B2M) expression in each pool sample. We used QPCR to determine the relative 
expression levels of some of the prognostic genes obtained from the microarray data analysis 
among multiple randomly chosen samples from each group. Pearson’s correlation coefficient 
(r) was calculated to examine the relation between microarray and real-time PCR results, P< 







Analysis of gene expression patterns between alcoholic cirrhotic and normal liver tissues 
 
 The Top over expressed genes between alcoholic cirrhotic tissue and normal liver tissue 
are involved in immune response (IGKC, IGL@, IGHM), antigen presentation (HLA-C) and 
inflammation (IL8). Genes involved in the immune response were down regulated in alcholic 
cirrhotic tissue. The top canonical pathways in alcoholic cirrhotic tissue were Jak/Stat signaling 
(P=5.39E-04), Protein Ubiquitination Pathway (P=8.22E-04), and VEGF signaling (P=1.06E-
3). Jak/Stat signaling is intracellular signal transduction used by cytokines, interferons and 
growth factors, and certain aspects of the immune response. 
In the protein ubiquitination pathway there was a down regulation of genes that code for 
protein subunits of the Proteasome. The proteasome plays a role in the turnover of cellular 
proteins and also in processes antigenic peptides for MHC class I antigen presentation.  The 
down-regulated genes code for proteins subunits that make up the 26S proteasome, including 
subunit members of the proteolytic 20S core particle (PSMA1, PSMA3, PSMB1, PSMB2, 
PSMB4, PSMB7) the 19S regulatory particle (e.g. PSMC2, PSMD1, PSMD2, PSMD4, 
PSMD12, PSMD14). The 26S proteasome degrades ubiquitinated proteins in an ATP –
dependent manner; we also found under-expression of several genes encoding proteins 
involved in ubiquitin mediated proteolysis (e.g. UBE2L3, UBE2A, UBE3A) as well as the 
regulatory subunits PA28gama (PSME3) and PA200 (PSME4). 
 Chronic ethanol abuse induces genes for enzymes that metabolize ethanol, notably 
members of the cytochrome P 450 family, alcohol dehydrogenase and aldehyde dehydrogenase; 
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we found representatives of this group ALDH3B1, CYP2W1, and CYP2C9 to be up-regulated 
compared to normal liver tissue. 
 The presence of other immune cells was suggested by the up-regulation of CD7, CD8B, 





















Differential gene expression between HCV cirrhotic liver tissue and Normal liver tissue 
 
 The top canonical pathway for HCV cirrhotic tissue was Hepatic Fibrosis/ Hepatic 
stellate cell activation (P=9.17E-06). Top over expressed genes were involved in the immune 
response (CXCL10, IGHM, IGL@, IGC, HLA-DQB1), response to virus (IFI27, IFIT1), and 
antigen presentation (HLA-DQB1). Many genes were up-regulated in the Hepatic 
Fibrosis/Hepatic stellate cell activation pathway including those encoding for extracellular 
matrix proteins (COL1A1, COL1A2, COL3A1), cell receptors (e.g. CD40, FAS, TGFBR2, 
TNFRSF1, LY96, FGFR1, IL10RA), signal transduction (STAT1, SMAD2, SMAD7) as well 
as cytokines and chemokines (CCL5, CCL21, TGFB1, IL8). 
 There was an over-abundance of cytokines and chemokines in HCV cirrhotic tissue. 
Chemokine signaling (P=0.0433) and CCR5 signaling (P=1.67E-03) canonical pathways 
emerged as significant in the analysis. XCL1, CCL3 (MIP1a), CCL4 (MIP1b), CCL5 
(RANTES), CCL21 (ALP) CXCL9 (MIG), and CXCL10 (IP10) were all up-regulated and 
suggest an inflammatory state. Interleukins that were present in HCV cirrhotic tissue include 
over-expression of IL8, IL15, IL18 and under-expression of IL4 and IL19. 
 HCV infection induces interferon signaling. We found up-regulation of IFN induced 
genes (e.g. IFI27, IFI35, IFITM1, IFIT1, OAS1) and for genes associated with viral response 
(e.g. MX1, IFIH1, PTPRC, ISG15). Moreover, IFN signaling (P=0.0132) was identified as a 
significant canonical pathway. A cartoon representation of this pathway can be seen in Figure 2 
 T-cell receptor signaling (P=0.00298) was also a top canonical pathway. Up-regulated 
genes in this pathway include CD3G, CD8A, ITK, LYK, FYN, LCP2, PTPRC (CD45), and 
TRA@.  Genes involved with CTL and NK killing of target cells were up-regulated (FAS, 
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GZMB, PFR1) Additionally, CTL-mediated apoptosis of target cells was another significant 
canonical pathway (P=0.049).  
 Genes encoding proteins expressed by B-cell presence is suggested by the up-regulation 
of BST2, CD24, and CD72. Macrophage and monocyte presence is suggested by over 




















Genes involved in the significant interaction of HCV and Ethanol 
 
 Probe set linear models were used to determine any synergistic or antagonistic effect of 
the interaction of HCV and ethanol in cirrhotic tissue set based on HCV status, Alcohol status, 
and interaction of Alcohol and HCV status. 
 The top canonical pathways of genes involved in the interaction between HCV and 
alcohol were antigen presentation pathway, IL-4 signaling , hepatic fibrosis/hepatic stellate cell 
activation, fatty acid biosynthesis, Protein ubiquitination pathway and ERK/MAPK signaling. 
A stacked bar chart showing the percentage of genes positively or negatively affected by the 
interaction can be seen in Figure 3.  
 In the top canonical pathway, antigen presentation, we observed a negative estimate for 
multiple genes that code for MHC class II molecules involved in presentation of antigenic 
peptides (e.g. HLA-DRB1, HLA-DRA, HLA-DPB1, HLA-DQB1), as well as peptide loading 
and processing (HLA-DMA, CD74 (CLIP)). This pathway can be viewed in Figure 4. 
 Interestingly, genes involved in hepatic fibrosis/hepatic stellate cell activation were 
negatively affected by the interaction of HCV and alcohol. There was a negative interaction of 
genes associated with the extra-cellular matrix (MMP2, MMP7, TIMP3, COL1A2) as well as 
growth factors and receptors (FGFR1, FGFR2, PDGFRA, PDGFRB, CTGF). The analysis 
revealed toxicology lists with hepatic fibrosis as significant. A stacked bar chart showing 
hepatic fibrosis and two other lists (pro-apoptosis, positive acute phase response proteins) can 
be seen in Figure 5. 
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 Genes involved in apoptosis were relevant in the analysis. AVEN, BAK1, BAD, and 
TRADD had a positive correlation and BCL2, BAX, CASP1, TNFSF21, DAP3K, BNIP3L, and 
TNFRSF21 had a negative correlation. 
 There was a negative estimate for genes involved in the immune response. These genes 
included chemokines (CXCL6, CXCL12, CCL19), chemokine receptors (CXCR4, CSF2RA, 
immune cell receptors (TRA@, TRBC1, TICAM2), immunoglobulins (IGP1, IGL, IGKC, IGJ, 
IGHG3). There were also negative estimates for genes present on the surface of immunotype 

















Gene Expression Validation by QPCR 
 
QPCR was used to confirm expression levels of mRNAs of CASP1, IL8, PDGFC, 
MX1, and TGFB1. There was significant differential expression of the genes between the 
different tissue types and the microarray results were reproduced (r=0.82, P<0.001; r=0.71, 




























Figure 2- HCV Cirrhotic vs. Normal Tissue: Interferon Signaling  
 





























Figure 4 - Significant interaction (HCV*EtOH): Antigen Presentation Pathway 
 
Red- Genes with positive estimate term 
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 Despite decades of directed research, the underlying molecular mechanisms involved in 
alcohol and HCV mediated liver disease are complex and not fully elucidated. The mechanisms 
in which alcohol worsens HCV infection outcome remain even more elusive. In the present 
study, we observed characteristic gene expression patterns in HCV cirrhotic tissue and 
alcoholic cirrhotic tissue. We were able to observe principle pathways of genes involved in 
molecular and cellular function by comparing each condition to normal liver tissue. 
Furthermore, we were able to identify genes synergistically or antagonistically involved in the 
direct interaction of alcohol and HCV. 
 Liver disease mediated by alcohol has been associated with modulated immune 
response, increased inflammation and oxidative stress, and hepatocyte apoptosis. Alcoholics 
have a diminished ability to clear bacterial and viral pathogenic challenges as infections are 
prolonged in the alcoholic patient. Additionally, both chronic and acute alcohol intake 
modulate host immunity differently. Hepatocyte apoptosis is marked with the appearance of 
Mallory hyaline bodies in alcoholic liver tissue (64). Inflammation results directly from the 
metabolism of ethanol and indirectly from subsequent leukocyte infiltration (65). However, the 
mechanisms involved in pathogenic damage from chronic alcohol and the events that lead to 
liver disease are still not understood very well. In the current study we identified gene 
expression patterns that may partially account for these characteristics of alcoholic liver 
disease.  
A hallmark characteristic of alcoholic liver disease is leukocyte infiltration, particularly 
by neutrophils (66, 67). We observed an over abundance of genes that suggest the presence of 
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leukocytes: CD7 (T-cells, NK cells), CD8B (Cytotoxic T-cells), KLRB1 (NK cells), and CD72 
(B-cells). B-cell presence is also suggested by the over abundance of imunnoglobulins. 
Importantly, one of our top up-regulated genes alcoholic cirrhotic tissue was CXC chemokine 
family member IL8, a very potent chemotactic attractant for neutrophils. Neutrophils release 
reactive oxygen species and are a major cellular contributor to inflammation and are 
characteristic of alcoholic hepatitis (67). IL8 is secreted by a wide variety of cell types and can 
be activated by transcription factors AP-1, NF- B, and C/EBP-B, which can activated by a 
wide variety of stimuli including cytokines, oxidative stress and pathogens (68). Pertaining to 
our study, IL8 can be induced by oxidative stress via the AP-1 transcription factor. We found 
up-regulation of JUN, which encodes for a protein that is part of the AP-1 transcription factor 
complex.  
Oxidative stress can lead to cell death via inactivation of the ubiquitin-proteasome 
pathway. We observed down-regulation of many genes involved the protein ubiquitination 
canonical pathway. The genes involved encode for proteins of the 20S proteasome, the 26S 
proteasome and ubiquitin-conjugating enzymes. The ubiquitin-proteasome system is vital for 
protein catabolism in mammalian cells as it degrades damaged, oxidized or misfolded proteins, 
as well as short-lived regulatory proteins involved in intracellular signaling. The proteasome 
plays a role in ethanol-induced diseases (69,70). Oxidative stress has been shown to inhibit the 
proteasome in hepatic tissue as well as extra-hepatic tissue such as retinal epithelial cells and 
endothelial cells (71,72,73,74). Inhibition of the proteasome may provide the link between IL8 
and oxidative stress (73) Proteasome inhibitors have been activate IL8 in a NF-kB independent 
manner via induction of AP-1 by enhance JUN phosphorylation (71). In the current study, we 
found several genes under-expressed in NF-KB signaling (MYD88, IRAK1, IKBKG, CHUCK) 
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and up-regulation of JUN. Furthermore, the proteasome function is critical in trimming 
antigenic peptides for MHC-class-1 antigen presentation and can be impaired by ethanol 
(53,54,75). 
Our results provide, at a transcriptional level, a possible mechanism that ties together 
oxidative stress, apoptosis, inflammation and impaired MHC class-I restricted antigen 
presentation via proteasome malfunction in alcoholic patients. This may contribute to liver 
injury, fibrogenic stimuli and decreased resistance to pathogens affecting the liver such as HBV 
and HCV. 
 
In HCV-induced cirrhotic liver tissue, we found gene expression patterns characteristic 
of chronic HCV infection. Studies have shown up-regulation of genes and associated with the 
immune response, inflammation, apoptosis and hepatic fibrosis (76, 77, 78,79). Hepatic gene 
expression has been found to discriminate non-responders to responders of anti-viral therapy 
(80,81). HCV infection induces interferon signaling regardless of outcome. Patients with 
elevated expression of interferon-stimulated genes tend to respond poorly to antiviral treatment. 
Sarasin-Filipowicz theorized that pre-activation of interferon signaling could cause adaptive 
evasive mechanisms by the virus. In the current study, we found up-regulation of chemokines, 
cytokines and interferon-stimulated genes (82).  
Plasma and intra-hepatic chemokine levels associated with poor outcome and liver 
damage in patients with HCV. CXCL9, CXCL10 and CXCL11 were elevated in both patients 
not currently on antiviral treatment and in comparing non-responders of treatment to responders 
(83). CXCL10 is a pro-inflammatory chemokine whose expression is up-regulated in HCV-
infected liver tissue compared to normal liver tissue, HBV liver tissue and in non-viral cirrhotic 
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liver tissue (84). CXCL10 expression in hepatocytes was also found to be correlated with 
histological severity and lobular inflammation (85). IL-18, a pro-inflammatory IFN-  inducing 
cytokine, has been found up-regulated in liver disease induced by HCV and also correlates with 
disease progression and hepatic damage (84,86). The over-expression of these cytokines is 
suggestive of an inflammatory state and may contribute to liver damage by the recruitment of 
non-specific T-cells that might result in non-specific inflammatory attack toward hepatocytes 
(87,88). The overabundance of inflammatory cytokines may lead to an unregulated cycle of 
inflammation as the immune response is activate but not resolved (89). The trafficking of T-
cells to liver is intended to control the virus by destruction of infected cells, but may ultimately 
result in non-specific inflammation cell death in infected cells and uninfected cells (90). 
Our results are in concordance with these studies. HCV mediated cirrhotic tissue 
showed a gene expression profile consistent of severe outcomes of HCV infection including 
genes that suggest pronounced inflammation, disease progression and probable failure to 
respond to anti-viral therapy. 
 
The mechanisms in which alcohol worsens the outcome of HCV infection are still 
unclear but there has been evidence that alcohol and HCV together increase oxidative stress, 
cytotoxicity, steatosis, apoptosis and impairment of the immune response (91). Our results 
show positive estimates for genes involved in the acute phase and for fatty acid biosynthesis. 
Surprisingly genes related to hepatic fibrosis and apoptosis revealed a negative estimate. Most 
importantly, a negative interaction was observed for genes associated with the immune 
response, including several genes in the antigen presentation pathway.  
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The negative estimate of several genes encoding proteins involved in MHC class II 
restricted antigen presentation may partially account for the persistence of HCV. MHC Class II 
molecules are expressed by professional APCs, which are able to activate the cellular adaptive 
immune response.  This step is critical in bridging the innate arm of the immune system for an 
effective adaptive response as it generates antigen specific T-helper cells which in turn promote 
the proliferation of antigen specific CTLs. Of the antigen presenting cells, (e.g. B-cells, 
sinusoidal endothelial cells, Kupffer Cells) the most potent APC in the liver are dendritic cells. 
Studies have suggested that both HCV infection and chronic alcohol intake individually impair 
the allostimulatory capacity of DCs and can have an additive effect of this inhibition in 
combination (58). HLA-DRB1, a gene we found to have a negative estimate in the interaction 
of HCV and ethanol, has been shown to target multiple epitopes of different HCV proteins and 
some alleles of HLA-DRB1 have been associated with patients that resolve HCV infection 
(92). Being that eradication of HCV from the host is dependent on a strong and coordinated 
response by the innate and adaptive immunity, it would be strategic for the virus to take 
advantage of this pathway for eluding the host defense response. 
In conclusion, we have found characteristic gene expression signatures of both alcoholic 
cirrhotic tissue and HCV cirrhotic tissue compared to normal liver tissue. We also, for the first 
time, were able to exhibit genes that may be responsible for the synergistic/additive effect of 
the interaction of HCV and alcohol in human liver tissue. We observed that the addition of 
alcohol to HCV results in decreased immune response, especially in antigen presentation to T-
cells by professional APCs.  
Here we show that HCV induced cirrhosis shows an over-expression of inflammatory 
response genes, consistent with gene profile expressions that is associated with poor disease 
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progression, outcome and liver damage. The profile is also consistent to patients with reduced 
response to antiviral therapy. While certain aspects of the immune response are activated, such 
as IFN stimulated genes and leukocyte trafficking, the response is insufficient to eradicate the 
virus and may perpetuate a cycle of inflammation. Alcoholic cirrhotic tissue also exhibits a 
gene expression profile favoring an inflammatory state as well as immunomodulation by the 
differential expression of genes involved in signal transduction pathways and antigen 
presentation. Further more, our results may offer a pathway for reduced class I antigen 
presentation possibly induced by oxidative stress, allowing virally infected cells to escape 
surveillance by CTLs . While decrease in Class-1 antigen presentation was not exhibited in the 
interaction of HCV and alcohol, we have found down regulation of genes involved in antigen 
loading and presentation in the context of class II restricted antigen presentation. This may 
account for may account for the reduced allostimulatory capacity of DCs observed in alcoholic 
patients with HCV which can result in increased viral persistence by possibly preventing the 
effective activation of the cellular immune response by DCs, resulting in inefficient effecter 
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Supplemental Table 1-  Genes Significantly Different Between ALD Cirrhotic Tissue 







Affy ID  Symbol  Gene Name  Fold  
2342 1773_at FNTB farnesyltransferase, CAAX box, beta -1.26 
5690 200039_s
_at 
PSMB2 proteasome (prosome, macropain) 




SFRS9 splicing factor, arginine/serine-rich 9 -1.49 
10899 200048_s
_at 
JTB jumping translocation breakpoint -1.99 
375 200065_s
_at 
ARF1 ADP-ribosylation factor 1 -1.55 
533 200078_s
_at 
ATP6V0B ATPase, H+ transporting, lysosomal 




ANAPC5 anaphase promoting complex subunit 5 -1.6 
7453 200628_s
_at 
WARS tryptophanyl-tRNA synthetase -1.81 
4924 200646_s
_at 
NUCB1 nucleobindin 1 -2.43 
3939 200650_s
_at 
LDHA lactate dehydrogenase A -1.67 
7332 200683_s
_at 
UBE2L3 ubiquitin-conjugating enzyme E2L 3 -2.19 
7332 200684_s
_at 
UBE2L3 ubiquitin-conjugating enzyme E2L 3 -1.25 
2782 200744_s
_at 
GNB1 guanine nucleotide binding protein (G 




CALU calumenin -1.59 
5695 200786_a
t 
PSMB7 proteasome (prosome, macropain) 




LMAN2 lectin, mannose-binding 2 -1.94 
3329 200807_s
_at 
















PSMD2 proteasome (prosome, macropain) 26S 




EPRS glutamyl-prolyl-tRNA synthetase -1.71 
5499 200846_s
_at 










PSMB1 proteasome (prosome, macropain) 









RAB14 RAB14, member RAS oncogene family -2.48 
10972 200929_a
t 
TMED10 transmembrane emp24-like trafficking 




VCL vinculin 2.15 
473 200938_s
_at 










PSME3 proteasome (prosome, macropain) 




SSR4 signal sequence receptor, delta 





























ANP32A acidic (leucine-rich) nuclear 




PSMF1 proteasome (prosome, macropain) 




CYC1 cytochrome c-1 -1.89 
5701 201068_s
_at 
PSMC2 proteasome (prosome, macropain) 26S 




SYNGR2 synaptogyrin 2 -1.89 
378 201097_s
_at 




COPB2 coatomer protein complex, subunit beta 




EIF2S1 eukaryotic translation initiation factor 2, 




HAX1 HCLS1 associated protein X-1 -1.59 
5878 201156_s
_at 
RAB5C RAB5C, member RAS oncogene family -1.61 
4836 201157_s
_at 
NMT1 N-myristoyltransferase 1 -1.7 
4836 201158_a
t 
NMT1 N-myristoyltransferase 1 -1.78 
51075 201175_a
t 
TXNDC14 thioredoxin domain containing 14 -1.85 
5707 201198_s
_at 
PSMD1 proteasome (prosome, macropain) 26S 




PPP1R7 protein phosphatase 1, regulatory 




ARIH2 ariadne homolog 2 (Drosophila) -1.49 
10425 201230_s
_at 
ARIH2 ariadne homolog 2 (Drosophila) -1.43 
9789 201239_s
_at 
SPCS2 signal peptidase complex subunit 2 









BAT3 HLA-B associated transcript 3 -1.42 
5869 201276_a
t 
RAB5B RAB5B, member RAS oncogene family -1.35 
11047 201281_a
t 
ADRM1 adhesion regulating molecule 1 -1.9 
10581 201315_x
_at 
IFITM2 interferon induced transmembrane 









PPP2CB protein phosphatase 2 (formerly 2A), 




CACYBP calcyclin binding protein -2.02 
5709 201388_a
t 
PSMD3 proteasome (prosome, macropain) 26S 














RUVBL2 RuvB-like 2 (E. coli) -1.52 
3725 201465_s
_at 
JUN jun oncogene 2.43 
3675 201474_s
_at 
ITGA3 integrin, alpha 3 (antigen CD49C, alpha 








AHSA1 AHA1, activator of heat shock 90kDa 




MYH11 myosin, heavy chain 11, smooth muscle 1.42 
6992 201500_s
_at 
PPP1R11 protein phosphatase 1, regulatory 




TSN translin -1.54 
5684 201532_a
t 
PSMA3 proteasome (prosome, macropain) 




DUSP3 dual specificity phosphatase 3 (vaccinia 




JARID1B jumonji, AT rich interactive domain 1B 1.27 
2720 201576_s
_at 
GLB1 galactosidase, beta 1 -1.72 
4830 201577_a
t 
NME1 non-metastatic cells 1, protein 









TXNL1 thioredoxin-like 1 -1.59 
8243 201589_a
t 





MBTPS1 membrane-bound transcription factor 




DARS aspartyl-tRNA synthetase -1.88 
1967 201632_a
t 
EIF2B1 eukaryotic translation initiation factor 









ARL1 ADP-ribosylation factor-like 1 -2.41 
10051 201663_s
_at 





PSMA1 proteasome (prosome, macropain) 




TPD52 tumor protein D52 -2.18 
7163 201691_s
_at 
TPD52 tumor protein D52 -1.4 
1786 201697_s
_at 
DNMT1 DNA (cytosine-5-)-methyltransferase 1 -1.64 
8683 201698_s
_at 
SFRS9 splicing factor, arginine/serine-rich 9 -1.95 
6642 201716_a
t 
SNX1 sorting nexin 1 -1.55 
740 201717_a
t 
MRPL49 mitochondrial ribosomal protein L49 -1.6 
1994 201726_a
t 
ELAVL1 ELAV (embryonic lethal, abnormal 






SFRS1 splicing factor, arginine/serine-rich 1 










KIAA0494 KIAA0494 -2.09 
9813 201777_s
_at 
KIAA0494 KIAA0494 -1.39 
949 201819_a
t 
SCARB1 scavenger receptor class B, member 1 -1.98 
822 201850_a
t 










ARIH1 ariadne homolog, ubiquitin-conjugating 





CYB5R3 cytochrome b5 reductase 3 -1.88 
1163 201897_s
_at 










CTDSPL CTD (carboxy-terminal domain, RNA 





DNPEP aspartyl aminopeptidase -1.52 
8443 201956_s
_at 
GNPAT glyceronephosphate O-acyltransferase -1.38 
221960 201973_s
_at 
C7orf28B chromosome 7 open reading frame 28B -1.84 
9812 201977_s
_at 
KIAA0141 KIAA0141 -1.53 
5536 201979_s
_at 
PPP5C protein phosphatase 5, catalytic subunit -1.62 
9643 201994_a
t 
MORF4L2 mortality factor 4 like 2 -1.54 
2132 202012_s
_at 
EXT2 exostoses (multiple) 2 -1.95 
2132 202013_s
_at 
EXT2 exostoses (multiple) 2 -1.8 
439 202024_a
t 
ASNA1 arsA arsenite transporter, ATP-binding, 









KPNA1 karyopherin alpha 1 (importin alpha 5) -2.39 
3836 202059_s
_at 
KPNA1 karyopherin alpha 1 (importin alpha 5) -1.93 
6400 202061_s
_at 
SEL1L sel-1 suppressor of lin-12-like (C. 
elegans) 
-2.04 





GOLGA3 golgi autoantigen, golgin subfamily a, 3 -1.67 
9870 202128_a
t 
KIAA0317 KIAA0317 -1.68 
2071 202176_a
t 
ERCC3 excision repair cross-complementing 
rodent repair deficiency, 
complementation group 3 (xeroderma 









PPP2R5A protein phosphatase 2, regulatory 




PPP2R5A protein phosphatase 2, regulatory 




GAS7 growth arrest-specific 7 1.69 
8522 202192_s
_at 
GAS7 growth arrest-specific 7 1.39 
50999 202194_a
t 
TMED5 transmembrane emp24 protein transport 




SRPK1 SFRS protein kinase 1 -1.85 
267 202204_s
_at 
AMFR autocrine motility factor receptor -2.14 
4802 202216_x
_at 
NFYC nuclear transcription factor Y, gamma -1.5 
1674 202222_s
_at 
DES desmin 1.57 
10523 202229_s
_at 





TSPAN7 tetraspanin 7 -1.81 
5692 202243_s
_at 
PSMB4 proteasome (prosome, macropain) 




PSMB4 proteasome (prosome, macropain) 




CDK4 cyclin-dependent kinase 4 -1.52 
6944 202261_a
t 










BCKDHA branched chain keto acid 




HIP2 huntingtin interacting protein 2 -1.82 
5718 202352_s
_at 
PSMD12 proteasome (prosome, macropain) 26S 




PSMD12 proteasome (prosome, macropain) 26S 






RAB3 GTPase activating protein 










ABCF3 ATP-binding cassette, sub-family F 




NUTF2 nuclear transport factor 2 -1.64 
10239 202398_a
t 
AP3S2 adaptor-related protein complex 3, 









KEAP1 kelch-like ECH-associated protein 1 -1.39 
3421 202471_s
_at 





RANBP1 RAN binding protein 1 1.53 
6903 202495_a
t 
TBCC tubulin folding cofactor C -1.6 
1739 202514_a
t 
DLG1 discs, large homolog 1 (Drosophila) -1.73 
4292 202520_s
_at 
MLH1 mutL homolog 1, colon cancer, 




PRPSAP1 phosphoribosyl pyrophosphate 




MAPK14 mitogen-activated protein kinase 14 -1.4 
2764 202543_s
_at 
GMFB glia maturation factor, beta -2.47 
26097 202560_s
_at 
C1orf77 chromosome 1 open reading frame 77 -1.81 
11161 202563_a
t 
C14orf1 chromosome 14 open reading frame 1 1.47 
10048 202583_s
_at 
RANBP9 RAN binding protein 9 -1.49 
4799 202584_a
t 





AK1 adenylate kinase 1 -1.85 
4893 202647_s
_at 





CAD carbamoyl-phosphate synthetase 2, 










R3HDM1 R3H domain containing 1 -1.76 
2817 202755_s
_at 
GPC1 glypican 1 1.38 
53 202767_a
t 
ACP2 acid phosphatase 2, lysosomal -1.49 
1725 202802_a
t 
DHPS deoxyhypusine synthase -1.57 





OGFR opioid growth factor receptor -1.88 
10928 202845_s
_at 
RALBP1 ralA binding protein 1 -1.38 
10775 202868_s
_at 
POP4 processing of precursor 4, ribonuclease 




ATP6V1C1 ATPase, H+ transporting, lysosomal 




PPP2R1B protein phosphatase 2 (formerly 2A), 




SIRPA signal-regulatory protein alpha -1.78 
4927 202900_s
_at 
NUP88 nucleoporin 88kDa -2.23 
6279 202917_s
_at 
S100A8 S100 calcium binding protein A8 -5.57 
10269 202939_a
t 





ARFGEF1 ADP-ribosylation factor guanine 





CREBZF CREB/ATF bZIP transcription factor 1.82 
9915 202986_a
t 





LOXL2 lysyl oxidase-like 2 1.26 
2271 203032_s
_at 
FH fumarate hydratase -2.34 
717 203052_a
t 
C2 complement component 2 -1.66 
9060 203059_s
_at 










HTRA2 HtrA serine peptidase 2 -1.65 
2235 203116_s
_at 
FECH ferrochelatase (protoporphyria) -1.83 
9159 203118_a
t 





TTC15 tetratricopeptide repeat domain 15 -1.69 
10244 203150_a
t 
RABEPK Rab9 effector protein with kelch motifs -1.86 
4728 203189_s
_at 
NDUFS8 NADH dehydrogenase (ubiquinone) Fe-





NDUFS8 NADH dehydrogenase (ubiquinone) Fe-





ABCB6 ATP-binding cassette, sub-family B 













PMM2 phosphomannomutase 2 -1.69 
5601 203218_a
t 
MAPK9 mitogen-activated protein kinase 9 -1.71 
55312 203225_s
_at 
RFK riboflavin kinase -2.32 
6302 203226_s
_at 
TSPAN31 tetraspanin 31 -1.51 
10641 203246_s
_at 
TUSC4 tumor suppressor candidate 4 -1.67 
23262 203253_s
_at 





F8A1 coagulation factor VIII-associated 




LMAN1 lectin, mannose-binding, 1 -2.95 
2794 203307_a
t 





TIMM17B translocase of inner mitochondrial 




AP1G1 adaptor-related protein complex 1, 



















TPP2 tripeptidyl peptidase II -1.72 
8624 203405_a
t 
DSCR2 Down syndrome critical region gene 2 -1.99 
3488 203426_s
_at 





TMEM11 transmembrane protein 11 -1.35 
1000 203440_a
t 





PSMD5 proteasome (prosome, macropain) 26S 




BPGM 2,3-bisphosphoglycerate mutase -1.57 
19 203504_s
_at 
ABCA1 ATP-binding cassette, sub-family A 




MTX2 metaxin 2 -1.56 
27257 203534_a
t 
LSM1 LSM1 homolog, U6 small nuclear RNA 













IFIT5 interferon-induced protein with 




UTP14C UTP14, U3 small nucleolar 









TATDN2 TatD DNase domain containing 2 -1.33 
8694 203669_s
_at 
DGAT1 diacylglycerol O-acyltransferase 









GNS glucosamine (N-acetyl)-6-sulfatase 




MPG N-methylpurine-DNA glycosylase -1.38 
2067 203720_s
_at 
ERCC1 excision repair cross-complementing 
rodent repair deficiency, 
complementation group 1 (includes 




RARA retinoic acid receptor, alpha -1.94 
5442 203782_s
_at 










TPD52L1 tumor protein D52-like 1 -2.04 
9936 203799_a
t 
CD302 CD302 molecule -1.81 
63931 203800_s
_at 
MRPS14 mitochondrial ribosomal protein S14 -1.89 
1716 203816_a
t 
DGUOK deoxyguanosine kinase -1.63 
10188 203838_s
_at 
TNK2 tyrosine kinase, non-receptor, 2 1.5 
57149 203897_a
t 
LYRM1 LYR motif containing 1 -2.07 
9111 203964_a
t 
NMI N-myc (and STAT) interactor -1.76 
8504 203970_s
_at 
PEX3 peroxisomal biogenesis factor 3 -2.23 
8504 203972_s
_at 
PEX3 peroxisomal biogenesis factor 3 -2.53 
8226 203974_a
t 
HDHD1A haloacid dehalogenase-like hydrolase 









NUBP1 nucleotide binding protein 1 (MinD 















PDCD2 programmed cell death 2 -1.77 
4234 204027_s
_at 
METTL1 methyltransferase like 1 -1.82 
1050 204039_a
t 





PBX3 pre-B-cell leukemia homeobox 3 -1.69 
8884 204087_s
_at 
SLC5A6 solute carrier family 5 (sodium-










ADK adenosine kinase -2.28 
55556 204143_s
_at 
ENOSF1 enolase superfamily member 1 -2.09 
7027 204147_s
_at 
TFDP1 transcription factor Dp-1 -1.26 
5481 204185_x
_at 





RARG retinoic acid receptor, gamma -1.41 
8732 204208_a
t 










C6orf108 chromosome 6 open reading frame 108 -2 
10592 204240_s
_at 





DBF4 DBF4 homolog (S. cerevisiae) -1.32 
11258 204246_s
_at 
DCTN3 dynactin 3 (p22) -1.62 
1020 204247_s
_at 
CDK5 cyclin-dependent kinase 5 -1.45 
2767 204248_a
t 
GNA11 guanine nucleotide binding protein (G 




TK2 thymidine kinase 2, mitochondrial -1.65 
9166 204278_s
_at 
EBAG9 estrogen receptor binding site 




STK11 serine/threonine kinase 11 1.76 
10772 204299_a
t 





TMC6 transmembrane channel-like 6 1.58 
6183 204331_s
_at 
MRPS12 mitochondrial ribosomal protein S12 -2.81 





POT1 POT1 protection of telomeres 1 









GTF3C2 general transcription factor IIIC, 




VPRBP Vpr (HIV-1) binding protein -1.15 
8805 204390_a
t 
TRIM24 tripartite motif-containing 24 1.55 
8501 204394_a
t 
SLC43A1 solute carrier family 43, member 1 -1.82 
4289 204423_a
t 
MKLN1 muskelin 1, intracellular mediator 




TMED2 transmembrane emp24 domain 




SPATA2 spermatogenesis associated 2 -1.33 
8425 204442_x
_at 
LTBP4 latent transforming growth factor beta 




ZNF592 zinc finger protein 592 -1.49 
79095 204480_s
_at 
C9orf16 chromosome 9 open reading frame 16 -1.79 
3784 204486_a
t 
KCNQ1 potassium voltage-gated channel, KQT-




DOLK dolichol kinase -1.49 
637 204493_a
t 
BID BH3 interacting domain death agonist -1.87 
5534 204507_s
_at 
PPP3R1 protein phosphatase 3 (formerly 2B), 




REST RE1-silencing transcription factor 1.87 
65082 204590_x
_at 





SMCR7L Smith-Magenis syndrome chromosome 




MRPL28 mitochondrial ribosomal protein L28 1.81 
80143 204666_s
_at 
SIKE suppressor of IKK epsilon -1.13 
25880 204676_a
t 
TMEM186 transmembrane protein 186 -1.44 
27042 204699_s
_at 
C1orf107 chromosome 1 open reading frame 107 -1.67 
27042 204700_x
_at 
C1orf107 chromosome 1 open reading frame 107 -2.67 
2051 204718_a
t 
EPHB6 EPH receptor B6 1.71 
4690 204725_s
_at 




CSPG4 chondroitin sulfate proteoglycan 4 1.27 
3376 204744_s
_at 
IARS isoleucyl-tRNA synthetase -1.95 
10038 204752_x
_at 















LEPREL2 leprecan-like 2 1.64 
9767 204866_a
t 
PHF16 PHD finger protein 16 -1.67 
3396 204868_a
t 
ICT1 immature colon carcinoma transcript 1 -1.52 
9344 204877_s
_at 
TAOK2 TAO kinase 2 1.3 
10232 204885_s
_at 
MSLN mesothelin 1.49 
8819 204899_s
_at 
SAP30 Sin3A-associated protein, 30kDa 1.47 
9521 204905_s
_at 
EEF1E1 eukaryotic translation elongation factor 




C11orf80 chromosome 11 open reading frame 80 1.44 
5871 204936_a
t 
MAP4K2 mitogen-activated protein kinase kinase 
















trafficking protein particle complex 6A -1.31 
7216 205028_a
t 
TRO trophinin 1.41 
9150 205035_a
t 
CTDP1 CTD (carboxy-terminal domain, RNA 
polymerase II, polypeptide A) 




MAPK8IP2 mitogen-activated protein kinase 8 




PRIM1 primase, DNA, polypeptide 1 (49kDa) -1.23 
3425 205058_a
t 
IDUA iduronidase, alpha-L- 1.7 
8790 205140_a
t 
FPGT fucose-1-phosphate guanylyltransferase -1.67 
215 205142_x
_at 
ABCD1 ATP-binding cassette, sub-family D 









STAT2 signal transducer and activator of 





HNRPD heterogeneous nuclear 
ribonucleoprotein D (AU-rich element 






M-phase phosphoprotein 1 -1.18 
9997 205241_a
t 
SCO2 SCO cytochrome oxidase deficient 









GTPBP1 GTP binding protein 1 1.32 
9567 205276_s
_at 
GTPBP1 GTP binding protein 1 1.47 
2533 205285_s
_at 
FYB FYN binding protein (FYB-120/130) 1.53 
2267 205305_a
t 
FGL1 fibrinogen-like 1 -1.59 
24140 205324_s
_at 
FTSJ1 FtsJ homolog 1 (E. coli) -2.86 
9986 205332_a
t 
RCE1 RCE1 homolog, prenyl protein 




SRP19 signal recognition particle 19kDa -2.25 
2355 205409_a
t 
FOSL2 FOS-like antigen 2 1.57 
493 205410_s
_at 





GSTT2 glutathione S-transferase theta 2 -1.75 
3241 205462_s
_at 
HPCAL1 hippocalcin-like 1 -1.47 
7410 205537_s
_at 





TYK2 tyrosine kinase 2 -1.5 
7425 205586_x
_at 
VGF VGF nerve growth factor inducible 1.35 
11116 205588_s
_at 
FGFR1OP FGFR1 oncogene partner -1.43 
57147 205607_s
_at 
SCYL3 SCY1-like 3 (S. cerevisiae) -1.52 
284 205608_s
_at 
ANGPT1 angiopoietin 1 1.59 
284 205609_a
t 
ANGPT1 angiopoietin 1 1.73 
8846 205621_a
t 





TNNT3 troponin T type 3 (skeletal, fast) 1.43 
23545 205704_s
_at 





ANKRD26 ankyrin repeat domain 26 1.21 





PCDHGC3 protocadherin gamma subfamily C, 3 -1.38 
3899 205734_s
_at 
AFF3 AF4/FMR2 family, member 3 1.44 
79171 205740_s
_at 
RBM42 RNA binding motif protein 42 -1.46 
2157 205756_s
_at 
F8 coagulation factor VIII, procoagulant 




TCAP titin-cap (telethonin) 1.88 
2936 205770_a
t 
GSR glutathione reductase -1.78 
9605 205781_a
t 
C16orf7 chromosome 16 open reading frame 7 1.5 
3316 205824_a
t 
HSPB2 heat shock 27kDa protein 2 1.41 
8941 205852_a
t 
CDK5R2 cyclin-dependent kinase 5, regulatory 




ZNF197 zinc finger protein 197 1.24 
2902 205914_s
_at 
GRIN1 glutamate receptor, ionotropic, N-




HBE1 hemoglobin, epsilon 1 1.37 
9466 205926_a
t 
IL27RA interleukin 27 receptor, alpha 1.31 
9093 205963_s
_at 





CSNK2A1 casein kinase 2, alpha 1 polypeptide -1.43 
575 206083_a
t 
BAI1 brain-specific angiogenesis inhibitor 1 1.45 
10772 206095_s
_at 





RAC3 ras-related C3 botulinum toxin substrate 





ADRA2C adrenergic, alpha-2C-, receptor 1.9 
7855 206136_a
t 
FZD5 frizzled homolog 5 (Drosophila) 1.56 
10389 206147_x
_at 
SCML2 sex comb on midleg-like 2 (Drosophila) -1.51 
23264 206169_x
_at 





M-phase phosphoprotein 9 -1.66 
762 206208_a
t 
CA4 carbonic anhydrase IV 1.6 
762 206209_s
_at 
CA4 carbonic anhydrase IV 1.48 
10138 206238_s
_at 









CLTB clathrin, light chain (Lcb) -1.5 
11163 206302_s
_at 
NUDT4 nudix (nucleoside diphosphate linked 




CRLF1 cytokine receptor-like factor 1 1.57 
4440 206333_a
t 
MSI1 musashi homolog 1 (Drosophila) 1.49 
1995 206338_a
t 
ELAVL3 ELAV (embryonic lethal, abnormal 




















PF4 platelet factor 4 (chemokine (C-X-C 




GDF1 growth differentiation factor 1 1.38 
773 206399_x
_at 
CACNA1A calcium channel, voltage-dependent, 









NAPA N-ethylmaleimide-sensitive factor 




ZRSR1 zinc finger (CCCH type), RNA-binding 




OPRL1 opiate receptor-like 1 1.42 
7141 206568_a
t 










IQCC IQ motif containing C 1.74 
2812 206655_s
_at 





GLRX glutaredoxin (thioltransferase) -1.65 
598 206665_s
_at 
BCL2L1 BCL2-like 1 1.54 
359 206672_a
t 
AQP2 aquaporin 2 (collecting duct) 1.41 
10524 206689_x
_at 
HTATIP HIV-1 Tat interacting protein, 60kDa -1.46 
4861 206699_x
_at 
NPAS1 neuronal PAS domain protein 1 1.44 
631 206746_a
t 






FCER2 Fc fragment of IgE, low affinity II, 




CD96 CD96 molecule 1.26 
9087 206769_a
t 
TMSB4Y thymosin, beta 4, Y-linked 1.31 
3338 206781_a
t 





SPAG8 sperm associated antigen 8 1.98 
26206 206816_s
_at 
SPAG8 sperm associated antigen 8 1.68 
98 206833_s
_at 
ACYP2 acylphosphatase 2, muscle type -1.87 
8545 206861_s
_at 
CGGBP1 CGG triplet repeat binding protein 1 -1.81 
8712 206897_a
t 





ENDOGL1 endonuclease G-like 1 1.25 
 206903_a
t 
 NA 1.28 
2323 206980_s
_at 
FLT3LG fms-related tyrosine kinase 3 ligand 1.33 
8817 206986_a
t 
FGF18 fibroblast growth factor 18 1.44 
596 207004_a
t 
BCL2 B-cell CLL/lymphoma 2 1.58 
3858 207023_x
_at 
KRT10 keratin 10 (epidermolytic 










SLC16A6 solute carrier family 16, member 6 









SLC25A11 solute carrier family 25 (mitochondrial 










C17orf73 chromosome 17 open reading frame 73 1.22 
64386 207289_a
t 
MMP25 matrix metallopeptidase 25 1.52 
23457 207321_s
_at 
ABCB9 ATP-binding cassette, sub-family B 




MBP myelin basic protein 1.54 
30848 207337_a
t 
CTAG2 cancer/testis antigen 2 1.51 
8674 207350_s
_at 




GABRB2 gamma-aminobutyric acid (GABA) A 




RS1 retinoschisis (X-linked, juvenile) 1 1.18 
10195 207396_s
_at 
ALG3 asparagine-linked glycosylation 3 





SNUPN snurportin 1 -1.62 
7355 207439_s
_at 
SLC35A2 solute carrier family 35 (UDP-galactose 




NKX2-8 NK2 homeobox 8 1.75 
50618 207476_a
t 
ITSN2 intersectin 2 1.52 
6953 207503_a
t 
TCP10 t-complex 10 (mouse) 1.36 
27013 207511_s
_at 
C2orf24 chromosome 2 open reading frame 24 1.52 
2779 207514_s
_at 
GNAT1 guanine nucleotide binding protein (G 





LAMC2 laminin, gamma 2 1.33 
6915 207555_s
_at 
TBXA2R thromboxane A2 receptor 1.89 
5020 207576_x
_at 





histone cluster 1, H2bl -1.16 
617 207618_s
_at 
BCS1L BCS1-like (yeast) -1.4 
7024 207627_s
_at 
TFCP2 transcription factor CP2 -1.39 
4917 207640_x
_at 
NTN2L netrin 2-like (chicken) 1.48 
7132 207643_s
_at 
TNFRSF1A tumor necrosis factor receptor 









SEC13 SEC13 homolog (S. cerevisiae) -1.73 
54900 207734_a
t 
LAX1 lymphocyte transmembrane adaptor 1 1.24 
9647 207758_a
t 










ATXN2L ataxin 2-like 1.44 
9921 207801_s
_at 
RNF10 ring finger protein 10 -1.57 
2220 207804_s
_at 
FCN2 ficolin (collagen/fibrinogen domain 





PSMD9 proteasome (prosome, macropain) 26S 




MAZ MYC-associated zinc finger protein 




BAIAP2 BAI1-associated protein 2 1.47 
55559 207891_s
_at 
UCHL5IP UCHL5 interacting protein -1.18 
2128 207914_x
_at 
EVX1 even-skipped homeobox 1 3.03 
3363 207927_a
t 
HTR7 5-hydroxytryptamine (serotonin) 




LCN1 lipocalin 1 (tear prealbumin) 1.46 
3382 207949_s
_at 
ICA1 islet cell autoantigen 1, 69kDa 1.57 
1770 207959_s
_at 
DNAH9 dynein, axonemal, heavy chain 9 1.49 
2741 207972_a
t 







mucosal vascular addressin cell 




AP2S1 adaptor-related protein complex 2, 




AIRE autoimmune regulator 1.49 
81605 208101_s
_at 





PSD pleckstrin and Sec7 domain containing 1.35 
554 208111_a
t 
AVPR2 arginine vasopressin receptor 2 




TCF2 transcription factor 2, hepatic; LF-B3; 









DUX4 double homeobox, 4 1.47 
8735 208208_a
t 
MYH13 myosin, heavy chain 13, skeletal muscle 1.55 
3084 208232_x
_at 
NRG1 neuregulin 1 1.87 
30062 208242_a
t 





GAS2L1 growth arrest-specific 2 like 1 1.89 
8669 208264_s
_at 





ADAM28 ADAM metallopeptidase domain 28 1.59 
8911 208299_a
t 
CACNA1I calcium channel, voltage-dependent, T 
type, alpha 1I subunit 
1.41 





FSTL1 follistatin-like 1 -1.9 
4952 208316_s
_at 
OCRL oculocerebrorenal syndrome of Lowe -1.34 
9524 208336_s
_at 
GPSN2 glycoprotein, synaptic 2 -1.94 
5594 208351_s
_at 
MAPK1 mitogen-activated protein kinase 1 -1.29 
6015 208371_s
_at 
RING1 ring finger protein 1 -1.51 
8879 208381_s
_at 
SGPL1 sphingosine-1-phosphate lyase 1 -1.21 
10111 208393_s
_at 
RAD50 RAD50 homolog (S. cerevisiae) -1.7 
720 208451_s
_at 





XPNPEP1 X-prolyl aminopeptidase 









KCNG2 potassium voltage-gated channel, 









POU4F3 POU class 4 homeobox 3 1.27 
6623 208584_a
t 
SNCG synuclein, gamma (breast cancer-















































PSMD11 proteasome (prosome, macropain) 26S 




MRPL3 mitochondrial ribosomal protein L3 -2 
6731 208801_a
t 




SRP72 signal recognition particle 72kDa -2.13 
3308 208814_a
t 
HSPA4 heat shock 70kDa protein 4 -1.7 
5127 208824_x
_at 
PCTK1 PCTAIRE protein kinase 1 -1.47 
26003 208842_s
_at 










THY1 Thy-1 cell surface antigen 2.22 
821 208852_s
_at 
CANX calnexin -1.99 
5110 208857_s
_at 





REEP5 receptor accessory protein 5 -1.94 
6234 208902_s
_at 
RPS28 ribosomal protein S28 1.28 
28973 208907_s
_at 
MRPS18B mitochondrial ribosomal protein S18B -1.93 
4758 208926_a
t 
NEU1 sialidase 1 (lysosomal sialidase) -2 
5531 208932_a
t 





SEPHS1 selenophosphate synthetase 1 -1.52 
22929 208941_s
_at 
SEPHS1 selenophosphate synthetase 1 -1.67 
5976 208947_s
_at 















AK2 adenylate kinase 2 -1.47 
8669 208985_s
_at 





POLR2C polymerase (RNA) II (DNA directed) 




SYNCRIP synaptotagmin binding, cytoplasmic 




COPS7A COP9 constitutive photomorphogenic 




EHD1 EH-domain containing 1 1.31 
7381 209065_a
t 





GLRX3 glutaredoxin 3 -1.98 
182 209097_s
_at 




NOLA2 nucleolar protein family A, member 2 




MYD88 myeloid differentiation primary 




UBE2G1 ubiquitin-conjugating enzyme E2G 1 




UBE2G1 ubiquitin-conjugating enzyme E2G 1 














AKR1C3 aldo-keto reductase family 1, member 
C3 (3-alpha hydroxysteroid 




SEC23IP SEC23 interacting protein -1.83 
10524 209192_x
_at 
HTATIP HIV-1 Tat interacting protein, 60kDa -1.42 
9554 209206_a
t 
SEC22B SEC22 vesicle trafficking protein 




MPDU1 mannose-P-dolichol utilization defect 1 -1.94 
10227 209215_a
t 
TETRAN tetracycline transporter-like protein 1.48 
11152 209217_s
_at 
WDR45 WD repeat domain 45 -1.95 
10061 209247_s
_at 
ABCF2 ATP-binding cassette, sub-family F 









CLN3 ceroid-lipofuscinosis, neuronal 3, 





GLRX glutaredoxin (thioltransferase) -2.54 
4781 209290_s
_at 
NFIB nuclear factor I/B 1.83 
5437 209302_a
t 





HBS1L HBS1-like (S. cerevisiae) -2.32 
10111 209349_a
t 
RAD50 RAD50 homolog (S. cerevisiae) -1.33 
8764 209354_a
t 
TNFRSF14 tumor necrosis factor receptor 










TMED7 transmembrane emp24 protein transport 




MSH2 mutS homolog 2, colon cancer, 










PHKA2 phosphorylase kinase, alpha 2 (liver) -1.74 
55744 209445_x
_at 
C7orf44 chromosome 7 open reading frame 44 -1.6 
57418 209461_x
_at 
WDR18 WD repeat domain 18 -1.74 
4041 209468_a
t 










POP7 processing of precursor 7, ribonuclease 














 NA -1.41 
7849 209552_a
t 
PAX8 paired box 8 1.49 
7737 209565_a
t 
RNF113A ring finger protein 113A -1.77 
27348 209593_s
_at 
TOR1B torsin family 1, member B (torsin B) -1.83 
64087 209623_a
t 
MCCC2 methylcrotonoyl-Coenzyme A 
























PTS 6-pyruvoyltetrahydropterin synthase -1.99 
10026 209707_a
t 
PIGK phosphatidylinositol glycan anchor 




GATA2 GATA binding protein 2 1.36 
23169 209713_s
_at 
SLC35D1 solute carrier family 35 (UDP-
glucuronic acid/UDP-N-















MYCN v-myc myelocytomatosis viral related 
oncogene, neuroblastoma derived 
(avian) 
1.47 





DBP D site of albumin promoter (albumin D-




PSME3 proteasome (prosome, macropain) 




KLK2 kallikrein-related peptidase 2 1.64 
310 209860_s
_at 
ANXA7 annexin A7 -1.88 
4091 209886_s
_at 
SMAD6 SMAD family member 6 1.67 
25956 209889_a
t 
SEC31B SEC31 homolog B (S. cerevisiae) -1.45 
22827 209899_s
_at 
PUF60 poly-U binding splicing factor 60KDa -1.74 
26097 209927_s
_at 
C1orf77 chromosome 1 open reading frame 77 1.49 
8517 209929_s
_at 
IKBKG inhibitor of kappa light polypeptide 




MAP2 microtubule-associated protein 2 1.41 
3910 210089_s
_at 
LAMA4 laminin, alpha 4 2.02 
8498 210120_s
_at 
RANBP3 RAN binding protein 3 -1.59 
5678 210126_a
t 





LTB4R leukotriene B4 receptor 1.43 
11074 210159_s
_at 
TRIM31 tripartite motif-containing 31 1.29 
4772 210161_a
t 
NFATC1 nuclear factor of activated T-cells, 









CORT cortistatin 1.83 
10745 210191_s
_at 





BAT3 HLA-B associated transcript 3 -1.49 
5810 210216_x
_at 
RAD1 RAD1 homolog (S. pombe) -1.78 
3140 210223_s
_at 










PPFIA1 protein tyrosine phosphatase, receptor 
type, f polypeptide (PTPRF), 




WNT7A wingless-type MMTV integration site 
family, member 7A 
1.26 





KCNF1 potassium voltage-gated channel, 




TRIM33 tripartite motif-containing 33 1.86 
4477 210297_s
_at 
MSMB microseminoprotein, beta- 1.21 
90410 210312_s
_at 





SYN2 synapsin II 1.14 
2324 210316_a
t 
FLT4 fms-related tyrosine kinase 4 1.28 
7531 210317_s
_at 
YWHAE tyrosine 3-monooxygenase/tryptophan 





RBP3 retinol binding protein 3, interstitial 1.53 
6444 210329_s
_at 





PTGES prostaglandin E synthase 1.46 
7164 210372_s
_at 
TPD52L1 tumor protein D52-like 1 -2.34 
84084 210406_s
_at 
RAB6C RAB6C, member RAS oncogene family -1.79 
5298 210417_s
_at 





ALPPL2 alkaline phosphatase, placental-like 2 1.57 
9468 210456_a
t 





PSMD4 proteasome (prosome, macropain) 26S 




PSMD4 proteasome (prosome, macropain) 26S 









AVIL advillin 1.49 
2637 210560_a
t 
GBX2 gastrulation brain homeobox 2 1.47 
3189 210588_x
_at 
HNRPH3 heterogeneous nuclear 









implantation-associated protein -1.94 
51035 210623_a
t 
LOC51035 SAPK substrate protein 1 1.39 
8165 210625_s
_at 




LTBP4 latent transforming growth factor beta 




FBXO9 F-box protein 9 -2.36 
7267 210645_s
_at 









TRIM5 tripartite motif-containing 5 -2.14 
6249 210716_s
_at 





HMG20B high-mobility group 20B -2.1 
5682 210759_s
_at 
PSMA1 proteasome (prosome, macropain) 









CNGB1 cyclic nucleotide gated channel beta 1 1.47 
2902 210782_x
_at 
GRIN1 glutamate receptor, ionotropic, N-









CLN3 ceroid-lipofuscinosis, neuronal 3, 










JTB jumping translocation breakpoint -1.7 
6049 210932_s
_at 
RNF6 ring finger protein (C3H2C3 type) 6 1.21 
4176 210983_s
_at 










GCNT2 glucosaminyl (N-acetyl) transferase 2, 




RGS14 regulator of G-protein signaling 14 1.85 
51433 211036_x
_at 
ANAPC5 anaphase promoting complex subunit 5 -1.49 
51512 211040_x
_at 
GTSE1 G-2 and S-phase expressed 1 1.56 
4162 211042_x
_at 
MCAM melanoma cell adhesion molecule -1.66 
81033 211045_s
_at 
KCNH6 potassium voltage-gated channel, 




NF1 neurofibromin 1 (neurofibromatosis, 
von Recklinghausen disease, Watson 
disease) 
-1.26 





















ADAM7 ADAM metallopeptidase domain 7 1.11 
5046 211263_s
_at 





TBX1 T-box 1 1.4 
4899 211280_s
_at 
NRF1 nuclear respiratory factor 1 1.22 
7157 211300_s
_at 





FCAR Fc fragment of IgA, receptor for 1.24 
9031 211313_s
_at 





CACNA1G calcium channel, voltage-dependent, T 




 NA 1.28 
27229 211337_s
_at 










KCNJ4 potassium inwardly-rectifying channel, 




 NA 1.11 
5600 211499_s
_at 
MAPK11 mitogen-activated protein kinase 11 -1.24 
652 211518_s
_at 
BMP4 bone morphogenetic protein 4 -1.4 
6622 211546_x
_at 





C19orf2 chromosome 19 open reading frame 2 -1.39 
7337 211575_s
_at 
UBE3A ubiquitin protein ligase E3A (human 





CACNA1C calcium channel, voltage-dependent, L 




MRPS11 mitochondrial ribosomal protein S11 -1.51 
26018 211596_s
_at 
LRIG1 leucine-rich repeats and 


















IGHA1 immunoglobulin heavy constant alpha 1 1.98 
10580 211705_s
_at 
SORBS1 sorbin and SH3 domain containing 1 1.62 
203068 211714_x
_at 
TUBB tubulin, beta -1.71 
637 211725_s
_at 
BID BH3 interacting domain death agonist -1.66 
2327 211726_s
_at 





PSMA1 proteasome (prosome, macropain) 




VAMP4 vesicle-associated membrane protein 4 -1.41 
5452 211771_s
_at 
POU2F2 POU class 2 homeobox 2 1.96 
161 211779_x
_at 
AP2A2 adaptor-related protein complex 2, 




NFYC nuclear transcription factor Y, gamma -1.37 
5818 211845_a
t 
PVRL1 poliovirus receptor-related 1 




PCDHGA9 protocadherin gamma subfamily A, 9 -1.3 
634 211889_x
_at 
CEACAM1 carcinoembryonic antigen-related cell 





EPHB1 EPH receptor B1 -1.24 
4352 211903_s
_at 





RAD52 RAD52 homolog (S. cerevisiae) 1.81 
5733 211909_x
_at 





TUBB4Q tubulin, beta polypeptide 4, member Q 1.47 
3843 211953_s
_at 
RANBP5 RAN binding protein 5 -2.22 
84364 211975_a
t 
ZNF289 zinc finger protein 289, ID1 regulated -1.57 
23214 211982_x
_at 
XPO6 exportin 6 -1.49 
26099 212005_a
t 
C1orf144 chromosome 1 open reading frame 144 -1.93 
23190 212008_a
t 
UBXD2 UBX domain containing 2 -2.8 
23199 212056_a
t 
KIAA0182 KIAA0182 -1.41 





TRIM27 tripartite motif-containing 27 -1.73 
81614 212129_a
t 
NIPA2 non imprinted in Prader-




NIPA2 non imprinted in Prader-




AP2A2 adaptor-related protein complex 2, 






transmembrane protein 183A -1.53 
204 212175_s
_at 
AK2 adenylate kinase 2 -1.96 
5270 212190_a
t 
SERPINE2 serpin peptidase inhibitor, clade E 
(nexin, plasminogen activator inhibitor 









IFITM3 interferon induced transmembrane 




INTS1 integrator complex subunit 1 1.48 
26057 212211_a
t 
ANKRD17 ankyrin repeat domain 17 -1.75 
4976 212214_a
t 
OPA1 optic atrophy 1 (autosomal dominant) -1.9 
9581 212216_a
t 
PREPL prolyl endopeptidase-like -1.79 
23198 212219_a
t 
PSME4 proteasome (prosome, macropain) 




COQ9 coenzyme Q9 homolog (S. cerevisiae) -1.55 
171023 212237_a
t 










MAPK1 mitogen-activated protein kinase 1 -1.78 
27346 212279_a
t 
TMEM97 transmembrane protein 97 -2.76 
375790 212285_s
_at 
AGRN agrin 1.71 
10213 212296_a
t 
PSMD14 proteasome (prosome, macropain) 26S 




RTF1 Rtf1, Paf1/RNA polymerase II complex 









CLASP2 cytoplasmic linker associated protein 2 1.53 
8879 212322_a
t 
SGPL1 sphingosine-1-phosphate lyase 1 -1.79 
22937 212329_a
t 

















USP24 ubiquitin specific peptidase 24 -1.39 
23065 212396_s
_at 
KIAA0090 KIAA0090 -1.51 
5962 212398_a
t 
RDX radixin -2.13 
89910 212403_a
t 
UBE3B ubiquitin protein ligase E3B -1.33 
92856 212411_a
t 
IMP4 IMP4, U3 small nucleolar 




GRPEL1 GrpE-like 1, mitochondrial (E. coli) -2.16 
23218 212443_a
t 
NBEAL2 neurobeachin-like 2 1.35 
23625 212484_a
t 





SCRIB scribbled homolog (Drosophila) -1.74 
91304 212575_a
t 
C19orf6 chromosome 19 open reading frame 6 1.87 
9716 212584_a
t 
AQR aquarius homolog (mouse) -1.53 
23140 212601_a
t 





TMEM41B transmembrane protein 41B -2.24 
23376 212633_a
t 
KIAA0776 KIAA0776 -1.93 
54505 212648_a
t 










NF1 neurofibromin 1 (neurofibromatosis, 





LOC644879 hypothetical LOC644879 -1.71 
26608 212685_s
_at 
TBL2 transducin (beta)-like 2 -1.73 
23511 212691_a
t 
NUP188 nucleoporin 188kDa -1.34 
1741 212728_a
t 





MON2 MON2 homolog (S. cerevisiae) -1.47 
818 212757_s
_at 
CAMK2G calcium/calmodulin-dependent protein 










RBBP6 retinoblastoma binding protein 6 1.44 
26130 212804_s
_at 





KIAA0828 adenosylhomocysteinase 3 -1.41 
22976 212825_a
t 
PAXIP1 PAX interacting (with transcription-




MEGF9 multiple EGF-like-domains 9 -2.53 
91137 212833_a
t 
SLC25A46 solute carrier family 25, member 46 -2.53 
23142 212851_a
t 
DCUN1D4 DCN1, defective in cullin neddylation 









PIAS4 protein inhibitor of activated STAT, 4 -1.51 
23517 212896_a
t 





CDC2L6 cell division cycle 2-like 6 (CDK8-like) 1.61 
10802 212900_a
t 










LRRC47 leucine rich repeat containing 47 -1.66 
23283 212905_a
t 
CSTF2T cleavage stimulation factor, 3' pre-









COL6A1 collagen, type VI, alpha 1 1.45 
23125 212948_a
t 





POLR2I polymerase (RNA) II (DNA directed) 




CXorf40B chromosome X open reading frame 40B -1.61 
23119 212964_a
t 
HIC2 hypermethylated in cancer 2 -1.3 
11011 212986_s
_at 
TLK2 tousled-like kinase 2 -1.44 
26268 212987_a
t 
FBXO9 F-box protein 9 -2.05 
80097 212995_x
_at 





TRIM37 tripartite motif-containing 37 -1.54 
9479 213013_a
t 
MAPK8IP1 mitogen-activated protein kinase 8 















RQCD1 RCD1 required for cell differentiation1 




 NA 1.33 
29015 213113_s
_at 
SLC43A3 solute carrier family 43, member 3 -2.2 
6625 213121_a
t 
SNRP70 small nuclear ribonucleoprotein 70kDa 









WSCD1 WSC domain containing 1 1.44 
 213156_a
t 
 NA 2.39 
653784 213166_x
_at 





MAPK8IP3 mitogen-activated protein kinase 8 




MOCS1 molybdenum cofactor synthesis 1 -1.48 
91 213198_a
t 
ACVR1B activin A receptor, type IB -1.58 
6855 213200_a
t 
SYP synaptophysin 1.64 
92482 213224_s
_at 
LOC92482 hypothetical protein LOC92482 -1.62 
3858 213287_s
_at 
KRT10 keratin 10 (epidermolytic 


















C6orf162 chromosome 6 open reading frame 162 -1.37 
91966 213315_x
_at 
CXorf40A chromosome X open reading frame 40A -1.86 
57608 213316_a
t 
KIAA1462 KIAA1462 1.27 
7917 213318_s
_at 
BAT3 HLA-B associated transcript 3 -1.67 
10196 213320_a
t 
PRMT3 protein arginine methyltransferase 3 -1.66 
152559 213372_a
t 





ZNF592 zinc finger protein 592 1.34 





KIAA0974 KIAA0974 -1.41 
5510 213465_s
_at 
PPP1R7 protein phosphatase 1, regulatory 




ERCC2 excision repair cross-complementing 
rodent repair deficiency, 










YY1 YY1 transcription factor -1.26 
9276 213500_a
t 
COPB2 coatomer protein complex, subunit beta 




PTPN18 protein tyrosine phosphatase, non-




 NA 1.4 
146542 213527_s
_at 
ZNF688 zinc finger protein 688 -1.49 
92342 213528_a
t 
C1orf156 chromosome 1 open reading frame 156 -1.67 
146542 213529_a
t 
ZNF688 zinc finger protein 688 2.09 
55573 213548_s
_at 










GUK1 guanylate kinase 1 1.3 
23155 213628_a
t 
CLCC1 chloride channel CLIC-like 1 -1.82 
 213637_a
t 
 NA -1.61 
221692 213638_a
t 
PHACTR1 phosphatase and actin regulator 1 1.35 
 213642_a
t 
 NA -2.33 
1763 213647_a
t 





ZNF75 zinc finger protein 75 (D8C6) -1.35 
23149 213669_a
t 
FCHO1 FCH domain only 1 1.74 
112950 213696_s
_at 
MED8 mediator complex subunit 8 -1.62 
6945 213708_s
_at 
MLX MAX-like protein X -1.46 
3887 213711_a
t 
KRT81 keratin 81 1.6 
256949 213715_s
_at 
ANKRD47 ankyrin repeat domain 47 1.28 





KPNA1 karyopherin alpha 1 (importin alpha 5) -1.77 
6497 213755_s
_at 





KSR1 kinase suppressor of ras 1 -1.26 
58509 213815_x
_at 
C19orf29 chromosome 19 open reading frame 29 -1.26 
51406 213838_a
t 
NOL7 nucleolar protein 7, 27kDa -1.62 
120526 213853_a
t 
DPH4 DPH4, JJJ3 homolog (S. cerevisiae) -2.2 
81688 213875_x
_at 
C6orf62 chromosome 6 open reading frame 62 -1.93 
79912 213878_a
t 
PYROXD1 pyridine nucleotide-disulphide 




APRT adenine phosphoribosyltransferase -1.95 
339005 213908_a
t 
WHDC1L1 WAS protein homology region 2 












MYL6 myosin, light chain 6, alkali, smooth 




ITGB5 integrin, beta 5 -1.21 
7535 214032_a
t 





DOK2 docking protein 2, 56kDa 1.57 
81577 214076_a
t 
GFOD2 glucose-fructose oxidoreductase 




PDLIM7 PDZ and LIM domain 7 (enigma) 1.7 
9659 214130_s
_at 





C2orf55 chromosome 2 open reading frame 55 1.23 
8034 214140_a
t 
SLC25A16 solute carrier family 25 (mitochondrial 










SPTB spectrin, beta, erythrocytic (includes 




CCPG1 cell cycle progression 1 -1.65 
284244 214162_a
t 
LOC284244 hypothetical protein LOC284244 -1.16 





C1orf107 chromosome 1 open reading frame 107 -2.31 
10539 214205_x
_at 
GLRX3 glutaredoxin 3 -1.7 
10478 214210_a
t 
SLC25A17 solute carrier family 25 (mitochondrial 
carrier; peroxisomal membrane protein, 






KIAA0564 protein -1.31 
5074 214237_x
_at 
PAWR PRKC, apoptosis, WT1, regulator 1.59 
57194 214255_a
t 
ATP10A ATPase, Class V, type 10A 1.37 
9554 214257_s
_at 
SEC22B SEC22 vesicle trafficking protein 




ITGB4 integrin, beta 4 1.38 
10570 214301_s
_at 
DPYSL4 dihydropyrimidinase-like 4 1.44 
4586 214303_x
_at 





DMN desmuslin 1.47 
130916 214364_a
t 
MTERFD2 MTERF domain containing 2 -1.27 
10595 214372_x
_at 





KLHDC3 kelch domain containing 3 -1.56 
4586 214385_s
_at 










PIAS2 protein inhibitor of activated STAT, 2 -1.44 
9306 214462_a
t 
SOCS6 suppressor of cytokine signaling 6 -1.4 
10280 214484_s
_at 
OPRS1 opioid receptor, sigma 1 -2.11 
2488 214489_a
t 





INADL InaD-like (Drosophila) 1.64 
23404 214507_s
_at 
EXOSC2 exosome component 2 -1.47 
1053 214523_a
t 





PQBP1 polyglutamine binding protein 1 -1.65 
57152 214536_a
t 











CD7 CD7 molecule 1.42 
8368 214562_a
t 
HIST1H4L histone cluster 1, H4l 1.32 
25812 214570_x
_at 





ATP8B1 ATPase, Class I, type 8B, member 1 3.41 
3755 214595_a
t 
KCNG1 potassium voltage-gated channel, 














MEGF8 multiple EGF-like-domains 8 1.35 
91442 214816_x
_at 
C19orf40 chromosome 19 open reading frame 40 1.59 
23096 214819_a
t 
IQSEC2 IQ motif and Sec7 domain 2 1.53 
80306 214831_a
t 
MED28 mediator complex subunit 28 -1.3 
157627 214839_a
t 
LOC157627 hypothetical protein LOC157627 1.49 
 214871_x
_at 
 NA 1.58 
7067 214883_a
t 
THRA thyroid hormone receptor, alpha 
(erythroblastic leukemia viral (v-erb-a) 




HCN2 hyperpolarization activated cyclic 









ATP9B ATPase, Class II, type 9B -1.4 
23636 214935_a
t 
NUP62 nucleoporin 62kDa 1.53 
8539 214959_s
_at 
API5 apoptosis inhibitor 5 -1.62 
8539 214960_a
t 
API5 apoptosis inhibitor 5 -1.49 
2901 214966_a
t 










PIGO phosphatidylinositol glycan anchor 




USP34 ubiquitin specific peptidase 34 1.38 
2926 215030_a
t 
GRSF1 G-rich RNA sequence binding factor 1 -1.38 
79625 215059_a
t 
C4orf31 chromosome 4 open reading frame 31 1.24 





DEDD death effector domain containing -1.36 
7372 215165_x
_at 
UMPS uridine monophosphate synthetase 





TIMM17A translocase of inner mitochondrial 




FLJ11292 hypothetical protein FLJ11292 1.23 
9612 215205_x
_at 
NCOR2 nuclear receptor co-repressor 2 1.47 
2707 215243_s
_at 
GJB3 gap junction protein, beta 3, 31kDa 1.33 
92106 215262_a
t 





EMX1 empty spiracles homeobox 1 1.38 
107 215348_a
t 
ADCY1 adenylate cyclase 1 (brain) 1.31 
27043 215354_s
_at 





MAP1A microtubule-associated protein 1A 1.93 
5380 215410_a
t 





HSDL2 hydroxysteroid dehydrogenase like 2 -1.5 
200205 215490_a
t 
C1orf69 chromosome 1 open reading frame 69 1.28 
 215502_a
t 
 NA 1.62 
202559 215527_a
t 
KHDRBS2 KH domain containing, RNA binding, 




LARGE like-glycosyltransferase 1.67 
23256 215548_s
_at 
SCFD1 sec1 family domain containing 1 -1.87 
54516 215560_x
_at 





 NA 1.49 
56910 215609_a
t 
STARD7 StAR-related lipid transfer (START) 




NEUROG2 neurogenin 2 1.21 
2972 215677_s
_at 
BRF1 BRF1 homolog, subunit of RNA 
polymerase III transcription initiation 




DLX2 distal-less homeobox 2 1.65 
23469 215718_s
_at 









ANKRD53 ankyrin repeat domain 53 1.75 
55547 215778_x
_at 
HAB1 B1 for mucin 1.81 
114819 215827_x
_at 





UBC ubiquitin C -1.35 
19 215869_a
t 
ABCA1 ATP-binding cassette, sub-family A 




ZNF440 zinc finger protein 440 1.19 
23550 215923_s
_at 










GTSE1 G-2 and S-phase expressed 1 1.42 
4946 215952_s
_at 
OAZ1 ornithine decarboxylase antizyme 1 -1.99 
25859 215972_a
t 
PART1 prostate androgen-regulated transcript 1 1.48 
23187 216019_x
_at 
PHLDB1 pleckstrin homology-like domain, 




JMJD2B jumonji domain containing 2B 1.35 
23162 216137_s
_at 
MAPK8IP3 mitogen-activated protein kinase 8 




MAPK8IP3 mitogen-activated protein kinase 8 




 NA 1.1 
5609 216206_x
_at 





ADORA1 adenosine A1 receptor 1.83 
5566 216234_s
_at 





PARVB parvin, beta 1.92 
10565 216266_s
_at 
ARFGEF1 ADP-ribosylation factor guanine 





DPP6 dipeptidyl-peptidase 6 1.46 
84162 216294_s
_at 
KIAA1109 KIAA1109 -1.2 
51750 216325_x
_at 





CYP2A7P1 cytochrome P450, family 2, subfamily 





YIPF3 Yip1 domain family, member 3 -1.58 
442233 216358_a
t 
LOC442233 similar to SWI/SNF-related matrix-





FBXL18 F-box and leucine-rich repeat protein 18 1.59 
7184 216450_x
_at 










LOC120364 similar to Heterogeneous nuclear 
ribonucleoprotein A1 (Helix-
destabilizing protein) (Single-strand 
binding protein) (hnRNP core protein 





FLJ13236 hypothetical protein FLJ13236 -1.26 
2193 216602_s
_at 





MAG myelin associated glycoprotein 1.6 
6929 216645_a
t 
TCF3 transcription factor 3 (E2A 





DR1 down-regulator of transcription 1, TBP-




 NA 1.46 
5101 216707_a
t 
PCDH9 protocadherin 9 1.46 
28 216716_a
t 
ABO ABO blood group (transferase A, alpha 
1-3-N-acetylgalactosaminyltransferase; 





DCLK2 doublecortin-like kinase 2 1.22 
323 216747_a
t 
APBB2 amyloid beta (A4) precursor protein-





 NA 1.85 
 216797_a
t 
 NA 1.2 
390418 216808_a
t 
KRT18P27 keratin 27 pseudogene 27 1.41 
862 216831_s
_at 
RUNX1T1 runt-related transcription factor 1; 




DOK1 docking protein 1, 62kDa (downstream 




EPHA5 EPH receptor A5 -1.14 





HNRNPU heterogeneous nuclear 
ribonucleoprotein U (scaffold 




ATP8B2 ATPase, Class I, type 8B, member 2 1.42 
55547 216875_x
_at 
HAB1 B1 for mucin 1.95 
11155 216888_a
t 
LDB3 LIM domain binding 3 1.37 
23119 216911_s
_at 
HIC2 hypermethylated in cancer 2 1.45 
388699 216935_a
t 
C1orf46 chromosome 1 open reading frame 46 1.34 
4861 216975_x
_at 
NPAS1 neuronal PAS domain protein 1 1.5 
177 217046_s
_at 





MUC3A mucin 3A, cell surface associated 1.58 
 217055_x
_at 
 NA 1.75 
1760 217062_a
t 
DMPK dystrophia myotonica-protein kinase 1.54 
1758 217067_s
_at 













OR2H2 olfactory receptor, family 2, subfamily 




C1orf34 chromosome 1 open reading frame 34 1.59 
55727 217141_a
t 
BTBD7 BTB (POZ) domain containing 7 1.36 
2099 217163_a
t 
ESR1 estrogen receptor 1 1.22 
4586 217182_a
t 





ESR1 estrogen receptor 1 2.51 
8935 217217_a
t 
SKAP2 src kinase associated phosphoprotein 2 1.37 
283820 217225_x
_at 
NOMO2 NODAL modulator 2 -1.9 
6337 217264_s
_at 





SHOX2 short stature homeobox 2 1.44 
6474 217283_a
t 
SHOX2 short stature homeobox 2 1.51 
 217314_a
t 




 NA 2.12 
3850 217325_a
t 
KRT3 keratin 3 2.09 
22809 217389_s
_at 
ATF5 activating transcription factor 5 1.6 
 217401_a
t 
 NA 1.41 
7290 217427_s
_at 
HIRA HIR histone cell cycle regulation 




 NA 2.01 
689 217461_x
_at 
BTF3 basic transcription factor 3 1.31 
745 217462_a
t 
C11orf9 chromosome 11 open reading frame 9 1.32 
400963 217466_x
_at 
LOC400963 hypothetical gene supported by 




THRA thyroid hormone receptor, alpha 
(erythroblastic leukemia viral (v-erb-a) 




FLJ45455 FLJ45455 protein -1.14 
1890 217497_a
t 





IFIT2 interferon-induced protein with 









CRX cone-rod homeobox 1.47 
2905 217573_a
t 
GRIN2C glutamate receptor, ionotropic, N-




ZSWIM1 zinc finger, SWIM-type containing 1 -1.25 
65110 217596_a
t 
UPF3A UPF3 regulator of nonsense transcripts 









 NA -1.87 
25950 217648_a
t 
RWDD3 RWD domain containing 3 -1.18 
79784 217660_a
t 
MYH14 myosin, heavy chain 14 1.85 
9123 217685_a
t 
SLC16A3 solute carrier family 16, member 3 




IL27RA interleukin 27 receptor, alpha 2.05 
26135 217725_x
_at 
SERBP1 SERPINE1 mRNA binding protein 1 -2.2 
22818 217726_a
t 






EIF2AK1 eukaryotic translation initiation factor 














SSR3 signal sequence receptor, gamma 




NDFIP1 Nedd4 family interacting protein 1 -1.63 
51714 217811_a
t 
SELT selenoprotein T -2.24 
10492 217832_a
t 
SYNCRIP synaptotagmin binding, cytoplasmic 




C20orf24 chromosome 20 open reading frame 24 -1.91 
51428 217840_a
t 





RBM8A RNA binding motif protein 8A -1.45 
55334 217859_s
_at 
SLC39A9 solute carrier family 39 (zinc 




PREB prolactin regulatory element binding -2.57 
9328 217876_a
t 
GTF3C5 general transcription factor IIIC, 









C15orf24 chromosome 15 open reading frame 24 -1.71 
29074 217907_a
t 
MRPL18 mitochondrial ribosomal protein L18 -1.83 
6945 217910_x
_at 
MLX MAX-like protein X -1.48 
28977 217919_s
_at 
MRPL42 mitochondrial ribosomal protein L42 -2.27 
10905 217920_a
t 





PEF1 penta-EF-hand domain containing 1 -1.47 
28972 217927_a
t 
SPCS1 signal peptidase complex subunit 1 









SLC25A38 solute carrier family 25, member 38 -1.6 
7260 217968_a
t 










MRPS2 mitochondrial ribosomal protein S2 -1.49 
55069 218008_a
t 




NUP85 nucleoporin 85kDa -1.47 
55718 218016_s
_at 
POLR3E polymerase (RNA) III (DNA directed) 




ZFAND3 zinc finger, AN1-type domain 3 -1.62 
64834 218028_a
t 
ELOVL1 elongation of very long chain fatty 





UFM1 ubiquitin-fold modifier 1 -1.66 
57130 218052_s
_at 
ATP13A1 ATPase type 13A1 -1.6 
10328 218057_x
_at 
COX4NB COX4 neighbor -1.95 
51123 218059_a
t 
ZNF706 zinc finger protein 706 -1.55 
51647 218074_a
t 





FAF1 Fas (TNFRSF6) associated factor 1 -1.42 
79004 218097_s
_at 
CUEDC2 CUE domain containing 2 -1.81 
 218098_a
t 
 NA -2.02 
55148 218108_a
t 





MRPS34 mitochondrial ribosomal protein S34 -1.45 
60491 218133_s
_at 





SMAP1 stromal membrane-associated protein 1 -1.57 
8195 218138_a
t 
MKKS McKusick-Kaufman syndrome -1.75 
55745 218139_s
_at 





SCAMP2 secretory carrier membrane protein 2 -1.4 
28985 218163_a
t 
MCTS1 malignant T cell amplified sequence 1 -2.18 
55697 218169_a
t 
VAC14 Vac14 homolog (S. cerevisiae) -1.72 
60684 218179_s
_at 
FLJ12716 FLJ12716 protein -1.67 
51026 218193_s
_at 





ALG5 asparagine-linked glycosylation 5 





P15RS hypothetical protein FLJ10656 -1.84 
79083 218211_s
_at 




C12orf10 chromosome 12 open reading frame 10 -1.64 
10101 218227_a
t 
NUBP2 nucleotide binding protein 2 (MinD 




ZDHHC6 zinc finger, DHHC-type containing 6 -1.48 
79016 218260_a
t 
C19orf58 chromosome 19 open reading frame 58 -2.01 
56647 218264_a
t 





MRPL24 mitochondrial ribosomal protein L24 -1.67 
54663 218278_a
t 
WDR74 WD repeat domain 74 1.64 
51642 218281_a
t 
MRPL48 mitochondrial ribosomal protein L48 -1.67 
10762 218295_s
_at 
NUP50 nucleoporin 50kDa -1.36 
80013 218297_a
t 
C10orf97 chromosome 10 open reading frame 97 -1.51 
55851 218302_a
t 





TIMM9 translocase of inner mitochondrial 




GIYD2 GIY-YIG domain containing 2 -1.71 
9342 218327_s
_at 





COQ4 coenzyme Q4 homolog (S. cerevisiae) -1.36 
11108 218329_a
t 
PRDM4 PR domain containing 4 1.3 
51009 218333_a
t 
DERL2 Der1-like domain family, member 2 -2.06 
29093 218339_a
t 
MRPL22 mitochondrial ribosomal protein L22 -1.76 
9330 218343_s
_at 
GTF3C3 general transcription factor IIIC, 




RCBTB1 regulator of chromosome condensation 
(RCC1) and BTB (POZ) domain 




NRSN2 neurensin 2 -1.28 
53343 218375_a
t 
NUDT9 nudix (nucleoside diphosphate linked 




PGLS 6-phosphogluconolactonase -1.56 
10884 218398_a
t 
MRPS30 mitochondrial ribosomal protein S30 -2.43 
26519 218408_a
t 
TIMM10 translocase of inner mitochondrial 




VPS33B vacuolar protein sorting 33 homolog B 
(yeast) 
-1.34 





COMMD10 COMM domain containing 10 -1.63 
9054 218455_a
t 





GMCL1 germ cell-less homolog 1 (Drosophila) -1.72 
54919 218460_a
t 
HEATR2 HEAT repeat containing 2 -1.52 
54442 218474_s
_at 
KCTD5 potassium channel tetramerisation 




C16orf33 chromosome 16 open reading frame 33 -1.65 
246243 218496_a
t 
RNASEH1 ribonuclease H1 -1.87 
246243 218497_s
_at 
RNASEH1 ribonuclease H1 -1.61 
55759 218512_a
t 
WDR12 WD repeat domain 12 -1.81 
55032 218519_a
t 
SLC35A5 solute carrier family 35, member A5 -1.83 
29098 218526_s
_at 
RANGRF RAN guanine nucleotide release factor -1.34 
54840 218527_a
t 
APTX aprataxin -1.43 
55109 218534_s
_at 
AGGF1 angiogenic factor with G patch and 




MRS2L MRS2-like, magnesium homeostasis 




MRS2L MRS2-like, magnesium homeostasis 






invasion inhibitory protein 45 1.69 
54148 218558_s
_at 
MRPL39 mitochondrial ribosomal protein L39 -1.87 
55219 218562_s
_at 
TMEM57 transmembrane protein 57 -1.67 
10072 218567_x
_at 
DPP3 dipeptidyl-peptidase 3 -1.6 
54998 218580_x
_at 
AURKAIP1 aurora kinase A interacting protein 1 -1.61 
55131 218593_a
t 
RBM28 RNA binding motif protein 28 -1.4 
55127 218594_a
t 
HEATR1 HEAT repeat containing 1 -1.83 
80774 218600_a
t 
LIMD2 LIM domain containing 2 1.48 
64216 218605_a
t 
TFB2M transcription factor B2, mitochondrial -2.31 
55153 218607_s
_at 
SDAD1 SDA1 domain containing 1 -1.52 
55254 218615_s
_at 
TMEM39A transmembrane protein 39A -1.79 










FLJ13611 hypothetical protein FLJ13611 -2.07 
55813 218715_a
t 
UTP6 UTP6, small subunit (SSU) processome 




CCDC51 coiled-coil domain containing 51 -1.72 
55294 218751_s
_at 





NOL9 nucleolar protein 9 -1.37 
51004 218760_a
t 
COQ6 coenzyme Q6 homolog, 









C11orf71 chromosome 11 open reading frame 71 -2.23 
54957 218794_s
_at 
TXNL4B thioredoxin-like 4B -1.55 
7145 218863_s
_at 
TNS1 tensin 1 2.13 
57180 218868_a
t 










FLJ10292 mago-nashi homolog 2 -1.69 
79724 218916_a
t 
ZNF768 zinc finger protein 768 1.72 
1486 218924_s
_at 
CTBS chitobiase, di-N-acetyl- -2.44 
79176 218938_a
t 
FBXL15 F-box and leucine-rich repeat protein 15 -1.36 
64852 218965_s
_at 





RMI1 RMI1, RecQ mediated genome 









RNMTL1 RNA methyltransferase like 1 -1.37 
60526 219008_a
t 
C2orf43 chromosome 2 open reading frame 43 -1.6 
55849 219015_s
_at 
ALG13 asparagine-linked glycosylation 13 




TPRKB TP53RK binding protein -2.21 
54956 219034_a
t 









ZNHIT2 zinc finger, HIT type 2 -1.38 
55133 219055_a
t 
SRBD1 S1 RNA binding domain 1 -1.45 
8270 219061_s
_at 
LAGE3 L antigen family, member 3 -1.61 
51072 219065_s
_at 
MEMO1 mediator of cell motility 1 -1.93 
55751 219074_a
t 
TMEM34 transmembrane protein 34 -1.62 
55105 219078_a
t 
GPATCH2 G patch domain containing 2 -1.3 
51167 219079_a
t 
CYB5R4 cytochrome b5 reductase 4 -1.46 
51005 219082_a
t 
AMDHD2 amidohydrolase domain containing 2 1.62 
55164 219083_a
t 
SHQ1 SHQ1 homolog (S. cerevisiae) -1.48 
79177 219088_s
_at 
ZNF576 zinc finger protein 576 -1.43 
51735 219112_a
t 





FKBP11 FK506 binding protein 11, 19 kDa -2.37 
51303 219118_a
t 
FKBP11 FK506 binding protein 11, 19 kDa -2.32 
7775 219123_a
t 
ZNF232 zinc finger protein 232 -1.44 
80185 219124_a
t 
C8orf41 chromosome 8 open reading frame 41 -1.37 
54482 219130_a
t 
CCDC76 coiled-coil domain containing 76 -1.87 
54995 219133_a
t 
OXSM 3-oxoacyl-ACP synthase, mitochondrial -1.92 
51163 219149_x
_at 















HSPA14 heat shock 70kDa protein 14 -1.64 
64080 219222_a
t 
RBKS ribokinase -1.52 
79634 219234_x
_at 
SCRN3 secernin 3 -1.18 
80007 219240_s
_at 
C10orf88 chromosome 10 open reading frame 88 -1.22 
80254 219242_a
t 
CEP63 centrosomal protein 63kDa -1.53 
55112 219251_s
_at 
WDR60 WD repeat domain 60 1.47 
55027 219289_a
t 




CEP76 centrosomal protein 76kDa -1.36 
64860 219335_a
t 
ARMCX5 armadillo repeat containing, X-linked 5 -1.84 
79414 219346_a
t 
LRFN3 leucine rich repeat and fibronectin type 




DIABLO diablo homolog (Drosophila) -1.38 
55086 219355_a
t 
CXorf57 chromosome X open reading frame 57 -1.2 
79796 219374_s
_at 
ALG9 asparagine-linked glycosylation 9 





DERL1 Der1-like domain family, member 1 -2.05 
79078 219406_a
t 
C1orf50 chromosome 1 open reading frame 50 -1.61 
25830 219425_a
t 
SULT4A1 sulfotransferase family 4A, member 1 1.39 
51006 219447_s
_at 
SLC35C2 solute carrier family 35, member C2 -1.32 
55703 219459_a
t 





GIN1 gypsy retrotransposon integrase 1 -1.43 
79070 219479_a
t 
KDELC1 KDEL (Lys-Asp-Glu-Leu) containing 1 -1.89 
7733 219495_s
_at 
ZNF180 zinc finger protein 180 -1.26 
23529 219500_a
t 
CLCF1 cardiotrophin-like cytokine factor 1 1.39 
10045 219513_s
_at 
SH2D3A SH2 domain containing 3A 1.25 
59341 219516_a
t 
TRPV4 transient receptor potential cation 









ZNF16 zinc finger protein 16 1.4 
55812 219583_s
_at 
SPATA7 spermatogenesis associated 7 1.32 
51134 219644_a
t 
CCDC41 coiled-coil domain containing 41 -1.28 
29929 219649_a
t 
ALG6 asparagine-linked glycosylation 6 










 NA -1.48 
56920 219689_a
t 
SEMA3G sema domain, immunoglobulin domain 
(Ig), short basic domain, secreted, 
(semaphorin) 3G 
1.42 










MGC4093 hypothetical protein MGC4093 1.76 
594855 219775_s
_at 
CPLX3 complexin 3 1.43 
79791 219785_s
_at 
FBXO31 F-box protein 31 -1.49 
55796 219814_a
t 
MBNL3 muscleblind-like 3 (Drosophila) -2.21 
55147 219816_s
_at 
RBM23 RNA binding motif protein 23 -1.38 
9617 219822_a
t 










RCAN3 RCAN family member 3 1.11 
64116 219869_s
_at 
SLC39A8 solute carrier family 39 (zinc 




CRNKL1 crooked neck pre-mRNA splicing 




KLHL12 kelch-like 12 (Drosophila) -1.23 
51022 219933_a
t 
GLRX2 glutaredoxin 2 -1.61 
79442 219949_a
t 
LRRC2 leucine rich repeat containing 2 -1.97 
26230 219950_s
_at 





C11orf73 chromosome 11 open reading frame 73 -2.03 
26277 220052_s
_at 





XAGE1D X antigen family, member 1D 1.67 
79807 220063_a
t 










ZNF659 zinc finger protein 659 1.42 
54850 220127_s
_at 
FBXL12 F-box and leucine-rich repeat protein 12 -1.69 
65980 220155_s
_at 
BRD9 bromodomain containing 9 1.48 
80067 220172_a
t 
C2orf37 chromosome 2 open reading frame 37 -1.12 
25803 220192_x
_at 











NSFL1C NSFL1 (p97) cofactor (p47) -1.67 
80231 220252_x
_at 
CXorf21 chromosome X open reading frame 21 1.73 
9597 220263_a
t 





IL17B interleukin 17B 1.58 
58157 220337_a
t 
NGB neuroglobin 1.81 
80267 220342_x
_at 





SAP130 Sin3A-associated protein, 130kDa -1.46 
11147 220387_s
_at 
HHLA3 HERV-H LTR-associating 3 -1.58 
22992 220410_s
_at 
FBXL11 F-box and leucine-rich repeat protein 11 1.15 
79444 220451_s
_at 





SLC16A8 solute carrier family 16, member 8 














BCAS3 breast carcinoma amplified sequence 3 1.43 
2974 220506_a
t 
GUCY1B2 guanylate cyclase 1, soluble, beta 2 1.25 
550 220525_s
_at 
AUP1 ancient ubiquitous protein 1 -1.72 
55237 220536_a
t 










IGF2AS insulin-like growth factor 2 antisense 1.74 
54905 220562_a
t 
CYP2W1 cytochrome P450, family 2, subfamily 




C6orf97 chromosome 6 open reading frame 97 1.13 
79092 220598_a
t 





SIRT2 sirtuin (silent mating type information 




TH1L TH1-like (Drosophila) -1.56 
53944 220640_a
t 
CSNK1G1 casein kinase 1, gamma 1 1.34 
51088 220682_s
_at 
KLHL5 kelch-like 5 (Drosophila) -1.15 
11173 220705_s
_at 
ADAMTS7 ADAM metallopeptidase with 





ADAMTS7 ADAM metallopeptidase with 




 NA 1.16 
55768 220742_s
_at 
NGLY1 N-glycanase 1 -1.51 
55065 220756_s
_at 
GPR172B G protein-coupled receptor 172B 1.4 
55293 220775_s
_at 










PRG2 plasticity-related gene 2 2.57 
 220837_a
t 
 NA 1.09 
23590 220865_s
_at 
PDSS1 prenyl (decaprenyl) diphosphate 




WDR19 WD repeat domain 19 -1.86 
80267 220926_s
_at 














SETD2 SET domain containing 2 1.42 
81624 220997_s
_at 
DIAPH3 diaphanous homolog 3 (Drosophila) -1.12 
81033 221023_s
_at 
KCNH6 potassium voltage-gated channel, 




TDRKH tudor and KH domain containing -1.15 
55239 221090_s
_at 
OGFOD1 2-oxoglutarate and iron-dependent 









HRASLS2 HRAS-like suppressor 2 1.29 
29919 221190_s
_at 
C18orf8 chromosome 18 open reading frame 8 -1.92 
51136 221194_s
_at 
LOC51136 PTD016 protein -1.59 
79184 221196_x
_at 





SCT secretin 1.66 
55118 221204_s
_at 
CRTAC1 cartilage acidic protein 1 1.29 
54964 221222_s
_at 
C1orf56 chromosome 1 open reading frame 56 -1.31 
1154 221223_x
_at 











COQ3 coenzyme Q3 homolog, 




FLJ20628 hypothetical protein FLJ20628 -1.66 
81567 221253_s
_at 
TXNDC5 thioredoxin domain containing 5 -1.91 
83460 221255_s
_at 
TMEM93 transmembrane protein 93 -1.89 
81926 221267_s
_at 





SRC v-src sarcoma (Schmidt-Ruppin A-2) 




ULBP2 UL16 binding protein 2 1.25 
50943 221333_a
t 
FOXP3 forkhead box P3 1.51 
2848 221363_x
_at 
GPR25 G protein-coupled receptor 25 1.25 
10316 221383_a
t 
NMUR1 neuromedin U receptor 1 1.67 
64106 221387_a
t 
NPFFR1 neuropeptide FF receptor 1 1.5 
27179 221404_a
t 





PCDHB12 protocadherin beta 12 1.42 
56132 221410_x
_at 
PCDHB3 protocadherin beta 3 1.39 
56123 221450_x
_at 
PCDHB13 protocadherin beta 13 1.51 
51271 221490_a
t 
UBAP1 ubiquitin associated protein 1 -1.42 
54471 221516_s
_at 
SMCR7L Smith-Magenis syndrome chromosome 




PRPF18 PRP18 pre-mRNA processing factor 18 




COX15 COX15 homolog, cytochrome c oxidase 




CDC14B CDC14 cell division cycle 14 homolog 




HSPC171 HSPC171 protein -1.5 
60626 221647_s
_at 
RIC8A resistance to inhibitors of cholinesterase 




MED18 mediator complex subunit 18 -1.39 
55726 221652_s
_at 
C12orf11 chromosome 12 open reading frame 11 -1.55 
27034 221669_s
_at 
ACAD8 acyl-Coenzyme A dehydrogenase 
family, member 8 
-1.79 





ABHD6 abhydrolase domain containing 6 -2.54 
1290 221730_a
t 
COL5A2 collagen, type V, alpha 2 1.69 
56005 221739_a
t 
C19orf10 chromosome 19 open reading frame 10 -2.51 
54915 221741_s
_at 
YTHDF1 YTH domain family, member 1 -1.55 
93436 221758_a
t 
ARMC6 armadillo repeat containing 6 -1.49 
54431 221782_a
t 





C6orf120 chromosome 6 open reading frame 120 -2.74 
5238 221788_a
t 
PGM3 phosphoglucomutase 3 -2.39 
11021 221819_a
t 
RAB35 RAB35, member RAS oncogene family -1.45 
10616 221827_a
t 
RBCK1 RanBP-type and C3HC4-type zinc 




 NA -1.78 
23232 221858_a
t 
TBC1D12 TBC1 domain family, member 12 -1.36 
27147 221885_a
t 
DENND2A DENN/MADD domain containing 2A 1.41 
57863 221921_s
_at 
CADM3 cell adhesion molecule 3 1.47 
51526 221954_a
t 





KRT8P12 keratin 8 pseudogene 12 1.71 
80755 222064_s
_at 





 NA 1.57 
64419 222143_s
_at 
MTMR14 myotubularin related protein 14 -1.35 
55288 222148_s
_at 
RHOT1 ras homolog gene family, member T1 -1.47 
79029 222163_s
_at 
SPATA5L1 spermatogenesis associated 5-like 1 -1.76 
4848 222182_s
_at 





LOC389517 Williams Beuren syndrome 




MRPL17 mitochondrial ribosomal protein L17 -1.56 
55500 222262_s
_at 
ETNK1 ethanolamine kinase 1 -2.38 
6141 222297_x
_at 
RPL18 ribosomal protein L18 1.62 





LOC643224 similar to tubulin, beta 8 1.14 
347853 222377_a
t 
TBX10 T-box 10 1.46 
9684 32062_at LRRC14 leucine rich repeat containing 14 1.26 
10555 32837_at AGPAT2 1-acylglycerol-3-phosphate O-
acyltransferase 2 (lysophosphatidic acid 
acyltransferase, beta) 
-1.97 
5939 34187_at RBMS2 RNA binding motif, single stranded 
interacting protein 2 
1.22 
23395 34764_at LARS2 leucyl-tRNA synthetase 2, 
mitochondrial 
-1.62 
203069 35156_at R3HCC1 R3H domain and coiled-coil containing 
1 
-1.43 
26229 35179_at B3GAT3 beta-1,3-glucuronyltransferase 3 
(glucuronosyltransferase I) 
1.51 
7067 35846_at THRA thyroid hormone receptor, alpha 
(erythroblastic leukemia viral (v-erb-a) 
oncogene homolog, avian) 
1.29 
1497 36566_at CTNS cystinosis, nephropathic -1.59 
4285 36830_at MIPEP mitochondrial intermediate peptidase -1.47 
7264 36936_at TSTA3 tissue specific transplantation antigen 
P35B 
-2.03 
527 36994_at ATP6V0C ATPase, H+ transporting, lysosomal 
16kDa, V0 subunit c 
-1.64 
23349 37566_at KIAA1045 KIAA1045 1.17 
8629 37872_at JRK jerky homolog (mouse) 1.4 
360 39248_at AQP3 aquaporin 3 (Gill blood group) -2.39 
80003 39650_s_
at 
PCNXL2 pecanex-like 2 (Drosophila) 1.56 
9416 40465_at DDX23 DEAD (Asp-Glu-Ala-Asp) box 
polypeptide 23 
-1.63 
254531 40472_at AGPAT7 1-acylglycerol-3-phosphate O-
acyltransferase 7 (lysophosphatidic acid 
acyltransferase, eta) 
1.6 
55101 45828_at FLJ10241 hypothetical protein FLJ10241 -1.46 
11108 49485_at PRDM4 PR domain containing 4 1.28 
54976 50314_i_
at 
C20orf27 chromosome 20 open reading frame 27 1.26 
79959 52285_f_
at 
CEP76 centrosomal protein 76kDa -1.62 
55337 53720_at FLJ11286 hypothetical protein FLJ11286 -1.95 
57787 55065_at MARK4 MAP/microtubule affinity-regulating 
kinase 4 
-2.26 
85377 55081_at MICALL1 MICAL-like 1 -1.5 
63916 55692_at ELMO2 engulfment and cell motility 2 -1.45 
2767 564_at GNA11 guanine nucleotide binding protein (G 
protein), alpha 11 (Gq class) 
-1.54 
63897 65493_at HEATR6 HEAT repeat containing 6 1.17 
63935 89948_at C20orf67 chromosome 20 open reading frame 67 1.23 
 104 





































Supplemental Table 2-  Genes Significantly Different Between HCV Cirrhotic Tissue 







Affy ID  Symbol  Gene Name  Fold  
7318 1294_at UBE1L ubiquitin-activating enzyme E1-like 1.36 
 105 
7067 1316_at THRA thyroid hormone receptor, alpha 
(erythroblastic leukemia viral (v-erb-a) 
oncogene homolog, avian) 
-1.31 
6352 1405_i_at CCL5 chemokine (C-C motif) ligand 5 4.71 
4323 160020_a
t 




















RPL18 ribosomal protein L18 1.38 
1655 200033_a
t 










WDR1 WD repeat domain 1 1.45 
9782 200624_s
_at 
MATR3 matrin 3 1.46 
5792 200635_s
_at 





YWHAZ tyrosine 3-monooxygenase/tryptophan 5-










CTSA cathepsin A 1.49 
9804 200662_s
_at 
TOMM20 translocase of outer mitochondrial 




XBP1 X-box binding protein 1 -1.54 
2896 200678_x
_at 
GRN granulin 1.58 
5518 200695_a
t 
PPP2R1A protein phosphatase 2 (formerly 2A), 




HK1 hexokinase 1 1.89 
10577 200701_a
t 
NPC2 Niemann-Pick disease, type C2 1.83 
6500 200711_s
_at 





MAPRE1 microtubule-associated protein, RP/EB 




MAPRE1 microtubule-associated protein, RP/EB 




ACTR1A ARP1 actin-related protein 1 homolog 




RPL10 ribosomal protein L10 -1.25 















TPP1 tripeptidyl peptidase I 1.44 
2782 200746_s
_at 
GNB1 guanine nucleotide binding protein (G 




SFRS2 splicing factor, arginine/serine-rich 2 1.67 
813 200757_s
_at 
CALU calumenin -1.54 
10550 200760_s
_at 
ARL6IP5 ADP-ribosylation-like factor 6 




ARL6IP5 ADP-ribosylation-like factor 6 




2-Sep septin 2 1.82 
2778 200780_x
_at 
GNAS GNAS complex locus 1.46 
4035 200785_s
_at 





PEA15 phosphoprotein enriched in astrocytes 15 2.38 
6136 200809_x
_at 
RPL12 ribosomal protein L12 1.56 
1153 200811_a
t 
CIRBP cold inducible RNA binding protein 2.01 
6209 200819_s
_at 
RPS15 ribosomal protein S15 1.48 
6159 200823_x
_at 
RPL29 ribosomal protein L29 1.43 
6633 200826_a
t 










NCOR1 nuclear receptor co-repressor 1 -1.71 
1718 200862_a
t 
DHCR24 24-dehydrocholesterol reductase -2.18 
8766 200863_s
_at 





S100A10 S100 calcium binding protein A10 2.5 
7385 200883_a
t 





STAT1 signal transducer and activator of 















AHCY S-adenosylhomocysteine hydrolase -1.57 
3133 200904_a
t 





EIF4A2 eukaryotic translation initiation factor 











DCTN2 dynactin 2 (p50) 1.3 
6191 200933_x
_at 
RPS4X ribosomal protein S4, X-linked 1.28 
473 200940_s
_at 





GLUD1 glutamate dehydrogenase 1 -2.2 
6224 200949_x
_at 
RPS20 ribosomal protein S20 1.45 
894 200953_s
_at 
CCND2 cyclin D2 2.09 
6386 200958_s
_at 
SDCBP syndecan binding protein (syntenin) 1.63 
22928 200961_a
t 
SEPHS2 selenophosphate synthetase 2 -1.65 
6160 200962_a
t 
RPL31 ribosomal protein L31 2.38 
6160 200963_x
_at 
RPL31 ribosomal protein L31 1.43 
5538 200975_a
t 
PPT1 palmitoyl-protein thioesterase 1 (ceroid-






Tax1 (human T-cell leukemia virus type 




MDH1 malate dehydrogenase 1, NAD (soluble) 1.49 
2778 200981_x
_at 
GNAS GNAS complex locus 1.51 
966 200983_x
_at 















HADHB hydroxyacyl-Coenzyme A 
dehydrogenase/3-ketoacyl-Coenzyme A 
thiolase/enoyl-Coenzyme A hydratase 




RPN1 ribophorin I -2.12 
3187 201031_s
_at 





















MYL9 myosin, light chain 9, regulatory 3.9 
23451 201070_x
_at 
SF3B1 splicing factor 3b, subunit 1, 155kDa 1.8 
23451 201071_x
_at 
SF3B1 splicing factor 3b, subunit 1, 155kDa 1.72 
5931 201092_a
t 
RBBP7 retinoblastoma binding protein 7 1.39 
7057 201108_s
_at 
THBS1 thrombospondin 1 2.52 
7057 201109_s
_at 
THBS1 thrombospondin 1 4 
1363 201116_s
_at 
CPE carboxypeptidase E 2.26 
3693 201125_s
_at 
ITGB5 integrin, beta 5 1.65 
7078 201147_s
_at 
TIMP3 TIMP metallopeptidase inhibitor 3 





MBNL1 muscleblind-like (Drosophila) 1.64 
4836 201159_s
_at 
NMT1 N-myristoyltransferase 1 -1.33 
9698 201164_s
_at 
PUM1 pumilio homolog 1 (Drosophila) 1.41 
25793 201178_a
t 
FBXO7 F-box protein 7 1.6 
1108 201182_s
_at 





LRPAP1 low density lipoprotein receptor-related 




RPL3 ribosomal protein L3 1.37 
1488 201218_a
t 
CTBP2 C-terminal binding protein 2 3.1 
7832 201235_s
_at 
BTG2 BTG family, member 2 1.74 
7832 201236_s
_at 
BTG2 BTG family, member 2 2.37 
6513 201249_a
t 
SLC2A1 solute carrier family 2 (facilitated 




BGN biglycan 2.23 
 201265_a
t 
 NA -1.25 
231 201272_a
t 
AKR1B1 aldo-keto reductase family 1, member 











Rho GDP dissociation inhibitor (GDI) 
beta 
3.1 





EIF4A3 eukaryotic translation initiation factor 




ANP32B acidic (leucine-rich) nuclear 


















SWI/SNF related, matrix associated, 
actin dependent regulator of chromatin, 



















UBE2D2 ubiquitin-conjugating enzyme E2D 2 






solute carrier family 9 (sodium/hydrogen 




ZFP36L2 zinc finger protein 36, C3H type-like 2 2.01 
1665 201386_s
_at 





RBM5 RNA binding motif protein 5 1.6 
10181 201395_a
t 
RBM5 RNA binding motif protein 5 1.41 
4259 201403_s
_at 
MGST3 microsomal glutathione S-transferase 3 1.44 
6173 201406_a
t 
RPL36A ribosomal protein L36a 1.57 
4676 201414_s
_at 
NAP1L4 nucleosome assembly protein 1-like 4 1.5 
6659 201416_a
t 
SOX4 SRY (sex determining region Y)-box 4 1.86 
6659 201417_a
t 
SOX4 SRY (sex determining region Y)-box 4 7.29 
1809 201431_s
_at 
DPYSL3 dihydropyrimidinase-like 3 2.09 
8729 201439_a
t 





BUB3 BUB3 budding uninhibited by 




JUN jun oncogene 3.77 
6829 201480_s
_at 





CTSC cathepsin C 2.08 
4629 201497_x
_at 




PFDN1 prefoldin subunit 1 1.6 
10146 201514_s
_at 
G3BP1 GTPase activating protein (SH3 domain) 




CBX1 chromobox homolog 1 (HP1 beta 









UBE2N ubiquitin-conjugating enzyme E2N 




ATP6V1F ATPase, H+ transporting, lysosomal 









FHL1 four and a half LIM domains 1 1.87 
2273 201540_a
t 
FHL1 four and a half LIM domains 1 2.08 
3916 201553_s
_at 





PODXL podocalyxin-like 2.13 
2195 201579_a
t 










IFITM1 interferon induced transmembrane 






protein phosphatase 1, regulatory 






protein phosphatase 1, regulatory 






protein phosphatase 1, regulatory 




AP1G2 adaptor-related protein complex 1, 




CALD1 caldesmon 1 2.12 
1209 201640_x
_at 
CLPTM1 cleft lip and palate associated 




BST2 bone marrow stromal cell antigen 2 2.55 
3880 201650_a
t 






















CCND3 cyclin D3 1.93 
10424 201701_s PGRMC2 progesterone receptor membrane -1.67 
 111 
_at component 2 
2037 201718_s
_at 





LAPTM5 lysosomal associated multispanning 




LAPTM5 lysosomal associated multispanning 









ECE1 endothelin converting enzyme 1 -1.58 
3073 201765_s
_at 
HEXA hexosaminidase A (alpha polypeptide) 1.45 
23394 201773_a
t 















VARS valyl-tRNA synthetase -1.37 
7407 201797_s
_at 
VARS valyl-tRNA synthetase -1.86 
26509 201798_s
_at 
FER1L3 fer-1-like 3, myoferlin (C. elegans) 3.51 
2022 201809_s
_at 





TOMM7 translocase of outer mitochondrial 




GBAS glioblastoma amplified sequence 1.66 
3852 201820_a
t 













RYBP RING1 and YY1 binding protein 1.62 
23429 201846_s
_at 
RYBP RING1 and YY1 binding protein 1.67 
1281 201852_x
_at 
COL3A1 collagen, type III, alpha 1 (Ehlers-










ABCE1 ATP-binding cassette, sub-family E 




ARIH1 ariadne homolog, ubiquitin-conjugating 














TINP1 TGF beta-inducible nuclear protein 1 1.56 
3074 201944_a
t 
HEXB hexosaminidase B (beta polypeptide) 1.46 
9987 201993_x
_at 





DYNLT1 dynein, light chain, Tctex-type 1 1.78 
7082 202011_a
t 





EIF1 eukaryotic translation initiation factor 1 1.78 
23466 202048_s
_at 
CBX6 chromobox homolog 6 -1.54 
8500 202065_s
_at 
PPFIA1 protein tyrosine phosphatase, receptor 
type, f polypeptide (PTPRF), interacting 




SEC14L1 SEC14-like 1 (S. cerevisiae) 1.91 
6397 202084_s
_at 
SEC14L1 SEC14-like 1 (S. cerevisiae) 1.83 
4599 202086_a
t 
MX1 myxovirus (influenza virus) resistance 1, 




SLC39A6 solute carrier family 39 (zinc 




SLC39A6 solute carrier family 39 (zinc 














COPS8 COP9 constitutive photomorphogenic 









NEDD9 neural precursor cell expressed, 




UBAC1 UBA domain containing 1 -1.37 
7392 202152_x
_at 




















PPP1R2 protein phosphatase 1, regulatory 




VEZF1 vascular endothelial zinc finger 1 1.94 
7716 202172_a
t 
VEZF1 vascular endothelial zinc finger 1 1.47 





DKK3 dickkopf homolog 3 (Xenopus laevis) 2.52 
10123 202206_a
t 
ARL4C ADP-ribosylation factor-like 4C 2.61 
3703 202223_a
t 
STT3A STT3, subunit of the 
oligosaccharyltransferase complex, 




NNMT nicotinamide N-methyltransferase -1.51 
9129 202251_a
t 
PRPF3 PRP3 pre-mRNA processing factor 3 




CD2BP2 CD2 (cytoplasmic tail) binding protein 2 1.27 
23219 202271_a
t 
FBXO28 F-box protein 28 -1.95 
11313 202292_x
_at 
LYPLA2 lysophospholipase II -1.5 
65117 202302_s
_at 
RSRC2 arginine/serine-rich coiled-coil 2 1.65 
1277 202310_s
_at 
COL1A1 collagen, type I, alpha 1 4.09 
10277 202317_s
_at 





GGPS1 geranylgeranyl diphosphate synthase 1 1.45 
10919 202326_a
t 












SNX19 sorting nexin 19 -1.48 
35 202366_a
t 
ACADS acyl-Coenzyme A dehydrogenase, C-2 




CBFB core-binding factor, beta subunit 1.99 
79921 202371_a
t 





HD huntingtin (Huntington disease) -1.41 
10409 202391_a
t 
BASP1 brain abundant, membrane attached 




COL1A2 collagen, type I, alpha 2 3.42 
3429 202411_a
t 
IFI27 interferon, alpha-inducible protein 27 21.72 
2531 202419_a
t 





IGSF3 immunoglobulin superfamily, member 3 1.43 
1545 202436_s
_at 
CYP1B1 cytochrome P450, family 1, subfamily 






















MBD2 methyl-CpG binding domain protein 2 -1.28 
79065 202492_a
t 





SLC2A3 solute carrier family 2 (facilitated 




SNAP25 synaptosomal-associated protein, 25kDa 1.64 
7127 202510_s
_at 





SPOCK2 sparc/osteonectin, cwcv and kazal-like 









MCRS1 microspherule protein 1 -1.44 
4140 202568_s
_at 












S100A13 S100 calcium binding protein A13 2.12 
2776 202615_a
t 
GNAQ guanine nucleotide binding protein (G 
















SERTA domain containing 2 2.07 
5699 202659_a
t 
PSMB10 proteasome (prosome, macropain) 




SLC39A7 solute carrier family 39 (zinc 




RASA1 RAS p21 protein activator (GTPase 




AXL AXL receptor tyrosine kinase 2.75 
1327 202698_x
_at 





FMOD fibromodulin 2.48 
11142 202732_a
t 
PKIG protein kinase (cAMP-dependent, 




PIK3R3 phosphoinositide-3-kinase, regulatory 




SLC20A2 solute carrier family 20 (phosphate 
transporter), member 2 
-1.35 





ITM2A integral membrane protein 2A 1.84 
7485 202749_a
t 
WRB tryptophan rich basic protein -1.64 
2200 202765_s
_at 
FBN1 fibrillin 1 1.73 
2200 202766_s
_at 
FBN1 fibrillin 1 2.72 
901 202769_a
t 
CCNG2 cyclin G2 2.21 
901 202770_s
_at 
CCNG2 cyclin G2 1.66 
5019 202780_a
t 
OXCT1 3-oxoacid CoA transferase 1 1.61 
4701 202785_a
t 
NDUFA7 NADH dehydrogenase (ubiquinone) 1 









TRIOBP TRIO and F-actin binding protein 1.62 
3689 202803_s
_at 
ITGB2 integrin, beta 2 (complement component 









serpin peptidase inhibitor, clade A 





FUCA1 fucosidase, alpha-L- 1, tissue 1.68 
5279 202846_s
_at 
PIGC phosphatidylinositol glycan anchor 




GRK6 G protein-coupled receptor kinase 6 -1.64 
3576 202859_x
_at 
IL8 interleukin 8 6.26 
5187 202861_a
t 
PER1 period homolog 1 (Drosophila) 1.86 
6672 202864_s
_at 
SP100 SP100 nuclear antigen 1.62 
4938 202869_a
t 





PPP2R1B protein phosphatase 2 (formerly 2A), 




DDIT4 DNA-damage-inducible transcript 4 2.9 
1869 2028_s_at E2F1 E2F transcription factor 1 -1.36 
1520 202902_s
_at 
CTSS cathepsin S 2.96 
7466 202908_a
t 
WFS1 Wolfram syndrome 1 (wolframin) -1.6 
133 202912_a
t 




MOBKL3 MOB1, Mps One Binder kinase 




PLAGL2 pleiomorphic adenoma gene-like 2 -1.36 
3099 202934_a
t 
HK2 hexokinase 2 1.54 
713 202953_a
t 
C1QB complement component 1, q 









CAPN6 calpain 6 1.38 
2192 202995_s
_at 
FBLN1 fibulin 1 1.89 
11075 203000_a
t 
STMN2 stathmin-like 2 2.77 
11075 203001_s
_at 
STMN2 stathmin-like 2 3.23 
6776 203010_a
t 





RPL23A ribosomal protein L23a 1.47 
11319 203013_a
t 





RAB GTPase activating protein 1-like 1.8 
56951 203024_s
_at 
C5orf15 chromosome 5 open reading frame 15 1.44 
1535 203028_s
_at 
CYBA cytochrome b-245, alpha polypeptide 2.65 
5796 203038_a
t 





CHSY1 carbohydrate (chondroitin) synthase 1 2.34 
11270 203061_s
_at 










annexin A8-like 2 1.78 
4087 203075_a
t 
SMAD2 SMAD family member 2 1.7 
7058 203083_a
t 
THBS2 thrombospondin 2 2.4 
7040 203085_s
_at 
TGFB1 transforming growth factor, beta 1 2.27 
10469 203093_s
_at 
TIMM44 translocase of inner mitochondrial 




CSF1R colony stimulating factor 1 receptor, 
formerly McDonough feline sarcoma 




SLC11A2 solute carrier family 11 (proton-coupled 






SLC11A2 solute carrier family 11 (proton-coupled 





DAPK1 death-associated protein kinase 1 1.86 
3434 203153_a
t 
IFIT1 interferon-induced protein with 




RNF8 ring finger protein 8 -1.2 
10428 203166_a
t 
CFDP1 craniofacial development protein 1 1.86 
7019 203177_x
_at 
TFAM transcription factor A, mitochondrial -1.74 
9770 203185_a
t 





C1orf123 chromosome 1 open reading frame 123 1.28 
8898 203211_s
_at 
MTMR2 myotubularin related protein 2 1.76 
7088 203221_a
t 
TLE1 transducin-like enhancer of split 1 




THOP1 thimet oligopeptidase 1 -1.77 
3965 203236_s
_at 





NOTCH3 Notch homolog 3 (Drosophila) -1.29 
7405 203241_a
t 
UVRAG UV radiation resistance associated gene 1.43 
2145 203249_a
t 







CDK2-associated protein 2 -1.89 
1819 203267_s
_at 





NSMAF neutral sphingomyelinase (N-SMase) 




GBE1 glucan (1,4-alpha-), branching enzyme 1 
(glycogen branching enzyme, Andersen 










DCK deoxycytidine kinase 2.63 
25805 203304_a
t 
BAMBI BMP and activin membrane-bound 




HPS1 Hermansky-Pudlak syndrome 1 -1.26 
7050 203313_s
_at 
TGIF1 TGFB-induced factor homeobox 1 2.16 
858 203324_s
_at 
CAV2 caveolin 2 2.28 
5797 203329_a PTPRM protein tyrosine phosphatase, receptor 1.73 
 118 
t type, M 
22920 203333_a
t 










SFRS5 splicing factor, arginine/serine-rich 5 1.57 
1606 203385_a
t 
DGKA diacylglycerol kinase, alpha 80kDa 1.59 
9882 203386_a
t 










ARMCX2 armadillo repeat containing, X-linked 2 1.57 
963 203416_a
t 
CD53 CD53 molecule 3.71 
5947 203423_a
t 
RBP1 retinol binding protein 1, cellular 4.11 
4311 203435_s
_at 
MME membrane metallo-endopeptidase -2.22 
10556 203436_a
t 
RPP30 ribonuclease P/MRP 30kDa subunit 1.45 
8417 203457_a
t 
STX7 syntaxin 7 1.4 
1106 203461_a
t 





TPBG trophoblast glycoprotein 1.77 
6252 203485_a
t 
RTN1 reticulon 1 1.53 
19 203505_a
t 
ABCA1 ATP-binding cassette, sub-family A 






tumor necrosis factor receptor 









LSP1 lymphocyte-specific protein 1 1.42 
10507 203528_a
t 
SEMA4D sema domain, immunoglobulin domain 
(Ig), transmembrane domain (TM) and 





IPO13 importin 13 -1.32 
10712 203550_s
_at 
C1orf2 chromosome 1 open reading frame 2 -1.39 
2212 203561_a
t 









AGL amylo-1, 6-glucosidase, 4-alpha-
glucanotransferase (glycogen 
debranching enzyme, glycogen storage 




OFD1 oral-facial-digital syndrome 1 2.07 
4016 203570_a
t 
LOXL1 lysyl oxidase-like 1 2.2 
7709 203602_s
_at 





FCHSD2 FCH and double SH3 domains 2 1.78 
1374 203633_a
t 
CPT1A carnitine palmitoyltransferase 1A (liver) 2.96 
4281 203636_a
t 
MID1 midline 1 (Opitz/BBB syndrome) 1.96 
2077 203643_a
t 
ERF Ets2 repressor factor 1.67 
10544 203650_a
t 
PROCR protein C receptor, endothelial (EPCR) 1.97 
9896 203656_a
t 





protein kinase, cAMP-dependent, 









FRZB frizzled-related protein 3.17 
2487 203698_s
_at 
FRZB frizzled-related protein 2.12 
9654 203703_s
_at 





FZD7 frizzled homolog 7 (Drosophila) 1.83 
5142 203708_a
t 
PDE4B phosphodiesterase 4B, cAMP-specific 

















LAMA3 laminin, alpha 3 1.38 
2014 203729_a
t 
EMP3 epithelial membrane protein 3 2.27 
6503 203760_s
_at 
SLA Src-like-adaptor 1.94 
25802 203766_s
_at 
LMOD1 leiomodin 1 (smooth muscle) 1.49 
23635 203787_a
t 
SSBP2 single-stranded DNA binding protein 2 1.68 
3489 203851_a
t 
IGFBP6 insulin-like growth factor binding 
protein 6 
2.73 





NLE1 notchless homolog 1 (Drosophila) -1.3 
5293 203879_a
t 





THBD thrombomodulin 3.03 
27297 203898_a
t 





HEPH hephaestin 2.09 
8671 203908_a
t 
SLC4A4 solute carrier family 4, sodium 




CXCL9 chemokine (C-X-C motif) ligand 9 6.7 
6919 203919_a
t 
TCEA2 transcription elongation factor A (SII), 2 3.07 
9371 203943_a
t 
KIF3B kinesin family member 3B -1.57 
11120 203944_x
_at 
BTN2A1 butyrophilin, subfamily 2, member A1 1.5 
10529 203962_s
_at 
NEBL nebulette 1.66 
1317 203971_a
t 
SLC31A1 solute carrier family 31 (copper 









GNB5 guanine nucleotide binding protein (G 




PAWR PRKC, apoptosis, WT1, regulator 1.63 
1846 204014_a
t 
DUSP4 dual specificity phosphatase 4 1.74 
1846 204015_s
_at 
DUSP4 dual specificity phosphatase 4 1.58 
3039 204018_x
_at 
HBA1 hemoglobin, alpha 1 5.55 
1902 204036_a
t 
EDG2 endothelial differentiation, 










PTEN phosphatase and tensin homolog 





MVK mevalonate kinase (mevalonic aciduria) -1.49 
3394 204057_a
t 
IRF8 interferon regulatory factor 8 2.13 
5613 204061_a
t 
PRKX protein kinase, X-linked 1.6 
9583 204077_x
_at 
ENTPD4 ectonucleoside triphosphate 
diphosphohydrolase 4 
-1.41 





CD48 CD48 molecule 2.97 
132 204120_s
_at 
ADK adenosine kinase -2.56 
7305 204122_a
t 





LIG3 ligase III, DNA, ATP-dependent -1.27 
2309 204132_s
_at 
FOXO3 forkhead box O3 2.24 
10403 204162_a
t 
NDC80 NDC80 homolog, kinetochore complex 














MB myoglobin -1.4 
2766 204187_a
t 
GMPR guanosine monophosphate reductase 1.56 
951 204192_a
t 
CD37 CD37 molecule 2.58 
864 204197_s
_at 
RUNX3 runt-related transcription factor 3 1.77 
864 204198_s
_at 
RUNX3 runt-related transcription factor 3 1.98 
5783 204201_s
_at 
PTPN13 protein tyrosine phosphatase, non-







apolipoprotein B mRNA editing 









C7orf23 chromosome 7 open reading frame 23 2.57 
11010 204221_x
_at 
GLIPR1 GLI pathogenesis-related 1 (glioma) 1.78 
11010 204222_s
_at 
GLIPR1 GLI pathogenesis-related 1 (glioma) 2.58 
5549 204223_a
t 










ZNF195 zinc finger protein 195 1.5 
2313 204236_a
t 
FLI1 Friend leukemia virus integration 1 1.98 
4005 204249_s
_at 
LMO2 LIM domain only 2 (rhombotin-like 1) 1.65 
1017 204252_a
t 
CDK2 cyclin-dependent kinase 2 -1.32 
9088 204267_x
_at 






PIM2 pim-2 oncogene 1.33 
1910 204271_s
_at 
EDNRB endothelin receptor type B 2.69 
1910 204273_a
t 
EDNRB endothelin receptor type B 2.52 
5698 204279_a
t 
PSMB9 proteasome (prosome, macropain) 
subunit, beta type, 9 (large 





















PROM1 prominin 1 3.95 
1385 204312_x
_at 










RGS10 regulator of G-protein signaling 10 1.22 
6001 204319_s
_at 
RGS10 regulator of G-protein signaling 10 3.18 
4763 204325_s
_at 
NF1 neurofibromin 1 (neurofibromatosis, von 










solute carrier family 25 (mitochondrial 









solute carrier organic anion transporter 




KYNU kynureninase (L-kynurenine hydrolase) -1.6 
4128 204388_s
_at 
MAOA monoamine oxidase A -2.38 
4128 204389_a
t 
MAOA monoamine oxidase A -1.98 
55 204393_s
_at 
ACPP acid phosphatase, prostate -1.14 
2869 204396_s
_at 
GRK5 G protein-coupled receptor kinase 5 1.89 
25807 204402_a
t 
RHBDD3 rhomboid domain containing 3 -1.4 
6558 204404_a
t 
SLC12A2 solute carrier family 12 
(sodium/potassium/chloride 




SLC2A5 solute carrier family 2 (facilitated 
glucose/fructose transporter), member 5 
-1.4 





FZD1 frizzled homolog 1 (Drosophila) 2.59 
23641 204454_a
t 





GAS1 growth arrest-specific 1 5.63 
960 204490_s
_at 
CD44 CD44 molecule (Indian blood group) 1.89 
5144 204491_a
t 
PDE4D phosphodiesterase 4D, cAMP-specific 





ADCY9 adenylate cyclase 9 -1.35 
6314 204516_a
t 
ATXN7 ataxin 7 2.01 
51090 204519_s
_at 










CXCL10 chemokine (C-X-C motif) ligand 10 10.89 
2564 204537_s
_at 





NPIP nuclear pore complex interacting protein 1.41 
 204552_a
t 
 NA 1.69 
5509 204554_a
t 
PPP1R3D protein phosphatase 1, regulatory 




DZIP1 DAZ interacting protein 1 1.32 
8438 204558_a
t 
RAD54L RAD54-like (S. cerevisiae) -1.28 
51690 204559_s
_at 
LSM7 LSM7 homolog, U6 small nuclear RNA 




KLK3 kallikrein-related peptidase 3 -1.22 
8927 204586_a
t 
BSN bassoon (presynaptic cytomatrix protein) -1.19 
6781 204595_s
_at 
STC1 stanniocalcin 1 2.37 
6781 204597_x
_at 
STC1 stanniocalcin 1 2.26 
6366 204606_a
t 
CCL21 chemokine (C-C motif) ligand 21 5.35 
5336 204613_a
t 





VCAN versican 2.26 
10495 204643_s
_at 
ENOX2 ecto-NOX disulfide-thiol exchanger 2 -1.54 
6352 204655_a
t 




CD52 CD52 molecule 3.71 
4053 204682_a
t 
LTBP2 latent transforming growth factor beta 




ICAM2 intercellular adhesion molecule 2 1.59 
8910 204688_a
t 
SGCE sarcoglycan, epsilon 2.53 
3669 204698_a
t 





STOML1 stomatin (EPB72)-like 1 -1.43 
9603 204702_s
_at 










PDE4A phosphodiesterase 4A, cAMP-specific 





TAGLN3 transgelin 3 -1.4 
4495 204745_x
_at 
MT1G metallothionein 1G -2.67 
3437 204747_a
t 
IFIT3 interferon-induced protein with 




TMEM24 transmembrane protein 24 -1.39 
1102 204759_a
t 
RCBTB2 regulator of chromosome condensation 
(RCC1) and BTB (POZ) domain 











EVI2A ecotropic viral integration site 2A 4.66 
355 204780_s
_at 










SMAD7 SMAD family member 7 2.39 
1844 204794_a
t 
DUSP2 dual specificity phosphatase 2 1.64 
3134 204806_x
_at 





BTN3A3 butyrophilin, subfamily 3, member A3 2.52 
10384 204821_a
t 
BTN3A3 butyrophilin, subfamily 3, member A3 1.88 
89795 204823_a
t 
NAV3 neuron navigator 3 2.02 
2350 204829_s
_at 
FOLR2 folate receptor 2 (fetal) 1.66 
10875 204834_a
t 
























Rho GTPase activating protein 25 1.72 
3932 204891_s
_at 





AOC3 amine oxidase, copper containing 3 









SAP30 Sin3A-associated protein, 30kDa 2 
3587 204912_a
t 
IL10RA interleukin 10 receptor, alpha 2.16 
662 204930_s
_at 
BNIP1 BCL2/adenovirus E1B 19kDa 




TCF21 transcription factor 21 1.93 
27076 204952_a
t 
LYPD3 LY6/PLAUR domain containing 3 -1.3 
8406 204955_a
t 







protein tyrosine phosphatase, receptor 









GPC4 glypican 4 2.46 
2244 204988_a
t 
FGB fibrinogen beta chain -1.34 
4600 204994_a
t 





ATF5 activating transcription factor 5 -3.4 
22809 204999_s
_at 
ATF5 activating transcription factor 5 -4.49 
55922 205004_a
t 
NKRF NF-kappaB repressing factor -1.28 
10124 205020_s
_at 
ARL4A ADP-ribosylation factor-like 4A 1.44 
1080 205043_a
t 
CFTR cystic fibrosis transmembrane 
conductance regulator (ATP-binding 












5167 205066_s ENPP1 ectonucleotide -2.14 
 126 





serpin peptidase inhibitor, clade F 
(alpha-2 antiplasmin, pigment 




AOX1 aldehyde oxidase 1 -2.29 
5193 205094_a
t 
PEX12 peroxisomal biogenesis factor 12 -1.51 
2258 205110_s
_at 
FGF13 fibroblast growth factor 13 1.37 
51196 205111_s
_at 
PLCE1 phospholipase C, epsilon 1 1.24 
6348 205114_s
_at 
CCL3 chemokine (C-C motif) ligand 3 2.14 
6443 205120_s
_at 





CLCN4 chloride channel 4 -1.21 
958 205153_s
_at 
CD40 CD40 molecule, TNF receptor 




CD58 CD58 molecule 2.03 
25797 205174_s
_at 





KHK ketohexokinase (fructokinase) -1.88 
2176 205189_s
_at 





STK17B serine/threonine kinase 17b 1.93 
3556 205227_a
t 
IL1RAP interleukin 1 receptor accessory protein -2.02 
79979 205238_a
t 
CXorf34 chromosome X open reading frame 34 -1.48 
374 205239_a
t 




















POU class 2 associating factor 1 3.65 
3937 205269_a
t 
LCP2 lymphocyte cytosolic protein 2 (SH2 





LCP2 lymphocyte cytosolic protein 2 (SH2 





CDC14A CDC14 cell division cycle 14 homolog 








BAIAP2 BAI1-associated protein 2 -1.48 
6645 205315_s
_at 
SNTB2 syntrophin, beta 2 (dystrophin-associated 




KIF5A kinesin family member 5A -1.43 
5816 205336_a
t 
PVALB parvalbumin -1.23 
2593 205354_a
t 
GAMT guanidinoacetate N-methyltransferase -1.96 
9472 205359_a
t 
AKAP6 A kinase (PRKA) anchor protein 6 -1.33 
10234 205381_a
t 
LRRC17 leucine rich repeat containing 17 2.52 
26137 205383_s
_at 





DCLK1 doublecortin-like kinase 1 1.26 
8434 205407_a
t 
RECK reversion-inducing-cysteine-rich protein 




BMP5 bone morphogenetic protein 5 1.38 
22848 205434_s
_at 
AAK1 AP2 associated kinase 1 1.56 
5617 205445_a
t 
PRL prolactin -1.27 
29901 205449_a
t 
SAC3D1 SAC3 domain containing 1 -1.74 
9957 205466_s
_at 





AMBP alpha-1-microglobulin/bikunin precursor -1.32 
9636 205483_s
_at 
ISG15 ISG15 ubiquitin-like modifier 7.65 
3001 205488_a
t 
GZMA granzyme A (granzyme 1, cytotoxic T-




GJB3 gap junction protein, beta 3, 31kDa -1.18 
10570 205492_s
_at 
DPYSL4 dihydropyrimidinase-like 4 -1.27 
55786 205514_a
t 




















runt-related transcription factor 1; 










STEAP1 six transmembrane epithelial antigen of 




BTG3 BTG family, member 3 2.2 
4938 205552_s
_at 















CXorf45 chromosome X open reading frame 45 1.59 
6521 205592_a
t 
SLC4A1 solute carrier family 4, anion exchanger, 
member 1 (erythrocyte membrane 









HOXB5 homeobox B5 -1.51 
51760 205613_a
t 
SYT17 synaptotagmin XVII -1.71 
79143 205634_x
_at 





SH3GL3 SH3-domain GRB2-like 3 -1.43 
577 205638_a
t 










CEP110 centrosomal protein 110kDa 1.27 
5521 205643_s
_at 
PPP2R2B protein phosphatase 2 (formerly 2A), 









FGA fibrinogen alpha chain -1.5 
722 205654_a
t 





OASL 2'-5'-oligoadenylate synthetase-like 3.18 
54039 205663_a
t 
PCBP3 poly(rC) binding protein 3 -1.46 
4065 205668_a
t 





DENN/MADD domain containing 4C 1.66 
1271 205723_a
t 
CNTFR ciliary neurotrophic factor receptor -1.43 
5317 205724_a
t 





F2 coagulation factor II (thrombin) -1.67 





KLK13 kallikrein-related peptidase 13 -1.41 
3684 205785_a
t 
ITGAM integrin, alpha M (complement 






zinc finger CCCH-type containing 11A 1.46 
7220 205802_a
t 
TRPC1 transient receptor potential cation 




TRPC1 transient receptor potential cation 




RGS12 regulator of G-protein signaling 12 -1.65 
25859 205834_s
_at 
PART1 prostate androgen-regulated transcript 1 -1.29 
2688 205840_x
_at 
GH1 growth hormone 1 -1.23 
1384 205843_x
_at 





calcium channel, voltage-dependent, T 









BDKRB2 bradykinin receptor B2 1.88 
5342 205871_a
t 
PLGLB2 plasminogen-like B2 -1.67 
5463 205878_a
t 
POU6F1 POU class 6 homeobox 1 1.43 
5979 205879_x
_at 
RET ret proto-oncogene -1.56 
4958 205907_s
_at 
OMD osteomodulin 1.7 
10223 205929_a
t 
GPA33 glycoprotein A33 (transmembrane) -1.31 
2294 205935_a
t 
FOXF1 forkhead box F1 1.36 
5166 205960_a
t 










MT3 metallothionein 3 -1.55 
3231 205975_s
_at 
HOXD1 homeobox D1 -1.24 
3600 205992_s
_at 
IL15 interleukin 15 1.57 
10863 205997_a
t 
ADAM28 ADAM metallopeptidase domain 28 1.55 
3680 206009_a
t 
ITGA9 integrin, alpha 9 1.42 
834 206011_a
t 
CASP1 caspase 1, apoptosis-related cysteine 






LEFTY2 left-right determination factor 2 -1.25 
10461 206028_s
_at 
MERTK c-mer proto-oncogene tyrosine kinase 2.42 
8926 206042_x
_at 
SNURF SNRPN upstream reading frame 2.55 
26191 206060_s
_at 
PTPN22 protein tyrosine phosphatase, non-




RAD51C RAD51 homolog C (S. cerevisiae) 1.35 
2042 206071_s
_at 
EPHA3 EPH receptor A3 1.63 
1368 206100_a
t 
CPM carboxypeptidase M 2.26 
3996 206123_a
t 





MCC mutated in colorectal cancers -1.7 
5322 206178_a
t 
PLA2G5 phospholipase A2, group V 1.54 
2689 206195_x
_at 
GH2 growth hormone 2 -1.3 
8382 206197_a
t 
NME5 non-metastatic cells 5, protein expressed 




ANXA11 annexin A11 1.92 
1358 206212_a
t 
CPA2 carboxypeptidase A2 (pancreatic) -1.3 
7941 206214_a
t 
PLA2G7 phospholipase A2, group VII (platelet-





KCNN1 potassium intermediate/small 
conductance calcium-activated channel, 






UDP-Gal:betaGlcNAc beta 1,4- 




AVPR1A arginine vasopressin receptor 1A -1.68 
552 206252_s
_at 
AVPR1A arginine vasopressin receptor 1A -1.56 
4922 206291_a
t 
NTS neurotensin 2.01 
3606 206295_a
t 





ABCB8 ATP-binding cassette, sub-family B 









solute carrier organic anion transporter 




XCL1 chemokine (C motif) ligand 1 1.93 
5294 206370_a
t 








retinoic acid receptor responder 




DGKG diacylglycerol kinase, gamma 90kDa -1.14 
9623 206413_s
_at 
TCL1B T-cell leukemia/lymphoma 1B -1.29 
1044 206430_a
t 
CDX1 caudal type homeobox 1 -1.39 
6010 206454_s
_at 
RHO rhodopsin (opsin 2, rod pigment) 





MT1H metallothionein 1H -1.78 
4948 206498_a
t 
OCA2 oculocutaneous albinism II (pink-eye 




PIP prolactin-induced protein -1.4 
946 206520_x
_at 
SIGLEC6 sialic acid binding Ig-like lectin 6 -1.33 
6862 206524_a
t 





aldo-keto reductase family 1, member 




PHF20 PHD finger protein 20 1.32 
23643 206584_a
t 
LY96 lymphocyte antigen 96 2.94 
1269 206586_a
t 
CNR2 cannabinoid receptor 2 (macrophage) -1.51 
23178 206594_a
t 





SLC16A5 solute carrier family 16, member 5 




GDF5 growth differentiation factor 5 -1.35 
5961 206625_a
t 





ADAMTS-like 2 1.87 
7299 206630_a
t 
TYR tyrosinase (oculocutaneous albinism IA) -1.28 
5732 206631_a
t 















SCAMP1 secretory carrier membrane protein 1 1.63 
40 206690_a
t 







pancreatic lipase-related protein 1 -1.29 





EDNRB endothelin receptor type B 2.68 
1140 206703_a
t 





C6orf32 chromosome 6 open reading frame 32 1.24 
23546 206719_a
t 
SYNGR4 synaptogyrin 4 -1.21 
9170 206723_s
_at 
EDG4 endothelial differentiation, 





C9 complement component 9 -1.87 
432 206743_s
_at 
ASGR1 asialoglycoprotein receptor 1 -2.01 
2572 206780_a
t 
GAD2 glutamate decarboxylase 2 (pancreatic 




FGF4 fibroblast growth factor 4 (heparin 





DLEC1 deleted in lung and esophageal cancer 1 -1.41 
917 206804_a
t 





ADD2 adducin 2 (beta) -1.5 
3268 206821_x
_at 
HRBL HIV-1 Rev binding protein-like -1.37 
2566 206849_a
t 
GABRG2 gamma-aminobutyric acid (GABA) A 




GNG7 guanine nucleotide binding protein (G 




CDH19 cadherin 19, type 2 4.91 
9023 206932_a
t 
CH25H cholesterol 25-hydroxylase 2.78 
8499 206973_a
t 
PPFIA2 protein tyrosine phosphatase, receptor 
type, f polypeptide (PTPRF), interacting 




ATP5S ATP synthase, H+ transporting, 





TSC22D3 TSC22 domain family, member 3 2.54 
5325 207002_s
_at 
PLAGL1 pleiomorphic adenoma gene-like 1 2.16 
1144 207024_a
t 





v-myc myelocytomatosis viral related 
oncogene, neuroblastoma derived 










SLC30A3 solute carrier family 30 (zinc 




THRB thyroid hormone receptor, beta 
(erythroblastic leukemia viral (v-erb-a) 




KRT75 keratin 75 -1.38 
10001 207079_s
_at 
MED6 mediator complex subunit 6 1.81 
1438 207085_x
_at 






PFDN5 prefoldin subunit 5 1.96 
5253 207138_a
t 
PHF2 PHD finger protein 2 -1.33 
9555 207168_s
_at 
H2AFY H2A histone family, member Y 1.53 
780 207169_x
_at 





LETMD1 LETM1 domain containing 1 1.52 
1009 207173_x
_at 

















carcinoembryonic antigen-related cell 




SPINK4 serine peptidase inhibitor, Kazal type 4 -1.26 
2158 207218_a
t 
F9 coagulation factor IX (plasma 
thromboplastic component, Christmas 









PLA2G10 phospholipase A2, group X -1.26 
5788 207238_s
_at 





LEPR leptin receptor 3.07 
319 207262_a
t 
APOF apolipoprotein F -2.59 
5937 207266_x
_at 
RBMS1 RNA binding motif, single stranded 









CASQ2 calsequestrin 2 (cardiac muscle) -1.51 
5858 207330_a
t 
PZP pregnancy-zone protein -3.63 





ATP12A ATPase, H+/K+ transporting, 









ADAM20 ADAM metallopeptidase domain 20 -1.27 
7101 207443_a
t 





GYPB glycophorin B (MNS blood group) -1.32 
4295 207473_a
t 
MLN motilin -1.32 
11119 207485_x
_at 
BTN3A1 butyrophilin, subfamily 3, member A1 1.39 
7743 207513_s
_at 
ZNF189 zinc finger protein 189 1.72 
7982 207524_a
t 
ST7 suppression of tumorigenicity 7 -1.56 
3565 207538_a
t 















DGKQ diacylglycerol kinase, theta 110kDa -1.26 
9473 207571_x
_at 
C1orf38 chromosome 1 open reading frame 38 1.87 
4018 207584_a
t 
LPA lipoprotein, Lp(a) -4.5 
147 207589_a
t 
ADRA1B adrenergic, alpha-1B-, receptor -1.41 
649 207595_s
_at 





transmembrane protease, serine 11D -1.45 
1390 207630_s
_at 
CREM cAMP responsive element modulator 2.52 
8928 207644_a
t 
FOXH1 forkhead box H1 -1.45 
9085 207646_s
_at 
CDY1 chromodomain protein, Y-linked, 1 -1.3 
1821 207648_a
t 
DRP2 dystrophin related protein 2 -1.47 
3891 207670_a
t 
KRT85 keratin 85 -1.35 
953 207691_x
_at 





NCOA3 nuclear receptor coactivator 3 1.96 
59344 207708_a
t 
ALOXE3 arachidonate lipoxygenase 3 -1.48 





LOR loricrin -1.18 
1741 207732_s
_at 





PSG9 pregnancy specific beta-1-glycoprotein 9 -1.31 
10721 207746_a
t 
POLQ polymerase (DNA directed), theta -1.16 
 207748_a
t 
 NA -1.39 
57343 207753_a
t 
ZNF304 zinc finger protein 304 1.43 
6524 207771_a
t 
SLC5A2 solute carrier family 5 (sodium/glucose 









PROS1 protein S (alpha) -1.58 
3399 207826_s
_at 
ID3 inhibitor of DNA binding 3, dominant 




BNIP1 BCL2/adenovirus E1B 19kDa 




FBLN1 fibulin 1 -1.44 
22794 207842_s
_at 
CASC3 cancer susceptibility candidate 3 1.42 
1142 207859_s
_at 





calcium channel, voltage-dependent, T 




KRT76 keratin 76 -1.29 
3000 207884_a
t 





TGM5 transglutaminase 5 -1.44 
417 207919_a
t 
ART1 ADP-ribosyltransferase 1 -1.59 
1473 207925_a
t 
CST5 cystatin D -1.24 
2925 207929_a
t 
GRPR gastrin-releasing peptide receptor -1.35 
7783 207933_a
t 





RBM39 RNA binding motif protein 39 1.53 
1453 207945_s
_at 
CSNK1D casein kinase 1, delta 1.73 
288 207950_s
_at 
ANK3 ankyrin 3, node of Ranvier (ankyrin G) 1.41 
5579 207957_s
_at 




IFNA4 interferon, alpha 4 -1.17 
23177 207971_s
_at 
CEP68 centrosomal protein 68kDa 1.25 
8013 207978_s
_at 





ACRV1 acrosomal vesicle protein 1 -1.15 
272 207992_s
_at 





ADARB1 adenosine deaminase, RNA-specific, B1 




 NA -1.34 
3431 208012_x
_at 
SP110 SP110 nuclear body protein 1.66 
56 208013_s
_at 
ACRV1 acrosomal vesicle protein 1 -1.16 
118 208030_s
_at 
ADD1 adducin 1 (alpha) 1.8 
5990 208031_s
_at 
RFX2 regulatory factor X, 2 (influences HLA 




GRM6 glutamate receptor, metabotropic 6 -1.26 
4607 208040_s
_at 
MYBPC3 myosin binding protein C, cardiac -1.42 
835 208050_s
_at 
CASP2 caspase 2, apoptosis-related cysteine 






PSG6 pregnancy specific beta-1-glycoprotein 6 -1.47 
554 208108_s
_at 
AVPR2 arginine vasopressin receptor 2 




PTGIS prostaglandin I2 (prostacyclin) synthase 3.38 
54504 208146_s
_at 
CPVL carboxypeptidase, vitellogenic-like 3.16 
4622 208148_a
t 







oxysterol binding protein-like 1A 1.68 
3804 208179_x
_at 
KIR2DL3 killer cell immunoglobulin-like receptor, 




IFNA14 interferon, alpha 14 -1.2 
 208187_s
_at 
 NA -1.19 
3857 208188_a
t 





LSR lipolysis stimulated lipoprotein receptor -1.5 
859 208204_s
_at 




ALK anaplastic lymphoma kinase (Ki-1) -1.14 
3211 208224_a
t 
HOXB1 homeobox B1 -1.54 
53616 208226_x
_at 
ADAM22 ADAM metallopeptidase domain 22 -1.21 
53616 208227_x
_at 
ADAM22 ADAM metallopeptidase domain 22 -1.29 
53616 208237_x
_at 
ADAM22 ADAM metallopeptidase domain 22 -1.26 
3444 208259_x
_at 





CDRT1 CMT1A duplicated region transcript 1 -1.39 
26659 208285_a
t 
OR7A5 olfactory receptor, family 7, subfamily 




BMP10 bone morphogenetic protein 10 -1.2 
25816 208296_x
_at 





XYLB xylulokinase homolog (H. influenzae) -1.41 
312 208323_s
_at 
ANXA13 annexin A13 2.49 
11214 208325_s
_at 








MID2 midline 2 -1.39 
2740 208391_s
_at 
GLP1R glucagon-like peptide 1 receptor -1.15 
5136 208396_s
_at 










TUB tubby homolog (mouse) -1.22 
3957 208450_a
t 
LGALS2 lectin, galactoside-binding, soluble, 2 2.18 
10052 208460_a
t 
GJA7 gap junction protein, alpha 7, 45kDa -1.34 
3250 208471_a
t 
HPR haptoglobin-related protein -3.01 
3736 208479_a
t 
KCNA1 potassium voltage-gated channel, 
shaker-related subfamily, member 1 




DRD5 dopamine receptor D5 -1.35 
26532 208520_a
t 
OR10H3 olfactory receptor, family 10, subfamily 












serpin peptidase inhibitor, clade A 














similar to Putative S100 calcium-binding 






histone cluster 1, H1e -1.14 
4161 208565_a
t 
MC5R melanocortin 5 receptor -1.33 
6336 208578_a
t 





FKSG2 apoptosis inhibitor -1.2 
1270 208597_a
t 
CNTF ciliary neurotrophic factor -1.32 
7148 208609_s
_at 
TNXB tenascin XB 1.44 
7430 208621_s
_at 
VIL2 villin 2 (ezrin) 2.29 
7430 208622_s
_at 
VIL2 villin 2 (ezrin) 2.25 
23499 208634_s
_at 
MACF1 microtubule-actin crosslinking factor 1 1.68 
5879 208640_a
t 
RAC1 ras-related C3 botulinum toxin substrate 





RAC1 ras-related C3 botulinum toxin substrate 





RPS14 ribosomal protein S14 1.41 
934 208651_x
_at 
CD24 CD24 molecule 3.74 
3151 208668_x
_at 
HMGN2 high-mobility group nucleosomal 






ATPase, H+ transporting, lysosomal 




ARPC2 actin related protein 2/3 complex, 




MAGED2 melanoma antigen family D, 2 1.69 
6046 208686_s
_at 
BRD2 bromodomain containing 2 1.35 
9124 208690_s
_at 
PDLIM1 PDZ and LIM domain 1 (elfin) 1.69 
3646 208697_s
_at 










EIF2S2 eukaryotic translation initiation factor 2, 
subunit 2 beta, 38kDa 
-1.45 
998 208728_s CDC42 cell division cycle 42 (GTP binding 1.47 
 139 
_at protein, 25kDa) 
3106 208729_x
_at 





CTDSP2 CTD (carboxy-terminal domain, RNA 










eukaryotic translation initiation factor 4E 














HMGB2 high-mobility group box 2 3.07 
3107 208812_x
_at 







annexin A2 pseudogene 2 1.63 
6147 208825_x
_at 
RPL23A ribosomal protein L23a 1.47 
6147 208834_x
_at 
RPL23A ribosomal protein L23a 1.37 
8428 208854_s
_at 










ATRX alpha thalassemia/mental retardation 





PAK2 p21 (CDKN1A)-activated kinase 2 -1.34 
5062 208877_a
t 
PAK2 p21 (CDKN1A)-activated kinase 2 -1.77 
23062 208915_s
_at 
GGA2 golgi associated, gamma adaptin ear 




NXF1 nuclear RNA export factor 1 2.11 
56650 208925_a
t 
CLDND1 claudin domain containing 1 2.06 
7048 208944_a
t 
TGFBR2 transforming growth factor, beta 




CRIP2 cysteine-rich protein 2 1.78 
7316 208980_s
_at 
UBC ubiquitin C 1.34 
5175 208981_a
t 
PECAM1 platelet/endothelial cell adhesion 




PECAM1 platelet/endothelial cell adhesion 




PECAM1 platelet/endothelial cell adhesion 










8-Sep septin 8 1.58 
57035 209006_s
_at 
C1orf63 chromosome 1 open reading frame 63 2.9 
57035 209007_s
_at 
C1orf63 chromosome 1 open reading frame 63 2.91 
3856 209008_x
_at 





chromosome 20 open reading frame 111 1.64 
10735 209022_a
t 
STAG2 stromal antigen 2 1.55 
23705 209030_s
_at 
CADM1 cell adhesion molecule 1 1.71 
9061 209043_a
t 





ZMYND8 zinc finger, MYND-type containing 8 1.94 
7381 209066_x
_at 





RGS5 regulator of G-protein signaling 5 2.37 
8490 209071_s
_at 















CORO1A coronin, actin binding protein, 1A 2.26 
26959 209102_s
_at 
HBP1 HMG-box transcription factor 1 1.51 
5863 209110_s
_at 





TSPAN1 tetraspanin 1 -1.41 
3043 209116_x
_at 





COMM domain containing 4 -1.23 
8575 209139_s
_at 
PRKRA protein kinase, interferon-inducible 












core-binding factor, runt domain, alpha 






Tax1 (human T-cell leukemia virus type 




COL6A2 collagen, type VI, alpha 2 2.93 





IRS2 insulin receptor substrate 2 1.66 
84617 209191_a
t 
TUBB6 tubulin, beta 6 3.14 
5292 209193_a
t 
PIM1 pim-1 oncogene -1.81 
4208 209199_s
_at 
MEF2C myocyte enhancer factor 2C 2.45 
4208 209200_a
t 
MEF2C myocyte enhancer factor 2C 1.87 
688 209211_a
t 
KLF5 Kruppel-like factor 5 (intestinal) 1.6 
688 209212_s
_at 
KLF5 Kruppel-like factor 5 (intestinal) 1.71 
7991 209228_x
_at 
TUSC3 tumor suppressor candidate 3 1.81 
8473 209240_a
t 







SFN stratifin -1.32 
7106 209263_x
_at 
TSPAN4 tetraspanin 4 1.88 
56339 209265_s
_at 
METTL3 methyltransferase like 3 1.59 
81689 209273_s
_at 












ID4 inhibitor of DNA binding 4, dominant 




SWAP70 SWAP-70 protein 2.82 
23075 209307_a
t 
SWAP70 SWAP-70 protein 1.91 
5325 209318_x
_at 
PLAGL1 pleiomorphic adenoma gene-like 1 2.1 
109 209320_a
t 
ADCY3 adenylate cyclase 3 1.23 
109 209321_s
_at 
ADCY3 adenylate cyclase 3 1.23 
7171 209344_a
t 
TPM4 tropomyosin 4 2.43 
30008 209356_x
_at 
EFEMP2 EGF-containing fibulin-like extracellular 




PCBP4 poly(rC) binding protein 4 1.36 
1893 209365_s
_at 
ECM1 extracellular matrix protein 1 1.7 
306 209369_a
t 
ANXA3 annexin A3 5.32 





TM4SF1 transmembrane 4 L six family member 1 2.91 
4071 209387_s
_at 
TM4SF1 transmembrane 4 L six family member 1 2.99 
1622 209389_x
_at 
DBI diazepam binding inhibitor (GABA 










IFI35 interferon-induced protein 35 1.87 
51230 209422_a
t 
PHF20 PHD finger protein 20 2.03 
7542 209428_s
_at 
ZFPL1 zinc finger protein-like 1 -1.52 
10418 209436_a
t 
SPON1 spondin 1, extracellular matrix protein 2.15 
3039 209458_x
_at 
HBA1 hemoglobin, alpha 1 6.16 
18 209459_s
_at 
ABAT 4-aminobutyrate aminotransferase -1.86 
18 209460_a
t 
ABAT 4-aminobutyrate aminotransferase -2.03 
5764 209465_x
_at 
PTN pleiotrophin (heparin binding growth 





PTN pleiotrophin (heparin binding growth 





GPM6A glycoprotein M6A 3.75 
2823 209470_s
_at 
GPM6A glycoprotein M6A 2.87 
 209473_a
t 
 NA 1.44 
953 209474_s
_at 










pleckstrin homology domain containing, 























PPAP2C phosphatidic acid phosphatase type 2C 1.68 
11214 209534_x
_at 
AKAP13 A kinase (PRKA) anchor protein 13 1.91 
30844 209536_s
_at 






Rac/Cdc42 guanine nucleotide exchange 









NDN necdin homolog (mouse) 1.98 
23179 209568_s
_at 







apolipoprotein B mRNA editing 




PSG9 pregnancy specific beta-1-glycoprotein 9 -1.37 
10687 209598_a
t 
PNMA2 paraneoplastic antigen MA2 1.45 
2625 209604_s
_at 
GATA3 GATA binding protein 3 1.32 
1501 209617_s
_at 
CTNND2 catenin (cadherin-associated protein), 





OSBPL3 oxysterol binding protein-like 3 1.5 
6002 209639_s
_at 
RGS12 regulator of G-protein signaling 12 -1.33 
7041 209651_a
t 
TGFB1I1 transforming growth factor beta 1 




TMEM47 transmembrane protein 47 1.76 
28755 209670_a
t 
TRAC T cell receptor alpha constant 2.74 
868 209682_a
t 
CBLB Cas-Br-M (murine) ecotropic retroviral 









PRKCB1 protein kinase C, beta 1 2.04 
27340 209725_a
t 
UTP20 UTP20, small subunit (SSU) processome 



















SP110 SP110 nuclear body protein 2.33 
3431 209762_x
_at 
SP110 SP110 nuclear body protein 1.92 
91851 209763_a
t 
CHRDL1 chordin-like 1 1.84 
11119 209770_a
t 
BTN3A1 butyrophilin, subfamily 3, member A1 2.03 
6573 209777_s
_at 
SLC19A1 solute carrier family 19 (folate 
transporter), member 1 
-1.65 
10473 209787_s HMGN4 high mobility group nucleosomal 1.98 
 144 





DNA cross-link repair 1A (PSO2 




TRGV9 T cell receptor gamma variable 9 1.53 
5727 209815_a
t 





major histocompatibility complex, class 




CD44 CD44 molecule (Indian blood group) 1.8 
11118 209846_s
_at 
BTN3A2 butyrophilin, subfamily 3, member A2 2.47 
5937 209868_s
_at 
RBMS1 RNA binding motif, single stranded 




ADRA2A adrenergic, alpha-2A-, receptor 1.75 
54805 209874_x
_at 
CNNM2 cyclin M2 -1.32 
6404 209879_a
t 
SELPLG selectin P ligand 1.38 
6016 209882_a
t 
RIT1 Ras-like without CAAX 1 1.49 
2526 209892_a
t 





SLIT2 slit homolog 2 (Drosophila) 1.81 
199 209901_x
_at 
AIF1 allograft inflammatory factor 1 2.29 
719 209906_a
t 
C3AR1 complement component 3a receptor 1 1.86 
11314 209933_s
_at 
CD300A CD300a molecule 1.68 
7424 209946_a
t 
VEGFC vascular endothelial growth factor C 1.84 
9898 209947_a
t 
UBAP2L ubiquitin associated protein 2-like -1.3 
2191 209955_s
_at 
FAP fibroblast activation protein, alpha 1.97 
6772 209969_s
_at 
STAT1 signal transducer and activator of 




CASP1 caspase 1, apoptosis-related cysteine 





ABCB1 ATP-binding cassette, sub-family B 




ABCB1 ATP-binding cassette, sub-family B 




HPX hemopexin -1.68 
9576 210033_s
_at 




KCNAB1 potassium voltage-gated channel, 




ELA3A elastase 3A, pancreatic -1.4 
7177 210084_x
_at 
TPSAB1 tryptase alpha/beta 1 2.46 
4635 210088_x
_at 















C7orf54 chromosome 7 open reading frame 54 -1.52 
26140 210129_s
_at 





SHOX2 short stature homeobox 2 -1.27 
8530 210140_a
t 















NFATC1 nuclear factor of activated T-cells, 




GZMB granzyme B (granzyme 2, cytotoxic T-




SEC14L5 SEC14-like 5 (S. cerevisiae) -1.17 
27295 210170_a
t 
PDLIM3 PDZ and LIM domain 3 1.75 
2494 210174_a
t 










TFR2 transferrin receptor 2 -1.91 
6672 210218_s
_at 
SP100 SP100 nuclear antigen 2.02 
25816 210260_s
_at 





TRIOBP TRIO and F-actin binding protein 1.75 
10605 210283_x
_at 





FHL1 four and a half LIM domains 1 1.82 
2273 210299_s
_at 
FHL1 four and a half LIM domains 1 2.48 
2250 210311_a
t 
FGF5 fibroblast growth factor 5 -1.23 
3817 210339_s
_at 










DNAH9 dynein, axonemal, heavy chain 9 -1.25 
2002 210376_x
_at 
ELK1 ELK1, member of ETS oncogene family -1.41 
8549 210393_a
t 
LGR5 leucine-rich repeat-containing G protein-




























RHD Rh blood group, D antigen -1.39 
6738 210438_x
_at 










GPR125 G protein-coupled receptor 125 -2.67 
5618 210476_s
_at 
PRLR prolactin receptor -1.33 
3135 210514_x
_at 





 NA -2.4 
7278 210527_x
_at 
TUBA3C tubulin, alpha 3c -1.53 
1488 210554_s
_at 
CTBP2 C-terminal binding protein 2 1.94 
26118 210561_s
_at 
WSB1 WD repeat and SOCS box-containing 1 2.02 
2642 210565_a
t 
GCGR glucagon receptor -1.58 
6007 210586_x
_at 
RHD Rh blood group, D antigen -1.32 
1837 210611_s
_at 
DTNA dystrobrevin, alpha 1.12 
5251 210617_a
t 
PHEX phosphate regulating endopeptidase 
homolog, X-linked (hypophosphatemia, 




KLHL20 kelch-like 20 (Drosophila) 1.45 
2852 210640_s
_at 
GPER G protein-coupled estrogen receptor 1 -2.11 
5414 210657_s
_at 
4-Sep septin 4 1.83 
8302 210690_a
t 
KLRC4 killer cell lectin-like receptor subfamily 





WWOX WW domain containing oxidoreductase -1.4 
 210717_a
t 
 NA 1.44 
4149 210734_x
_at 
MAX MYC associated factor X 1.42 
8671 210738_s
_at 
SLC4A4 solute carrier family 4, sodium 




TRIP11 thyroid hormone receptor interactor 11 -1.27 
9473 210785_s
_at 
C1orf38 chromosome 1 open reading frame 38 2.54 
946 210796_x
_at 
SIGLEC6 sialic acid binding Ig-like lectin 6 -1.28 
10587 210803_a
t 
TXNRD2 thioredoxin reductase 2 -1.27 
6546 210804_x
_at 
SLC8A1 solute carrier family 8 (sodium/calcium 


























HFE hemochromatosis -1.35 
1949 210883_x
_at 
EFNB3 ephrin-B3 -1.4 
3697 210888_s
_at 
ITIH1 inter-alpha (globulin) inhibitor H1 -2.03 
960 210916_s
_at 
CD44 CD44 molecule (Indian blood group) 1.32 
10439 210924_a
t 
OLFM1 olfactomedin 1 -1.48 
25998 210970_s
_at 





PFKM phosphofructokinase, muscle 1.75 
427 210980_s
_at 





TPM1 tropomyosin 1 (alpha) 2.56 
9783 210991_s
_at 
























MAP4K5 mitogen-activated protein kinase kinase 




STK4 serine/threonine kinase 4 1.63 
6528 211123_a
t 
SLC5A5 solute carrier family 5 (sodium iodide 




THPO thrombopoietin (myeloproliferative 
leukemia virus oncogene ligand, 





COL3A1 collagen, type III, alpha 1 (Ehlers-





HIATL1 hippocampus abundant transcript-like 1 1.63 
2492 211201_a
t 
FSHR follicle stimulating hormone receptor -1.19 
8756 211238_a
t 
ADAM7 ADAM metallopeptidase domain 7 -1.2 
6005 211254_x
_at 
RHAG Rh-associated glycoprotein -1.28 
8021 211261_a
t 
NUP214 nucleoporin 214kDa -1.42 
5046 211262_a
t 





GRN granulin 1.61 
7316 211296_x
_at 
UBC ubiquitin C 1.31 
10076 211320_s
_at 





HFE hemochromatosis -1.28 
3702 211339_s
_at 
ITK IL2-inducible T-cell kinase 3.9 
4162 211340_s
_at 
MCAM melanoma cell adhesion molecule 2.16 
3953 211354_s
_at 
LEPR leptin receptor 4.08 
3953 211355_x
_at 
LEPR leptin receptor 3.72 
3953 211356_x
_at 
LEPR leptin receptor 3.92 
834 211366_x
_at 
CASP1 caspase 1, apoptosis-related cysteine 





CASP1 caspase 1, apoptosis-related cysteine 







sperm associated antigen 11B -1.29 
 211388_s
_at 




FGFR2 fibroblast growth factor receptor 2 
(bacteria-expressed kinase, keratinocyte 
growth factor receptor, craniofacial 
dysostosis 1, Crouzon syndrome, 










serpin peptidase inhibitor, clade A 










TRHR thyrotropin-releasing hormone receptor -1.53 
84227 211446_a
t 





MT1P2 metallothionein 1 pseudogene 2 -1.48 
23654 211472_a
t 





serpin peptidase inhibitor, clade B 




NKX3-1 NK3 homeobox 1 -1.31 
9475 211504_x
_at 
ROCK2 Rho-associated, coiled-coil containing 




IL8 interleukin 8 3.82 
3135 211528_x
_at 















FGFR1 fibroblast growth factor receptor 1 (fms-












guanylate cyclase 1, soluble, beta 3 1.72 
901 211559_s
_at 
CCNG2 cyclin G2 1.6 
1462 211571_s
_at 
VCAN versican 2.6 
1136 211587_x
_at 
CHRNA3 cholinergic receptor, nicotinic, alpha 3 -1.37 
84525 211597_s
_at 
HOP homeodomain-only protein 1.75 
367 211621_a
t 
AR androgen receptor (dihydrotestosterone 
receptor; testicular feminization; spinal 








UDP-Gal:betaGlcNAc beta 1,4- 




IGHG1 immunoglobulin heavy constant gamma 




























immunoglobulin heavy variable 1-69 2.69 
 211641_x
_at 
 NA 1.65 
3514 211643_x
_at 
IGKC immunoglobulin kappa constant 5.3 
3514 211644_x
_at 
IGKC immunoglobulin kappa constant 16.04 
3500 211647_x
_at 
IGHG1 immunoglobulin heavy constant gamma 




IGHG1 immunoglobulin heavy constant gamma 




IL8 interleukin 8 2.99 
7001 211658_a
t 
PRDX2 peroxiredoxin 2 -1.31 
7417 211662_s
_at 
VDAC2 voltage-dependent anion channel 2 1.72 
5730 211663_x
_at 
PTGDS prostaglandin D2 synthase 21kDa (brain) 3.35 
2908 211671_s
_at 
NR3C1 nuclear receptor subfamily 3, group C, 









HBB hemoglobin, beta 6.06 
3039 211699_x
_at 
HBA1 hemoglobin, alpha 1 5.78 
83941 211703_s
_at 





SPIN2B spindlin family, member 2B 1.24 
644 211729_x
_at 
BLVRA biliverdin reductase A 2.39 
2205 211734_s
_at 
FCER1A Fc fragment of IgE, high affinity I, 




PTN pleiotrophin (heparin binding growth 









EVI2B ecotropic viral integration site 2B 2.98 
3040 211745_x
_at 
HBA2 hemoglobin, alpha 2 5.33 
9341 211749_s
_at 










IGLJ3 immunoglobulin lambda joining 3 5.5 
3107 211799_x
_at 










SLC8A1 solute carrier family 8 (sodium/calcium 






immunoglobulin heavy variable 4-31 1.36 
2778 211858_x
_at 
GNAS GNAS complex locus 1.84 
26509 211864_s
_at 
FER1L3 fer-1-like 3, myoferlin (C. elegans) 1.62 
2537 211868_x
_at 
IFI6 interferon, alpha-inducible protein 6 2.92 
56145 211870_s
_at 
PCDHA3 protocadherin alpha 3 -1.37 
6955 211902_x
_at 
TRA@ T cell receptor alpha locus 1.39 
3576 211908_x
_at 
IL8 interleukin 8 2.17 
3106 211911_x
_at 




















H3F3A H3 histone, family 3A 1.51 
23215 211944_a
t 
BAT2D1 BAT2 domain containing 1 1.94 
10092 211963_s
_at 
ARPC5 actin related protein 2/3 complex, 




COL4A2 collagen, type IV, alpha 2 2.64 
 211973_a
t 
 NA -1.42 
57720 211977_a
t 
GPR107 G protein-coupled receptor 107 -1.53 
1282 211981_a
t 





SWI/SNF related, matrix associated, 
actin dependent regulator of chromatin, 
1.42 
 152 
subfamily e, member 1 
3021 211997_x
_at 
H3F3B H3 histone, family 3B (H3.3B) 1.86 
3021 211998_a
t 
H3F3B H3 histone, family 3B (H3.3B) 1.66 
3021 211999_a
t 
H3F3B H3 histone, family 3B (H3.3B) 2.07 
4288 212021_s
_at 





RPL3 ribosomal protein L3 1.33 
6157 212044_s
_at 
RPL27A ribosomal protein L27a 1.69 
960 212063_a
t 
CD44 CD44 molecule (Indian blood group) 4.61 
715 212067_s
_at 





UNC84A unc-84 homolog A (C. elegans) 1.65 
800 212077_a
t 
CALD1 caldesmon 1 1.41 
4297 212080_a
t 
MLL myeloid/lymphoid or mixed-lineage 





SLC25A6 solute carrier family 25 (mitochondrial 





LMNA lamin A/C 1.78 
26284 212087_s
_at 
ERAL1 Era G-protein-like 1 (E. coli) -1.39 
857 212097_a
t 
CAV1 caveolin 1, caveolae protein, 22kDa 3.12 
23633 212102_s
_at 
KPNA6 karyopherin alpha 6 (importin alpha 7) -1.22 
23673 212111_a
t 
STX12 syntaxin 12 1.47 
10209 212130_x
_at 
EIF1 eukaryotic translation initiation factor 1 1.65 
23244 212140_a
t 
PDS5A PDS5, regulator of cohesion 









PBX1 pre-B-cell leukemia homeobox 1 2.92 
23126 212153_a
t 







RNF187 ring finger protein 187 -1.58 
161 212161_a
t 









FKBP9 FK506 binding protein 9, 63 kDa 1.63 
204 212172_a
t 
AK2 adenylate kinase 2 -1.3 
204 212173_a
t 
AK2 adenylate kinase 2 -1.29 
1399 212180_a
t 















INTS1 integrator complex subunit 1 -1.42 
10209 212227_x
_at 
EIF1 eukaryotic translation initiation factor 1 1.9 
23014 212231_a
t 
FBXO21 F-box protein 21 1.6 
23360 212232_a
t 
FNBP4 formin binding protein 4 1.85 
 212233_a
t 
 NA 1.94 
57326 212259_s
_at 
PBXIP1 pre-B-cell leukemia homeobox 




SFRS5 splicing factor, arginine/serine-rich 5 1.72 
2778 212273_x
_at 





AGRN agrin -1.41 
23048 212288_a
t 





KIAA0746 protein 3.49 
23534 212318_a
t 
TNPO3 transportin 3 1.45 
55000 212337_a
t 
TUG1 taurine upregulated gene 1 1.66 
23036 212366_a
t 










TCF4 transcription factor 4 2.22 
9686 212399_s
_at 
VGLL4 vestigial like 4 (Drosophila) 1.75 
23157 212415_a
t 
6-Sep septin 6 1.67 
1997 212418_a
t 










NEDD4L neural precursor cell expressed, 



















chromosome 14 open reading frame 147 1.96 
966 212463_a
t 





TPM4 tropomyosin 4 1.95 
1289 212488_a
t 
COL5A1 collagen, type V, alpha 1 2.42 
1289 212489_a
t 
COL5A1 collagen, type V, alpha 1 1.49 
23171 212510_a
t 





STK38L serine/threonine kinase 38 like 1.62 
23347 212579_a
t 
SMCHD1 structural maintenance of chromosomes 






OSBPL8 oxysterol binding protein-like 8 2.05 
831 212586_a
t 
CAST calpastatin 1.66 
5788 212587_s
_at 





HMG2L1 high-mobility group protein 2-like 1 1.62 
11118 212613_a
t 
BTN3A2 butyrophilin, subfamily 3, member A2 1.7 
84159 212614_a
t 





ZNF609 zinc finger protein 609 -1.31 
8417 212632_a
t 
STX7 syntaxin 7 1.81 
11059 212637_s
_at 
WWP1 WW domain containing E3 ubiquitin 




HIVEP2 human immunodeficiency virus type I 









CEP68 centrosomal protein 68kDa 2.21 
23177 212677_s
_at 
CEP68 centrosomal protein 68kDa 2.08 
3987 212687_a
t 
















pleckstrin homology domain containing, 




JMJD6 jumonji domain containing 6 1.65 
55000 212725_s
_at 
TUG1 taurine upregulated gene 1 1.83 
23294 212747_a
t 
ANKS1A ankyrin repeat and sterile alpha motif 




PCGF3 polycomb group ring finger 3 1.38 
6935 212764_a
t 
ZEB1 zinc finger E-box binding homeobox 1 1.72 
51574 212785_s
_at 




















pleckstrin homology domain containing, 





HEG1 HEG homolog 1 (zebrafish) 1.28 
8939 212824_a
t 





SLC25A6 solute carrier family 25 (mitochondrial 





IGHM immunoglobulin heavy constant mu 1.89 
8871 212828_a
t 
SYNJ2 synaptojanin 2 1.67 
23526 212873_a
t 
HMHA1 histocompatibility (minor) HA-1 1.55 
3831 212878_s
_at 
KLC1 kinesin light chain 1 1.72 
29 212895_s
_at 
ABR active BCR-related gene 1.3 
56950 212922_s
_at 
SMYD2 SET and MYND domain containing 2 1.91 
23158 212956_a
t 





USP34 ubiquitin specific peptidase 34 1.89 
 212985_a
t 





major histocompatibility complex, class 






angiopoietin-like 2 1.61 
4798 213028_a
t 











rho/rac guanine nucleotide exchange 




ROCK1 Rho-associated, coiled-coil containing 













coiled-coil domain containing 131 1.76 
1805 213068_a
t 
DPT dermatopontin 7.54 
57493 213069_a
t 
HEG1 HEG homolog 1 (zebrafish) 2.01 
6147 213084_x
_at 
RPL23A ribosomal protein L23a 1.51 
57211 213094_a
t 
GPR126 G protein-coupled receptor 126 -1.68 
199 213095_x
_at 
AIF1 allograft inflammatory factor 1 2.15 
23357 213099_a
t 





olfactomedin-like 2B 1.29 
10950 213134_x
_at 
BTG3 BTG family, member 3 2.15 
6591 213139_a
t 












hypothetical protein LOC257407 -1.83 
989 213151_s
_at 
7-Sep septin 7 2.02 
9037 213169_a
t 
SEMA5A sema domain, seven thrombospondin 
repeats (type 1 and type 1-like), 
transmembrane domain (TM) and short 






mitogen-activated protein kinase 8 














TRBC1 T cell receptor beta constant 1 3.15 
6091 213194_a
t 
ROBO1 roundabout, axon guidance receptor, 




TAF6L TAF6-like RNA polymerase II, 
p300/CBP-associated factor (PCAF)-





























transmembrane protein 30B 3.04 
1292 213290_a
t 
COL6A2 collagen, type VI, alpha 2 1.52 
 213294_a
t 
 NA 1.93 
53405 213317_a
t 
CLIC5 chloride intracellular channel 5 1.32 
6843 213326_a
t 





FEM1C fem-1 homolog c (C. elegans) 1.72 
3014 213344_s
_at 
H2AFX H2A histone family, member X -1.39 
1028 213348_a
t 







CA5BL carbonic anhydrase VB-like -1.34 
6642 213364_s
_at 





IQCK IQ motif containing K 1.67 
283 213397_x
_at 





 NA -1.65 
6009 213404_s
_at 
RHEB Ras homolog enriched in brain -1.39 
11037 213413_a
t 
STON1 stonin 1 2.72 
1193 213415_a
t 





CERKL ceramide kinase-like 3.32 
54587 213422_s
_at 
MXRA8 matrix-remodelling associated 8 1.47 
7991 213423_x
_at 
TUSC3 tumor suppressor candidate 3 3.29 
1291 213428_s
_at 
COL6A1 collagen, type VI, alpha 1 2.87 
23114 213438_a
t 
NFASC neurofascin homolog (chicken) 2.55 
4580 213448_a
t 
MTX1 metaxin 1 -1.31 
7148 213451_x
_at 
















ITGAL integrin, alpha L (antigen CD11A 
(p180), lymphocyte function-associated 




PPWD1 peptidylprolyl isomerase domain and 










SFRS14 splicing factor, arginine/serine-rich 14 1.39 
7329 213535_s
_at 
UBE2I ubiquitin-conjugating enzyme E2I 






major histocompatibility complex, class 













hypothetical protein DKFZp586I1420 1.71 
9470 213570_a
t 
EIF4E2 eukaryotic translation initiation factor 4E 




PDCD2 programmed cell death 2 1.45 
6585 213601_a
t 
SLIT1 slit homolog 1 (Drosophila) -1.23 
5880 213603_s
_at 
RAC2 ras-related C3 botulinum toxin substrate 





 NA -1.54 
3187 213619_a
t 





MAGED2 melanoma antigen family D, 2 1.61 
4498 213629_x
_at 
MT1JP metallothionein 1J (pseudogene) -2.6 
1723 213631_x
_at 
DHODH dihydroorotate dehydrogenase -3.3 
23016 213648_a
t 
EXOSC7 exosome component 7 -1.23 
6432 213649_a
t 

















RSBN1 round spermatid basic protein 1 1.7 
9204 213698_a
t 













hypothetical protein LOC150759 1.68 
54898 213712_a
t 
ELOVL2 elongation of very long chain fatty acids 






hypothetical protein BC008326 -1.34 
6398 213716_s
_at 
SECTM1 secreted and transmembrane 1 1.5 
2316 213746_s
_at 





SPRR1A small proline-rich protein 1A -1.19 
 213813_x
_at 
 NA 1.77 
3207 213823_a
t 
HOXA11 homeobox A11 -1.47 
3020 213828_x
_at 
H3F3A H3 histone, family 3A 1.5 
6183 213840_s
_at 
MRPS12 mitochondrial ribosomal protein S12 -1.21 
1350 213846_a
t 





collagen, type XI, alpha 2 -1.4 
83941 213882_a
t 






























CADM3 cell adhesion molecule 3 -1.19 
240 213952_s
_at 
ALOX5 arachidonate 5-lipoxygenase -1.16 
6159 213969_x
_at 


















SPON1 spondin 1, extracellular matrix protein 2.62 
10581 214022_s
_at 
IFITM2 interferon induced transmembrane 









hypothetical protein DKFZp667G2110 1.43 
4882 214066_x
_at 
NPR2 natriuretic peptide receptor B/guanylate 





NENF neuron derived neurotrophic factor -1.26 
11103 214085_x
_at 
KRR1 KRR1, small subunit (SSU) processome 




GPX3 glutathione peroxidase 3 (plasma) 1.66 
10147 214092_x
_at 
SFRS14 splicing factor, arginine/serine-rich 14 1.64 
9659 214099_s
_at 












ATP5C1 ATP synthase, H+ transporting, 





PBXIP1 pre-B-cell leukemia homeobox 




PBXIP1 pre-B-cell leukemia homeobox 




ARF6 ADP-ribosylation factor 6 1.9 
2495 214211_a
t 
FTH1 ferritin, heavy polypeptide 1 1.85 
23185 214215_s
_at 





ATP10A ATPase, Class V, type 10A -1.32 
6136 214271_x
_at 
RPL12 ribosomal protein L12 1.46 
1540 214272_a
t 















6-Sep septin 6 1.73 
23451 214305_s
_at 
SF3B1 splicing factor 3b, subunit 1, 155kDa 1.81 
6203 214317_x
_at 










ACACA acetyl-Coenzyme A carboxylase alpha -1.59 
9782 214363_s
_at 
MATR3 matrin 3 1.35 
54346 214382_a
t 














GYPB glycophorin B (MNS blood group) -1.23 
1504 214411_x
_at 
CTRB1 chymotrypsinogen B1 -1.31 
3039 214414_x
_at 
HBA1 hemoglobin, alpha 1 3.76 
1559 214419_s
_at 
CYP2C9 cytochrome P450, family 2, subfamily 




CYP2C9 cytochrome P450, family 2, subfamily 




ALDOB aldolase B, fructose-bisphosphate 1.56 
720 214428_x
_at 





IFI44 interferon-induced protein 44 4.86 
6289 214456_x
_at 
SAA2 serum amyloid A2 -3.47 
3107 214459_x
_at 





GPR65 G protein-coupled receptor 65 1.77 
3820 214470_a
t 
KLRB1 killer cell lectin-like receptor subfamily 




SPP2 secreted phosphoprotein 2, 24kDa 4.12 
4956 214485_a
t 
ODF1 outer dense fiber of sperm tails 1 -1.49 
9555 214500_a
t 
H2AFY H2A histone family, member Y 1.77 
2273 214505_s
_at 
FHL1 four and a half LIM domains 1 1.97 
10923 214512_s
_at 
SUB1 SUB1 homolog (S. cerevisiae) 1.84 
1385 214513_s
_at 





ARPP-19 cyclic AMP phosphoprotein, 19 kD 1.52 
6846 214567_s
_at 
XCL2 chemokine (C motif) ligand 2 2.13 
4131 214577_a
t 
MAP1B microtubule-associated protein 1B 1.27 
6093 214578_s
_at 
ROCK1 Rho-associated, coiled-coil containing 






tumor necrosis factor receptor 















PRF1 perforin 1 (pore forming protein) 1.64 
50488 214625_s
_at 
MINK1 misshapen-like kinase 1 (zebrafish) -1.29 
8898 214649_s
_at 
MTMR2 myotubularin related protein 2 1.42 
1195 214683_s
_at 
CLK1 CDC-like kinase 1 2.2 
10781 214686_a
t 








EXPH5 exophilin 5 -2.26 
118 214736_s
_at 
ADD1 adducin 1 (alpha) 1.62 
9349 214744_s
_at 





PLAC4 placenta-specific 4 -1.29 
2316 214752_x
_at 










WDR21A WD repeat domain 21A -1.29 
3514 214768_x
_at 
IGKC immunoglobulin kappa constant 11.95 
23164 214771_x
_at 





 NA 12.24 
26054 214790_a
t 
SENP6 SUMO1/sentrin specific peptidase 6 1.48 
23114 214799_a
t 
NFASC neurofascin homolog (chicken) 1.21 
 214807_a
t 





MOB1, Mps One Binder kinase 




 NA -1.38 
8801 214835_s
_at 












TOM1L2 target of myb1-like 2 (chicken) -1.36 
 214848_a
t 
 NA 1.16 
23105 214859_a
t 
FSTL4 follistatin-like 4 -1.26 
84444 214865_a
t 
DOT1L DOT1-like, histone H3 









hypothetical protein LOC339047 1.52 
7392 214879_x
_at 





CALD1 caldesmon 1 1.83 
6427 214882_s
_at 





carcinoembryonic antigen-related cell 








































IGHD immunoglobulin heavy constant delta 3.82 
25787 215003_a
t 





TM4SF1 transmembrane 4 L six family member 1 4.95 
199 215051_x
_at 





FMNL2 formin-like 2 1.24 
1281 215076_s
_at 
COL3A1 collagen, type III, alpha 1 (Ehlers-















KIAA0508 protein -1.28 
55619 215151_a
t 
DOCK10 dedicator of cytokinesis 10 1.17 
6925 215164_a
t 
TCF4 transcription factor 4 1.19 
53371 215213_a
t 
NUP54 nucleoporin 54kDa -1.13 
3535 215214_a
t 
IGL@ immunoglobulin lambda locus 3.1 
7266 215252_a
t 





TCF3 transcription factor 3 (E2A 






FRAG1 FGF receptor activating protein 1 -1.37 
3105 215313_x
_at 





LONRF1 LON peptidase N-terminal domain and 




CD8B CD8b molecule 1.17 
107 215340_a
t 
ADCY1 adenylate cyclase 1 (brain) -1.32 
 215344_a
t 
 NA -1.15 
8634 215351_a
t 










EXOC6B exocyst complex component 6B 1.11 
 215421_a
t 
 NA -1.26 
22938 215424_s
_at 
SNW1 SNW domain containing 1 1.49 
23333 215433_a
t 
DPY19L1 dpy-19-like 1 (C. elegans) -1.23 
56271 215440_s
_at 
BEXL1 brain expressed X-linked-like 1 2.75 
4015 215446_s
_at 
LOX lysyl oxidase 1.49 
7035 215447_a
t 













 NA -1.26 
 215477_a
t 
 NA -1.14 
10612 215484_a
t 
TRIM3 tripartite motif-containing 3 -1.56 
4610 215491_a
t 
MYCL1 v-myc myelocytomatosis viral oncogene 





BTN2A1 butyrophilin, subfamily 2, member A1 1.4 
6942 215511_a
t 
TCF20 transcription factor 20 (AR1) -1.32 
55243 215515_a
t 
KIRREL kin of IRRE like (Drosophila) -1.41 
1729 215541_s
_at 
DIAPH1 diaphanous homolog 1 (Drosophila) -1.42 
11313 215568_x
_at 




 NA -1.21 
51533 215622_x
_at 
PHF7 PHD finger protein 7 -1.34 
23348 215626_a
t 
DOCK9 dedicator of cytokinesis 9 1.2 
9849 215644_a
t 
ZNF518 zinc finger protein 518 -1.21 
1462 215646_s
_at 
VCAN versican 3.67 
5364 215668_s
_at 





KIAA1654 protein -1.22 
8733 215690_x
_at 
GPAA1 glycosylphosphatidylinositol anchor 




CFTR cystic fibrosis transmembrane 
conductance regulator (ATP-binding 




IGFALS insulin-like growth factor binding 




SLC6A2 solute carrier family 6 (neurotransmitter 




























CYP2D6 cytochrome P450, family 2, subfamily 









NUDT7 nudix (nucleoside diphosphate linked 




SYT12 synaptotagmin XII -1.27 
5322 215870_s
_at 
PLA2G5 phospholipase A2, group V 2.97 
 215906_a
t 
 NA -1.37 
971 215925_s
_at 





ADP-ribosylation factor guanine 





ZMYM5 zinc finger, MYM-type 5 1.17 
3507 215949_x
_at 
IGHM immunoglobulin heavy constant mu 2.07 
8495 215959_a
t 
PPFIBP2 PTPRF interacting protein, binding 
























CDRT1 CMT1A duplicated region transcript 1 -1.2 
55334 216011_a
t 
SLC39A9 solute carrier family 39 (zinc 









WDTC1 WD and tetratricopeptide repeats 1 -1.49 
2896 216041_x
_at 
GRN granulin 1.77 
4635 216054_x
_at 










SLC7A8 solute carrier family 7 (cationic amino 




PHLDB1 pleckstrin homology-like domain, family 




 NA -1.4 
399 216166_a
t 
RHOH ras homolog gene family, member H 1.17 
5425 216175_a
t 
POLD2 polymerase (DNA directed), delta 2, 






C1orf20 chromosome 1 open reading frame 20 -1.4 
2173 216192_a
t 
FABP7 fatty acid binding protein 7, brain -1.27 
1312 216204_a
t 












hypothetical gene supported by 




TRIOBP TRIO and F-actin binding protein 1.49 
23369 216221_s
_at 
PUM2 pumilio homolog 2 (Drosophila) 1.35 
9332 216233_a
t 
CD163 CD163 molecule 1.82 
2244 216238_s
_at 
FGB fibrinogen beta chain -1.47 
355 216252_x
_at 





SYDE1 synapse defective 1, Rho GTPase, 





BUB1 BUB1 budding uninhibited by 




MTMR1 myotubularin related protein 1 -1.24 
8629 216309_x
_at 





TUBA3D tubulin, alpha 3d -1.52 
7148 216333_x
_at 





protocadherin beta 17 pseudogene -1.37 
 216366_x
_at 
 NA -1.45 
27318 216382_s
_at 







docking protein 1-like protein -1.58 
3712 216412_x
_at 
IVD isovaleryl Coenzyme A dehydrogenase 2.46 
90011 216428_x
_at 
KIR3DX1 killer cell immunoglobulin-like receptor, 




IGL@ immunoglobulin lambda locus 2.33 
80314 216437_a
t 





IGHM immunoglobulin heavy constant mu 6.8 
 216500_a
t 












DCT dopachrome tautomerase (dopachrome 





IGKV1-5 immunoglobulin kappa variable 1-5 2.36 
3107 216526_x
_at 





 NA -1.22 
57863 216535_a
t 





immunoglobulin heavy variable 1-69 1.72 
3493 216542_x
_at 












IFI6 interferon, alpha-inducible protein 6 3.82 
 216558_x
_at 




IGL@ immunoglobulin lambda locus 5.06 
 216573_a
t 
 NA 1.43 
4917 216576_x
_at 





GJB4 gap junction protein, beta 4 -1.48 
 216582_a
t 
 NA -1.26 
1645 216594_x
_at 
AKR1C1 aldo-keto reductase family 1, member 










lysophospholipase II pseudogene 1 -1.24 
6093 216621_a
t 
ROCK1 Rho-associated, coiled-coil containing 








similar to 60S ribosomal protein L29 







C9orf106 chromosome 9 open reading frame 106 -1.42 
55764 216678_a
t 







FLJ40330 similar to protein immuno-reactive with 











OR7E47P olfactory receptor, family 7, subfamily 











similar to potassium channel 




HRH1 histamine receptor H1 -1.28 
 216757_a
t 





ankyrin repeat domain 15 -1.17 
 216774_a
t 
















 NA -1.16 
26707 216818_s
_at 











runt-related transcription factor 1; 




GYPB glycophorin B (MNS blood group) -1.22 
2064 216836_s
_at 
ERBB2 v-erb-b2 erythroblastic leukemia viral 
oncogene homolog 2, 















KIAA1660 protein -1.36 
3535 216852_x
_at 
IGL@ immunoglobulin lambda locus -1.27 
27251 216879_a
t 
HR44 Hr44 antigen -1.35 
6768 216905_s
_at 





PTPN12 protein tyrosine phosphatase, non-














TAL1 T-cell acute lymphocytic leukemia 1 -1.35 
6927 216930_a
t 
TCF1 transcription factor 1, hepatic; LF-B1, 





 NA -1.34 
51412 216978_x
_at 
ACTL6B actin-like 6B -1.11 
7767 216983_s
_at 
ZNF224 zinc finger protein 224 1.39 
3535 216984_x
_at 
IGL@ immunoglobulin lambda locus 7.09 
2918 216992_s
_at 
GRM8 glutamate receptor, metabotropic 8 -1.28 
 217018_a
t 
 NA -1.26 
 217030_a
t 
 NA -1.44 
3500 217039_x
_at 
IGHG1 immunoglobulin heavy constant gamma 




NCR2 natural cytotoxicity triggering receptor 2 -1.49 
6760 217051_s
_at 













NCR1 natural cytotoxicity triggering receptor 1 -1.29 
27445 217096_a
t 
PCLO piccolo (presynaptic cytomatrix protein) -1.23 
4507 217134_a
t 







similar to ubiquitin B precursor -2.15 
3514 217145_a
t 
IGKC immunoglobulin kappa constant 1.34 
50852 217147_s
_at 
TRAT1 T cell receptor associated 




IGL@ immunoglobulin lambda locus 10.56 
 217152_a
t 
 NA 1.57 
 217157_x
_at 







similar to Prostaglandin E2 receptor, 
EP4 subtype (Prostanoid EP4 receptor) 




MT1F metallothionein 1F -1.71 
10297 217174_s
_at 












hypothetical gene LOC96610 5.34 
1534 217200_x
_at 







similar to cytoplasmic beta-actin -1.76 
27030 217216_x
_at 
MLH3 mutL homolog 3 (E. coli) 1.26 
 217224_a
t 
 NA -1.21 
3576 217227_x
_at 
IL8 interleukin 8 5.4 
3043 217232_x
_at 
HBB hemoglobin, beta 6.65 
7430 217234_s
_at 
VIL2 villin 2 (ezrin) 1.96 
 217235_x
_at 
 NA 4.06 
3500 217236_x
_at 
IGHG1 immunoglobulin heavy constant gamma 




CPVL carboxypeptidase, vitellogenic-like 1.74 
 217249_x
_at 




IVD isovaleryl Coenzyme A dehydrogenase 4.46 
8220 217275_a
t 










NDRG3 NDRG family member 3 1.6 
27185 217330_a
t 

















major histocompatibility complex, class 




ZHX3 zinc fingers and homeoboxes 3 -1.48 
2521 217370_x
_at 









similar to Signal-regulatory protein 
gamma precursor (Signal-regulatory 





 NA 12.89 
3576 217384_x
_at 
IL8 interleukin 8 1.58 
84560 217395_a
t 
MT4 metallothionein 4 -1.54 
2309 217399_s
_at 





mitochondrial ribosomal protein S18B -1.84 
3039 217414_x
_at 
HBA1 hemoglobin, alpha 1 5.26 
1277 217430_x
_at 
COL1A1 collagen, type I, alpha 1 -1.45 
4158 217434_a
t 









hypothetical protein LOC730399 2.04 
6867 217437_s
_at 
TACC1 transforming, acidic coiled-coil 



















PTENP1 phosphatase and tensin homolog 
(mutated in multiple advanced cancers 
1), pseudogene 1 
1.62 







OLFML1 olfactomedin-like 1 2.03 
4499 217546_a
t 















POLG polymerase (DNA directed), gamma -1.21 
6834 217646_a
t 
SURF1 surfeit 1 -1.3 
2778 217673_x
_at 
GNAS GNAS complex locus 1.33 
 217676_a
t 
 NA -1.26 
5770 217686_a
t 
PTPN1 protein tyrosine phosphatase, non-




ADCY2 adenylate cyclase 2 (brain) -1.28 
7763 217741_s
_at 





GSTK1 glutathione S-transferase kappa 1 1.65 
718 217767_a
t 
C3 complement component 3 -1.26 
51280 217771_a
t 
GOLM1 golgi membrane protein 1 3.52 
51109 217776_a
t 





C19orf56 chromosome 19 open reading frame 56 1.34 
58533 217789_a
t 
SNX6 sorting nexin 6 1.33 
4848 217798_a
t 





POLDIP2 polymerase (DNA-directed), delta 






glioma tumor suppressor candidate 




ARPC4 actin related protein 2/3 complex, 




UBE2J1 ubiquitin-conjugating enzyme E2, J1 




YY1AP1 YY1 associated protein 1 1.45 
55207 217852_s
_at 
ARL8B ADP-ribosylation factor-like 8B 1.42 
25825 217867_x
_at 
BACE2 beta-site APP-cleaving enzyme 2 3.16 
51108 217868_s
_at 




PIH1D1 PIH1 domain containing 1 -1.36 
2060 217886_a
t 
EPS15 epidermal growth factor receptor 




CYBRD1 cytochrome b reductase 1 1.81 
55742 217890_s
_at 
PARVA parvin, alpha 1.73 
51474 217892_s
_at 
LIMA1 LIM domain and actin binding 1 1.99 
54867 217899_a
t 
FLJ20254 hypothetical protein FLJ20254 -1.42 
23621 217904_s
_at 
BACE1 beta-site APP-cleaving enzyme 1 -1.54 
55827 217908_s
_at 










dynein, light chain, roadblock-type 1 1.79 
64771 217925_s
_at 
C6orf106 chromosome 6 open reading frame 106 -1.52 
29115 217965_s
_at 






















cyclin B1 interacting protein 1 2.36 
51292 217990_a
t 
GMPR2 guanosine monophosphate reductase 2 1.49 
27430 217993_s
_at 





chromosome 20 open reading frame 149 1.54 
8303 218032_a
t 
SNN stannin 1.68 
79650 218060_s
_at 
C16orf57 chromosome 16 open reading frame 57 -1.45 
56674 218065_s
_at 
TMEM9B TMEM9 domain family, member B 1.38 
55082 218067_s
_at 
FLJ10154 hypothetical protein FLJ10154 2.05 
53827 218084_x
_at 





DBNDD2 dysbindin (dystrobrevin binding protein 















CDC42 small effector 1 1.84 
64769 218165_a
t 
C1orf149 chromosome 1 open reading frame 149 1.79 
57111 218186_a
t 
RAB25 RAB25, member RAS oncogene family 1.94 
29796 218190_s
_at 
UCRC ubiquinol-cytochrome c reductase 




IHPK2 inositol hexaphosphate kinase 2 1.54 
55760 218198_a
t 





SCPEP1 serine carboxypeptidase 1 1.53 
55198 218218_a
t 
APPL2 adaptor protein, phosphotyrosine 
interaction, PH domain and leucine 











pleckstrin homology domain containing, 




NAGK N-acetylglucosamine kinase 1.35 
51082 218258_a
t 





RMND5B required for meiotic nuclear division 5 









solute carrier family 25 (mitochondrial 












chromosome 14 open reading frame 159 2.23 
79711 218305_a
t 
IPO4 importin 4 -1.53 
55316 218307_a
t 












RCOR3 REST corepressor 3 1.7 
27244 218346_s
_at 
SESN1 sestrin 1 2.07 
51053 218350_s
_at 
GMNN geminin, DNA replication inhibitor 3.46 
8490 218353_a
t 





tumor necrosis factor receptor 








MICAL1 microtubule associated monoxygenase, 









NLRP1 NLR family, pyrin domain containing 1 1.31 
94081 218392_x
_at 
SFXN1 sideroflexin 1 -1.71 
55038 218399_s
_at 
CDCA4 cell division cycle associated 4 -1.25 
55240 218424_s
_at 





tumor necrosis factor superfamily, 














TRPS1 trichorhinophalangeal syndrome I 1.71 
55030 218539_a
t 
FBXO34 F-box protein 34 1.36 
79762 218546_a
t 
C1orf115 chromosome 1 open reading frame 115 -1.68 
9935 218559_s
_at 
MAFB v-maf musculoaponeurotic fibrosarcoma 




LMCD1 LIM and cysteine-rich domains 1 1.65 
11266 218576_s
_at 
DUSP12 dual specificity phosphatase 12 1.44 
10161 218589_a
t 





ZDHHC7 zinc finger, DHHC-type containing 7 1.43 
51278 218611_a
t 
IER5 immediate early response 5 2.6 
10078 218612_s
_at 












MKS1 Meckel syndrome, type 1 -1.27 
79364 218639_s
_at 
ZXDC ZXD family zinc finger C -1.35 
64285 218686_s
_at 
RHBDF1 rhomboid 5 homolog 1 (Drosophila) 1.68 
56667 218687_s
_at 
MUC13 mucin 13, cell surface associated 2.55 
51309 218694_a
t 
ARMCX1 armadillo repeat containing, X-linked 1 2.26 
8436 218711_s
_at 
SDPR serum deprivation response 








LXN latexin 5.11 
29763 218744_s
_at 
PACSIN3 protein kinase C and casein kinase 




TAPBPL TAP binding protein-like 1.8 
5583 218764_a
t 
PRKCH protein kinase C, eta 3 
80021 218776_s
_at 





coiled-coil domain containing 109B 1.93 
80228 218811_a
t 










DEPDC6 DEP domain containing 6 1.86 
79050 218860_a
t 



























G patch domain containing 3 -1.35 
23586 218943_s
_at 





FLJ20035 hypothetical protein FLJ20035 3.9 
63897 218991_a
t 
HEATR6 HEAT repeat containing 6 1.23 
1906 218995_s
_at 










C14orf65 chromosome 14 open reading frame 65 -1.26 
79668 219033_a
t 





RNF34 ring finger protein 34 1.73 
55790 219049_a
t 







OSBPL10 oxysterol binding protein-like 10 1.87 
55022 219093_a
t 






ABHD8 abhydrolase domain containing 8 -1.42 
55616 219103_a
t 
DDEFL1 development and differentiation 




IL20RA interleukin 20 receptor, alpha 1.27 
51192 219161_s
_at 
CKLF chemokine-like factor 1.84 
79187 219170_a
t 





DACT1 dapper, antagonist of beta-catenin, 




PEX26 peroxisome biogenesis factor 26 -1.41 
63943 219187_a
t 
FKBPL FK506 binding protein like -1.5 
55833 219192_a
t 
UBAP2 ubiquitin associated protein 2 1.84 
64135 219209_a
t 





C9orf7 chromosome 9 open reading frame 7 -1.42 
55422 219228_a
t 





solute carrier organic anion transporter 






transmembrane protein 100 2.89 
55303 219243_a
t 
GIMAP4 GTPase, IMAP family member 4 1.84 
79676 219245_s
_at 
OGFOD2 2-oxoglutarate and iron-dependent 




C9orf82 chromosome 9 open reading frame 82 -1.63 
55619 219279_a
t 
DOCK10 dedicator of cytokinesis 10 1.73 
79652 219315_s
_at 
C16orf30 chromosome 16 open reading frame 30 2.46 
51003 219318_x
_at 





myosin head domain containing 1 -1.34 
51374 219329_s
_at 





MICAL-like 2 1.55 
55008 219352_a
t 
HERC6 hect domain and RLD 6 2.18 
10365 219371_s
_at 
KLF2 Kruppel-like factor 2 (lung) 2.01 
28981 219372_a
t 









C18orf22 chromosome 18 open reading frame 22 -1.4 
10742 219440_a
t 
RAI2 retinoic acid induced 2 2.17 
79705 219441_s
_at 





dynein, cytoplasmic 2, heavy chain 1 1.35 
54920 219486_a
t 
DUS2L dihydrouridine synthase 2-like, SMM1 









C1orf54 chromosome 1 open reading frame 54 1.73 
54996 219527_a
t 















ZNF267 zinc finger protein 267 1.79 
79987 219552_a
t 
SVEP1 sushi, von Willebrand factor type A, 




LRRC16 leucine rich repeat containing 16 1.62 
55378 219599_a
t 
 NA 2.52 
7551 219605_a
t 
ZNF3 zinc finger protein 3 -1.3 
64793 219611_s
_at 
CCDC21 coiled-coil domain containing 21 -1.35 
51548 219613_s
_at 
SIRT6 sirtuin (silent mating type information 































C16orf24 chromosome 16 open reading frame 24 -1.44 
23729 219712_s
_at 








PCDH9 protocadherin 9 1.27 
9946 219767_s
_at 











ZFPM2 zinc finger protein, multitype 2 2.76 
54978 219783_a
t 
C2orf18 chromosome 2 open reading frame 18 -1.31 
80778 219801_a
t 
ZNF34 zinc finger protein 34 1.24 
54853 219809_a
t 
WDR55 WD repeat domain 55 -1.44 
79037 219812_a
t 
PVRIG poliovirus receptor related 




C9orf86 chromosome 9 open reading frame 86 -1.46 
79885 219847_a
t 
HDAC11 histone deacetylase 11 -1.47 
80741 219860_a
t 





HERC5 hect domain and RLD 5 2.47 
29092 219865_a
t 
HSPC157 HSPC157 protein -1.55 
79667 219871_a
t 
FLJ13197 hypothetical FLJ13197 1.42 
79698 219877_a
t 
ZMAT4 zinc finger, matrin type 4 -1.2 
55106 219885_a
t 
SLFN12 schlafen family member 12 1.38 
9204 219924_s
_at 
ZMYM6 zinc finger, MYM-type 6 1.38 
4122 219999_a
t 
MAN2A2 mannosidase, alpha, class 2A, member 2 -1.49 
79836 220009_a
t 
LONRF3 LON peptidase N-terminal domain and 




PRR16 proline rich 16 1.45 
54897 220015_a
t 










SGK3 serum/glucocorticoid regulated kinase 




CCNL1 cyclin L1 2.06 
10913 220048_a
t 
EDAR ectodysplasin A receptor -1.22 
9573 220053_a
t 





pleckstrin homology domain containing, 







protein phosphatase 1, regulatory 
(inhibitor) subunit 14D 
-1.33 





RTDR1 rhabdoid tumor deletion region gene 1 -1.18 
29881 220106_a
t 





KCNN2 potassium intermediate/small 
conductance calcium-activated channel, 
























lectin, galactoside-binding, soluble, 14 -1.15 
11133 220160_s
_at 
KPTN kaptin (actin binding protein) -1.28 
24150 220167_s
_at 





transmembrane protease, serine 3 1.99 
54542 220201_a
t 







BMP8A bone morphogenetic protein 8a -1.41 
51700 220230_s
_at 
CYB5R2 cytochrome b5 reductase 2 1.39 
55066 220236_a
t 





SLC45A2 solute carrier family 45, member 2 -1.36 
65989 220262_s
_at 
DLK2 delta-like 2 homolog (Drosophila) -1.4 
79781 220274_a
t 
IQCA IQ motif containing with AAA domain -1.18 
55693 220278_a
t 


















coiled-coil domain containing 102B 1.55 
55001 220309_a
t 
TTC22 tetratricopeptide repeat domain 22 -1.23 
64092 220330_s
_at 
SAMSN1 SAM domain, SH3 domain and nuclear 













DCHS2 dachsous 2 (Drosophila) -1.22 
55466 220395_a
t 










UBQLN3 ubiquilin 3 -1.22 
7827 220424_a
t 





RIN3 Ras and Rab interactor 3 -1.26 
23418 220522_a
t 
CRB1 crumbs homolog 1 (Drosophila) -1.32 
79907 220531_a
t 






















BICC1 bicaudal C homolog 1 (Drosophila) 1.56 
56985 220606_s
_at 
C17orf48 chromosome 17 open reading frame 48 1.78 
55205 220617_s
_at 
ZNF532 zinc finger protein 532 1.41 
54827 220645_a
t 










IKZF1 IKAROS family zinc finger 1 (Ikaros) 1.25 
 220708_a
t 
 NA -1.35 
60482 220722_s
_at 
SLC5A7 solute carrier family 5 (choline 




IL19 interleukin 19 -1.45 
79741 220749_a
t 
C10orf68 chromosome 10 open reading frame 68 -1.41 
3770 220776_a
t 
KCNJ14 potassium inwardly-rectifying channel, 




PADI3 peptidyl arginine deiminase, type III -1.3 
10394 220811_a
t 
PRG3 proteoglycan 3 -1.18 
29119 220815_a
t 














 NA -1.25 
29968 220892_s
_at 
PSAT1 phosphoserine aminotransferase 1 -2.62 
54878 220939_s
_at 















TBC1 domain family, member 10B -1.4 
29943 220962_s
_at 
PADI1 peptidyl arginine deiminase, type I -1.47 
29091 220995_a
t 





unc-93 homolog B1 (C. elegans) 1.64 
63969 221001_a
t 
C15orf49 chromosome 15 open reading frame 49 -1.22 
81618 221004_s
_at 
ITM2C integral membrane protein 2C 1.36 
83448 221025_x
_at 












TEX13B testis expressed 13B -1.45 
50807 221039_s
_at 
DDEF1 development and differentiation 




TDRKH tudor and KH domain containing -1.22 
51192 221058_s
_at 
CKLF chemokine-like factor 1.68 
80833 221087_s
_at 
APOL3 apolipoprotein L, 3 2.56 
10242 221097_s
_at 
KCNMB2 potassium large conductance calcium-







solute carrier family 22 (organic cation 




WNT16 wingless-type MMTV integration site 




LENEP lens epithelial protein -1.26 
51741 221147_x
_at 
WWOX WW domain containing oxidoreductase -1.49 
56344 221160_s
_at 
CABP5 calcium binding protein 5 -1.19 
10086 221162_a
t 
HHLA1 HERV-H LTR-associating 1 -1.39 





GFRA4 GDNF family receptor alpha 4 -1.45 
26960 221207_s
_at 
NBEA neurobeachin 1.53 
26012 221214_s
_at 
NELF nasal embryonic LHRH factor -1.41 
79366 221238_a
t 








 NA -1.47 
7145 221246_x
_at 












SH3 domain binding glutamic acid-rich 











hypothetical protein MGC29506 3.11 
6041 221287_a
t 





GPR173 G protein-coupled receptor 173 -1.29 
9293 221313_a
t 
GPR52 G protein-coupled receptor 52 -1.43 
2661 221314_a
t 





neurogenic differentiation 4 -1.27 
1132 221357_a
t 
CHRM4 cholinergic receptor, muscarinic 4 -1.27 
 221382_a
t 





phospholipase A2, group IIE -1.23 
50832 221392_a
t 
TAS2R4 taste receptor, type 2, member 4 -1.22 
60401 221399_a
t 
EDA2R ectodysplasin A2 receptor -1.42 
56656 221409_a
t 
OR2S2 olfactory receptor, family 2, subfamily 




DEFB126 defensin, beta 126 -1.14 
53637 221417_x
_at 
EDG8 endothelial differentiation, sphingolipid 




CCNL2 cyclin L2 1.97 
81847 221430_s
_at 




OR12D3 olfactory receptor, family 12, subfamily 




MRPS15 mitochondrial ribosomal protein S15 -1.42 
50833 221444_a
t 
TAS2R16 taste receptor, type 2, member 16 -1.15 
83468 221447_s
_at 





TEX15 testis expressed 15 -1.17 
57818 221453_a
t 
G6PC2 glucose-6-phosphatase, catalytic, 2 -1.33 
4993 221460_a
t 
OR2C1 olfactory receptor, family 2, subfamily 









MRLC2 myosin regulatory light chain MRLC2 1.39 
6138 221475_s
_at 
RPL15 ribosomal protein L15 1.55 
6138 221476_s
_at 
RPL15 ribosomal protein L15 1.38 
665 221479_s
_at 
BNIP3L BCL2/adenovirus E1B 19kDa 








hypothetical protein LOC339047 1.5 
2744 221510_s
_at 
GLS glutaminase 2.36 
9440 221517_s
_at 
MED17 mediator complex subunit 17 1.76 
55143 221520_s
_at 
CDCA8 cell division cycle associated 8 -1.29 
83483 221529_s
_at 
PLVAP plasmalemma vesicle associated protein 2.73 
79365 221530_s
_at 
BHLHB3 basic helix-loop-helix domain 









implantation-associated protein -1.92 
6160 221593_s
_at 
RPL31 ribosomal protein L31 1.96 
57408 221612_a
t 





TREX1 three prime repair exonuclease 1 -1.19 
8022 221670_s
_at 
LHX3 LIM homeobox 3 -1.53 
64581 221698_s
_at 














COL5A2 collagen, type V, alpha 2 2.07 
8266 221746_a
t 
UBL4A ubiquitin-like 4A -1.36 
7145 221747_a
t 
TNS1 tensin 1 1.91 
7145 221748_s
_at 










MAN1A1 mannosidase, alpha, class 1A, member 1 -2.15 
7357 221765_a
t 





SFPQ splicing factor proline/glutamine-rich 





ELK3 ELK3, ETS-domain protein (SRF 









RAB9A RAB9A, member RAS oncogene family 1.75 
51131 221816_s
_at 
PHF11 PHD finger protein 11 2.18 
57171 221817_a
t 
DOLPP1 dolichyl pyrophosphate phosphatase 1 -1.79 
54934 221821_s
_at 















CTGLF1 centaurin, gamma-like family, member 1 1.49 
55793 221856_s
_at 










retinoic acid receptor responder 









COL8A2 collagen, type VIII, alpha 2 1.26 
79848 221925_s
_at 







guanylate cyclase 1, soluble, alpha 3 2.45 
6169 221943_x
_at 
RPL38 ribosomal protein L38 1.63 
84861 221948_s
_at 
KLHL22 kelch-like 22 (Drosophila) -1.25 
22207 221949_a LOC2220 hypothetical protein LOC222070 -1.42 
 186 
0 t 70 
57570 221952_x
_at 
TRMT5 TRM5 tRNA methyltransferase 5 




 NA 1.51 
63968 221974_a
t 










RPL10 ribosomal protein L10 1.94 
11248 221991_a
t 
NXPH3 neurexophilin 3 -1.34 
51231 221998_s
_at 
VRK3 vaccinia related kinase 3 -1.63 
10471 222019_a
t 
PFDN6 prefoldin subunit 6 -1.46 
11214 222023_a
t 







hypothetical protein LOC728844 2.1 
1191 222043_a
t 





C19orf54 chromosome 19 open reading frame 54 -1.39 
9466 222062_a
t 







solute carrier organic anion transporter 






SLC2A14 solute carrier family 2 (facilitated 
























PVRL3 poliovirus receptor-related 3 -1.42 
63876 222185_a
t 
PKNOX2 PBX/knotted 1 homeobox 2 -1.36 
29992 222218_s
_at 







DNA cross-link repair 1C (PSO2 




DDEFL1 development and differentiation 




ISYNA1 myo-inositol 1-phosphate synthase A1 1.35 
84928 222267_a
t 




 NA -1.49 
 222281_s
_at 
 NA 1.44 
 222288_a
t 
 NA 1.27 
 222296_a
t 
 NA -1.51 
 222298_a
t 
 NA -1.16 
 222302_a
t 
 NA -1.44 
26628 222304_x
_at 
OR7E47P olfactory receptor, family 7, subfamily 









 NA -1.47 
8554 222371_a
t 
PIAS1 protein inhibitor of activated STAT, 1 2.28 
59344 222383_s
_at 
ALOXE3 arachidonate lipoxygenase 3 -1.22 
9572 31637_s_
at 
NR1D1 nuclear receptor subfamily 1, group D, 
member 1 
-1.95 
5190 320_at PEX6 peroxisomal biogenesis factor 6 -1.49 





SYMPK symplekin -1.3 
5533 32541_at PPP3CC protein phosphatase 3 (formerly 2B), 
catalytic subunit, gamma isoform 
1.71 
4647 33197_at MYO7A myosin VIIA -1.47 
3669 33304_at ISG20 interferon stimulated exonuclease gene 
20kDa 
2.58 
9399 33736_at STOML1 stomatin (EPB72)-like 1 -1.33 
1762 33768_at DMWD dystrophia myotonica, WD repeat 
containing 
-1.48 
4626 34471_at MYH8 myosin, heavy chain 8, skeletal muscle, 
perinatal 
-1.16 
816 34846_at CAMK2B calcium/calmodulin-dependent protein 
kinase (CaM kinase) II beta 
-1.38 
23381 34868_at SMG5 Smg-5 homolog, nonsense mediated 
mRNA decay factor (C. elegans) 
-1.51 
8859 36019_at STK19 serine/threonine kinase 19 -1.27 




23764 36711_at MAFF v-maf musculoaponeurotic fibrosarcoma 
oncogene homolog F (avian) 
5.51 
4598 36907_at MVK mevalonate kinase (mevalonic aciduria) -1.75 




9902 37408_at MRC2 mannose receptor, C type 2 1.45 
7701 37586_at ZNF142 zinc finger protein 142 -1.13 





Rho GTPase activating protein 25 1.42 
10384 38241_at BTN3A3 butyrophilin, subfamily 3, member A3 2.12 
10636 38290_at RGS14 regulator of G-protein signaling 14 -1.5 
156 38447_at ADRBK1 adrenergic, beta, receptor kinase 1 -1.42 
6440 38691_s_
at 





E2F4 E2F transcription factor 4, p107/p130-
binding 
-2 
55611 38710_at OTUB1 OTU domain, ubiquitin aldehyde 
binding 1 
-1.42 
10847 38766_at SRCAP Snf2-related CBP activator protein -1.25 
9580 38918_at SOX13 SRY (sex determining region Y)-box 13 -1.35 
4862 39548_at NPAS2 neuronal PAS domain protein 2 -1.25 
1540 39582_at CYLD cylindromatosis (turban tumor 
syndrome) 
1.57 
2057 396_f_at EPOR erythropoietin receptor -1.89 
3263 39763_at HPX hemopexin -1.54 
29781 40640_at NCAPH2 non-SMC condensin II complex, subunit 
H2 
-1.29 
5266 41469_at PI3 peptidase inhibitor 3, skin-derived 
(SKALP) 
-1.19 
6794 41657_at STK11 serine/threonine kinase 11 -1.67 
32 43427_at ACACB acetyl-Coenzyme A carboxylase beta -2.03 
10025 43544_at MED16 mediator complex subunit 16 -1.72 
54929 43977_at TMEM16
1A 
transmembrane protein 161A -1.29 
90956 44120_at ADCK2 aarF domain containing kinase 2 -1.24 
55135 44563_at WDR79 WD repeat domain 79 -1.44 
54662 44696_at TBC1D13 TBC1 domain family, member 13 -1.29 
7776 47571_at ZNF236 zinc finger protein 236 -2.38 
10826 48030_i_
at 
C5orf4 chromosome 5 open reading frame 4 -1.97 
30827 48580_at CXXC1 CXXC finger 1 (PHD domain) -1.28 
9683 48612_at N4BP1 Nedd4 binding protein 1 -1.42 









hypothetical protein LOC222070 -2.06 
59307 52940_at SIGIRR single immunoglobulin and toll-
interleukin 1 receptor (TIR) domain 
-1.51 
83637 54970_at ZMIZ2 zinc finger, MIZ-type containing 2 -1.55 
91300 55705_at C19orf22 chromosome 19 open reading frame 22 -1.46 





hypothetical protein LOC222070 -1.88 
 189 
8996 59625_at NOL3 nucleolar protein 3 (apoptosis repressor 




CACNG4 calcium channel, voltage-dependent, 
gamma subunit 4 
-1.6 
51275 64432_at C12orf47 chromosome 12 open reading frame 47 1.31 
84818 64440_at IL17RC interleukin 17 receptor C -1.74 
54487 64474_g_
at 





64883_at MOSPD2 motile sperm domain containing 2 -1.25 
85002 65585_at FAM86B
1 
family with sequence similarity 86, 
member B1 
-1.54 
57599 65591_at WDR48 WD repeat domain 48 -1.38 
25960 65718_at GPR124 G protein-coupled receptor 124 1.4 
54512 91682_at EXOSC4 exosome component 4 -1.36 
90379 91952_at LOC9037
9 





STAT1 signal transducer and activator of 







STAT1 signal transducer and activator of 







STAT1 signal transducer and activator of 









 NA 1.49 































Affy ID  Symbol  Gene Name  Estimate  
2101 1487_at ESRRA estrogen-related receptor alpha 0.86 





179_at PMS2L11 postmeiotic segregation increased 
2-like 11 
0.83 
572 1861_at BAD BCL2-antagonist of cell death 0.59 
4735 200015_s
_at 
SEPT2 septin 2 -0.92 
23 200045_a
t 
ABCF1 ATP-binding cassette, sub-family F 




TAF10 TAF10 RNA polymerase II, TATA 
box binding protein (TBP)-









CANX calnexin 0.55 
27013 200070_a
t 





USP22 ubiquitin specific peptidase 22 0.88 
10959 200087_s
_at 
TMED2 transmembrane emp24 domain 




HSP90B1 heat shock protein 90kDa beta 



















PTPRF protein tyrosine phosphatase, 




PTPRF protein tyrosine phosphatase, 












NUCB1 nucleobindin 1 1.35 
5034 200654_a
t 
P4HB procollagen-proline, 2-oxoglutarate 
4-dioxygenase (proline 4-




P4HB procollagen-proline, 2-oxoglutarate 
4-dioxygenase (proline 4-









GSN gelsolin (amyloidosis, Finnish type) -1.93 
11014 200698_a
t 
KDELR2 KDEL (Lys-Asp-Glu-Leu) 
endoplasmic reticulum protein 




KDELR2 KDEL (Lys-Asp-Glu-Leu) 
endoplasmic reticulum protein 




DPYSL2 dihydropyrimidinase-like 2 -1.59 
3915 200771_a
t 










IQGAP1 IQ motif containing GTPase 






SPARC-like 1 (mast9, hevin) -2.51 
1153 200810_s
_at 





GSTP1 glutathione S-transferase pi -1.21 
10525 200825_s
_at 





















































TACC1 transforming, acidic coiled-coil 










KDELR1 KDEL (Lys-Asp-Glu-Leu) 
endoplasmic reticulum protein 




CALR calreticulin 2.4 
3150 200944_s
_at 
HMGN1 high-mobility group nucleosome 




GLUD1 glutamate dehydrogenase 1 1.3 
10552 200950_a
t 
ARPC1A actin related protein 2/3 complex, 














SERP1 stress-associated endoplasmic 




SERP1 stress-associated endoplasmic 




SNX17 sorting nexin 17 0.7 
16 201000_a
t 
AARS alanyl-tRNA synthetase 0.82 
10628 201008_s
_at 
TXNIP thioredoxin interacting protein -1.93 
10628 201009_s
_at 
TXNIP thioredoxin interacting protein -1.86 
10628 201010_s
_at 
TXNIP thioredoxin interacting protein -1.77 
301 201012_a
t 
ANXA1 annexin A1 -2.52 
3945 201030_x
_at 
LDHB lactate dehydrogenase B -2.53 
120 201034_a
t 
ADD3 adducin 3 (gamma) -1.46 
4313 201069_a
t 
MMP2 matrix metallopeptidase 2 
(gelatinase A, 72kDa gelatinase, 




DAP death-associated protein 0.92 
378 201096_s
_at 




LGALS1 lectin, galactoside-binding, soluble, 




THBS1 thrombospondin 1 -2.67 
999 201131_s
_at 







major histocompatibility complex, 




GPNMB glycoprotein (transmembrane) nmb -2.42 
7078 201150_s
_at 
TIMP3 TIMP metallopeptidase inhibitor 3 















ARCN1 archain 1 0.84 
5510 201213_a
t 
PPP1R7 protein phosphatase 1, regulatory 




CTBP2 C-terminal binding protein 2 -1.06 
9789 201240_s
_at 
SPCS2 signal peptidase complex subunit 2 




PSMC4 proteasome (prosome, macropain) 




BGN biglycan -1.66 
11316 201264_a
t 






















ANXA4 annexin A4 -1.43 
307 201302_a
t 





SH3 domain binding glutamic acid-




EMP1 epithelial membrane protein 1 -3.2 
9341 201336_a
t 
VAMP3 vesicle-associated membrane 




FLOT2 flotillin 2 1.04 
10131 201391_a
t 









PSMB3 proteasome (prosome, macropain) 




PSMB2 proteasome (prosome, macropain) 















WDR77 WD repeat domain 77 0.66 
7431 201426_s
_at 
VIM vimentin -1.92 
9791 201433_s
_at 
PTDSS1 phosphatidylserine synthase 1 0.61 
1293 201438_a
t 
COL6A3 collagen, type VI, alpha 3 -1.74 
4629 201496_x
_at 





LAMB1 laminin, beta 1 -2.03 
14 201511_a
t 







translocase of outer mitochondrial 





SRM spermidine synthase 0.98 
22883 201561_s
_at 
CLSTN1 calsyntenin 1 -1.02 
2803 201567_s
_at 





SEC23B Sec23 homolog B (S. cerevisiae) 1.79 
10483 201583_s
_at 
SEC23B Sec23 homolog B (S. cerevisiae) 1.22 
302 201590_x
_at 
ANXA2 annexin A2 -1.25 
800 201615_x
_at 
CALD1 caldesmon 1 -1.25 
27044 201622_a
t 
SND1 staphylococcal nuclease and tudor 




ARL1 ADP-ribosylation factor-like 1 1.33 
2697 201667_a
t 





DLG5 discs, large homolog 5 (Drosophila) -0.65 
7163 201688_s
_at 
TPD52 tumor protein D52 1.52 
7163 201689_s
_at 




TUBG1 tubulin, gamma 1 1.34 
2037 201719_s
_at 















LUM lumican -4.04 
120 201752_s
_at 
ADD3 adducin 3 (gamma) -0.91 
120 201753_s
_at 
ADD3 adducin 3 (gamma) -1.23 
55884 201760_s
_at 













AEBP1 AE binding protein 1 -1.52 
5007 201799_s
_at 
OSBP oxysterol binding protein 1.09 
5007 201800_s
_at 
OSBP oxysterol binding protein 0.96 
9467 201810_s
_at 















translocase of inner mitochondrial 











EFEMP1 EGF-containing fibulin-like 




EFEMP1 EGF-containing fibulin-like 




SH3GL1 SH3-domain GRB2-like 1 0.56 
5552 201858_s
_at 
SRGN serglycin -2.25 
5552 201859_a
t 
SRGN serglycin -1.2 
5327 201860_s
_at 
PLAT plasminogen activator, tissue -1.91 
1634 201893_x
_at 
DCN decorin -1.7 
1634 201894_s
_at 









CTDSPL CTD (carboxy-terminal domain, 





COASY Coenzyme A synthase 0.97 
11231 201915_a
t 










solute carrier family 25, member 36 -1.02 
10549 201923_a
t 
PRDX4 peroxiredoxin 4 1.03 
4299 201924_a
t 
AFF1 AF4/FMR2 family, member 1 -0.86 
23064 201964_a
t 
SETX senataxin 1.03 
4651 201976_s
_at 















FIBP fibroblast growth factor (acidic) 




GRLF1 glucocorticoid receptor DNA 
























ARFIP2 ADP-ribosylation factor interacting 




SLC4A2 solute carrier family 4, anion 
exchanger, member 2 (erythrocyte 




VWF von Willebrand factor -1.85 
25937 202132_a
t 
WWTR1 WW domain containing 




WWTR1 WW domain containing 




ACTR1B ARP1 actin-related protein 1 




NEDD9 neural precursor cell expressed, 
developmentally down-regulated 9 
-2.13 
10659 202157_s CUGBP2 CUG triplet repeat, RNA binding -2.11 
 197 
_at protein 2 
2621 202177_a
t 
GAS6 growth arrest-specific 6 -0.86 
50999 202195_s
_at 
TMED5 transmembrane emp24 protein 




SRPK1 SFRS protein kinase 1 0.64 
10123 202207_a
t 
ARL4C ADP-ribosylation factor-like 4C -1.97 
10123 202208_s
_at 
ARL4C ADP-ribosylation factor-like 4C -1 
4802 202215_s
_at 










PDGFRB platelet-derived growth factor 











MGP matrix Gla protein -3.47 
1512 202295_s
_at 
CTSH cathepsin H -1.31 
11079 202296_s
_at 
RER1 RER1 retention in endoplasmic 









CSNK1E casein kinase 1, epsilon -1.01 
5066 202336_s
_at 





TRIM2 tripartite motif-containing 2 -0.96 
1861 202348_s
_at 





GTF2F1 general transcription factor IIF, 






SNX19 sorting nexin 19 0.87 
9632 202361_a
t 
SEC24C SEC24 related gene family, 






unc-119 homolog B (C. elegans) 1.05 
9697 202369_s
_at 





SEC24D SEC24 related gene family, 






serpin peptidase inhibitor, clade A 
(alpha-1 antiproteinase, 




RGS2 regulator of G-protein signaling 2, 
24kDa 
-2.76 





COL1A2 collagen, type I, alpha 2 -2.1 
10897 202418_a
t 










RXRA retinoid X receptor, alpha 1.29 
10237 202433_a
t 













MPI mannose phosphate isomerase 0.58 
9474 202511_s
_at 
ATG5 ATG5 autophagy related 5 




PPP2R5D protein phosphatase 2, regulatory 




SCYE1 small inducible cytokine subfamily 





CRIM1 cysteine rich transmembrane BMP 




CRIM1 cysteine rich transmembrane BMP 





































WIPF1 WAS/WASL interacting protein 









RBM15B RNA binding motif protein 15B 0.64 
7372 202707_a
t 
UMPS uridine monophosphate synthetase 



















SLC7A8 solute carrier family 7 (cationic 

















TCEB3 transcription elongation factor B 





LPP LIM domain containing preferred 









DNAJB9 DnaJ (Hsp40) homolog, subfamily 




PSCD1 pleckstrin homology, Sec7 and 




UNC13B unc-13 homolog B (C. elegans) 0.99 
976 202910_s
_at 





Rho guanine nucleotide exchange 




ANK2 ankyrin 2, neuronal -1.26 
6662 202935_s
_at 
SOX9 SRY (sex determining region Y)-





SOX9 SRY (sex determining region Y)-










FHL2 four and a half LIM domains 2 -1.78 
5996 202988_s
_at 
RGS1 regulator of G-protein signaling 1 -3.3 
730 202992_a
t 
C7 complement component 7 -2.37 
2192 202994_s
_at 
FBLN1 fibulin 1 -1.78 
51421 203002_a
t 
AMOTL2 angiomotin like 2 -1.28 
5799 203029_s
_at 
PTPRN2 protein tyrosine phosphatase, 















B cell RAG associated protein -1.04 
7869 203071_a
t 
SEMA3B sema domain, immunoglobulin 
domain (Ig), short basic domain, 




FBLN5 fibulin 5 -2.43 
4247 203102_s
_at 






UBE2M ubiquitin-conjugating enzyme E2M 




USP52 ubiquitin specific peptidase 52 1 
4891 203123_s
_at 
SLC11A2 solute carrier family 11 (proton-
coupled divalent metal ion 




PDGFRA platelet-derived growth factor 




SEC61B Sec61 beta subunit 0.89 
10567 203136_a
t 
RABAC1 Rab acceptor 1 (prenylated) 1.55 
10298 203154_s
_at 
PAK4 p21(CDKN1A)-activated kinase 4 0.67 
2744 203159_a
t 
GLS glutaminase -1.35 
9197 203164_a
t 
SLC33A1 solute carrier family 33 (acetyl-




SLC33A1 solute carrier family 33 (acetyl-




ABCC4 ATP-binding cassette, sub-family C 










MTFR1 mitochondrial fission regulator 1 1.26 
9650 203208_s
_at 










PEX5 peroxisomal biogenesis factor 5 0.75 
3660 203275_a
t 
IRF2 interferon regulatory factor 2 0.91 
9695 203279_a
t 
EDEM1 ER degradation enhancer, 




SAFB2 scaffold attachment factor B2 -1.01 
9653 203285_s
_at 
HS2ST1 heparan sulfate 2-O-
sulfotransferase 1 
0.95 










NCK2 NCK adaptor protein 2 -1.45 
23550 203317_a
t 





IDE insulin-degrading enzyme 0.98 
3416 203328_x
_at 


























CTBP1 C-terminal binding protein 1 1.25 
6304 203408_s
_at 
SATB1 SATB homeobox 1 -0.91 
10106 203445_s
_at 
CTDSP2 CTD (carboxy-terminal domain, 
RNA polymerase II, polypeptide A) 










EIF3B eukaryotic translation initiation 




SEC61G Sec61 gamma subunit 0.94 
5195 203503_s
_at 
PEX14 peroxisomal biogenesis factor 14 0.74 
9391 203536_s
_at 
CIAO1 cytosolic iron-sulfur protein 




ALG8 asparagine-linked glycosylation 8 

















FAIM2 Fas apoptotic inhibitory molecule 2 0.29 
51704 203632_s
_at 
GPRC5B G protein-coupled receptor, family 








FGFR2 fibroblast growth factor receptor 2 
(bacteria-expressed kinase, 
keratinocyte growth factor receptor, 
craniofacial dysostosis 1, Crouzon 





FGFR2 fibroblast growth factor receptor 2 
(bacteria-expressed kinase, 
keratinocyte growth factor receptor, 
craniofacial dysostosis 1, Crouzon 





MON1B MON1 homolog B (yeast) 0.83 
5433 203664_s
_at 
POLR2D polymerase (RNA) II (DNA 




CXCL12 chemokine (C-X-C motif) ligand 




NUCB2 nucleobindin 2 1.83 
6895 203677_s
_at 





BCL2 B-cell CLL/lymphoma 2 -1.22 
8324 203706_s
_at 
FZD7 frizzled homolog 7 (Drosophila) -2.09 
5261 203709_a
t 





BAK1 BCL2-antagonist/killer 1 0.63 
28955 203733_a
t 
DEXI dexamethasone-induced transcript 1.04 
360 203747_a
t 
AQP3 aquaporin 3 (Gill blood group) 1.11 
5937 203748_x
_at 
RBMS1 RNA binding motif, single stranded 




TCF4 transcription factor 4 -1.65 
6503 203761_a
t 
SLA Src-like-adaptor -1.28 
644 203771_s
_at 
BLVRA biliverdin reductase A -0.82 
644 203773_x
_at 
BLVRA biliverdin reductase A -1.05 
7103 203824_a
t 
TSPAN8 tetraspanin 8 -1.91 
26610 203829_a
t 





FBLN2 fibulin 2 -0.92 
1613 203891_s
_at 














NR1H3 nuclear receptor subfamily 1, group 




CSTF3 cleavage stimulation factor, 3' pre-














PTPN3 protein tyrosine phosphatase, non-




SNAPC3 small nuclear RNA activating 




PAWR PRKC, apoptosis, WT1, regulator -0.95 
26751 204019_s
_at 
SH3YL1 SH3 domain containing, Ysc84-like 






RAB GTPase activating protein 1 -0.73 
1902 204037_a
t 
EDG2 endothelial differentiation, 
lysophosphatidic acid G-protein-











CENTG2 centaurin, gamma 2 0.65 
10609 204078_a
t 





TPST2 tyrosylprotein sulfotransferase 2 1.14 
7169 204083_s
_at 





SWI/SNF related, matrix 
associated, actin dependent 
regulator of chromatin, subfamily 




FOXO3 forkhead box O3 -1.83 
11259 204135_a
t 
FILIP1L filamin A interacting protein 1-like -1.98 
27252 204177_s
_at 
KLHL20 kelch-like 20 (Drosophila) -0.72 
10432 204178_s
_at 
RBM14 RNA binding motif protein 14 0.85 
5481 204186_s
_at 





















GMFG glia maturation factor, gamma -1.27 
9759 204225_a
t 
HDAC4 histone deacetylase 4 0.65 
4316 204259_a
t 





LGALS4 lectin, galactoside-binding, soluble, 











collagen, type XVI, alpha 1 -1.32 
2152 204363_a
t 
F3 coagulation factor III 




CLP1 CLP1, cleavage and 
polyadenylation factor I subunit, 










TMED2 transmembrane emp24 domain 




GEM GTP binding protein overexpressed 




ZNF142 zinc finger protein 142 0.7 
5091 204476_s
_at 
PC pyruvate carboxylase 1.66 
1802 204514_a
t 
DPH2 DPH2 homolog (S. cerevisiae) 0.52 
4673 204528_s
_at 





COX7A1 cytochrome c oxidase subunit VIIa 




SMCR7L Smith-Magenis syndrome 





VCAN versican -2.08 
7033 204623_a
t 
TFF3 trefoil factor 3 (intestinal) -0.6 
540 204624_a
t 







ribosomal protein S6 kinase, 









major histocompatibility complex, 






Rap guanine nucleotide exchange 

























RAD9A RAD9 homolog A (S. pombe) 0.44 
8411 204841_s
_at 
EEA1 early endosome antigen 1 0.29 
2644 204867_a
t 





CTNS cystinosis, nephropathic 0.91 
9815 204982_a
t 





GPC4 glypican 4 -0.52 
11020 205037_a
t 





ORM1 orosomucoid 1 0.78 
5004 205041_s
_at 
ORM1 orosomucoid 1 0.73 
9904 205115_s
_at 
RBM19 RNA binding motif protein 19 0.6 
3908 205116_a
t 
LAMA2 laminin, alpha 2 (merosin, 














GALK2 galactokinase 2 1.03 
9122 205234_a
t 
SLC16A4 solute carrier family 16, member 4 




INHBB inhibin, beta B -1.53 
10531 205273_s
_at 
PITRM1 pitrilysin metallopeptidase 1 1.11 
51101 205308_a
t 





CLDN10 claudin 10 -2.24 
580 205345_a
t 




















HIP1 huntingtin interacting protein 1 0.57 
9848 205442_a
t 





PPP1R1A protein phosphatase 1, regulatory 




TESK2 testis-specific kinase 2 0.56 
2626 205517_a
t 
GATA4 GATA binding protein 4 0.9 
7410 205536_a
t 





GSPT2 G1 to S phase transition 2 1.07 
6876 205547_s
_at 
TAGLN transgelin -2.23 
313 205639_a
t 
AOAH acyloxyacyl hydrolase (neutrophil) -0.79 
2243 205650_s
_at 
FGA fibrinogen alpha chain 0.48 
486 205674_x
_at 
FXYD2 FXYD domain containing ion 




DLEU1 deleted in lymphocytic leukemia, 1 1.21 
2674 205696_s
_at 
GFRA1 GDNF family receptor alpha 1 0.43 
10745 205702_a
t 
PHTF1 putative homeodomain 














DUSP9 dual specificity phosphatase 9 -0.77 
3575 205798_a
t 
IL7R interleukin 7 receptor -3.29 
22914 205821_a
t 
KLRK1 killer cell lectin-like receptor 




ADD3 adducin 3 (gamma) -0.99 
10537 205890_s
_at 
UBD ubiquitin D -2.91 
4776 205897_a
t 






POLE2 polymerase (DNA directed), 




PLCL1 phospholipase C-like 1 -0.3 
22843 205938_a
t 














PRG4 proteoglycan 4 2.08 
22887 206015_s
_at 
FOXJ3 forkhead box J3 -0.87 
2042 206070_s
_at 
EPHA3 EPH receptor A3 -3.18 
9651 206080_a
t 
PLCH2 phospholipase C, eta 2 -0.78 
7148 206093_x
_at 
TNXB tenascin XB -1.03 
7168 206116_s
_at 
TPM1 tropomyosin 1 (alpha) -1.63 
411 206129_s
_at 
ARSB arylsulfatase B 0.31 
27304 206141_a
t 
MOCS3 molybdenum cofactor synthesis 3 0.4 
57834 206153_a
t 
CYP4F11 cytochrome P450, family 4, 




ZNF747 zinc finger protein 747 0.75 
1041 206192_a
t 
CDSN corneodesmosin 0.75 
22821 206221_a
t 
RASA3 RAS p21 protein activator 3 -0.51 
22847 206225_a
t 
ZNF507 zinc finger protein 507 0.73 
1369 206256_a
t 
CPN1 carboxypeptidase N, polypeptide 1 1.74 
3428 206332_s
_at 





CXCL6 chemokine (C-X-C motif) ligand 6 














serpin peptidase inhibitor, clade B 












SIX2 SIX homeobox 2 0.43 
5680 206570_s
_at 





EFEMP2 EGF-containing fibulin-like 




DRD2 dopamine receptor D2 0.49 
8943 206592_s
_at 
AP3D1 adaptor-related protein complex 3, 

















CPSF4 cleavage and polyadenylation 









TRPV6 transient receptor potential cation 




SALL1 sal-like 1 (Drosophila) 1.65 
10021 206946_a
t 
HCN4 hyperpolarization activated cyclic 















SLC17A4 solute carrier family 17 (sodium 




SLC17A2 solute carrier family 17 (sodium 









ART4 ADP-ribosyltransferase 4 









NOS1 nitric oxide synthase 1 (neuronal) 0.45 
4050 207339_s
_at 
LTB lymphotoxin beta (TNF 






solute carrier family 22 (organic 









FXYD2 FXYD domain containing ion 




SFRP5 secreted frizzled-related protein 5 -1.22 
6532 207519_a
t 
SLC6A4 solute carrier family 6 
(neurotransmitter transporter, 




AQP1 aquaporin 1 (Colton blood group) -1.98 
27284 207601_a
t 
SULT1B1 sulfotransferase family, cytosolic, 




GPR171 G protein-coupled receptor 171 -1.97 
10130 207668_x
_at 
PDIA6 protein disulfide isomerase family 
A, member 6 
1.19 





SPAST spastin 0.43 
1443 207770_x
_at 












ST7 suppression of tumorigenicity 7 1.23 
4629 207961_x
_at 





DPT dermatopontin -2.14 
81030 208087_s
_at 
ZBP1 Z-DNA binding protein 1 -0.62 
81875 208114_s
_at 
ISG20L2 interferon stimulated exonuclease 









MAS1 MAS1 oncogene 0.84 
6585 208221_s
_at 
SLIT1 slit homolog 1 (Drosophila) -0.63 
2263 208228_s
_at 
FGFR2 fibroblast growth factor receptor 2 
(bacteria-expressed kinase, 
keratinocyte growth factor receptor, 
craniofacial dysostosis 1, Crouzon 










DMBT1 deleted in malignant brain tumors 1 0.67 
553 208260_a
t 





major histocompatibility complex, 




NR5A2 nuclear receptor subfamily 5, group 




NR5A2 nuclear receptor subfamily 5, group 




URB1 URB1 ribosome biogenesis 1 














XPO7 exportin 7 0.55 
2557 208463_a
t 
GABRA4 gamma-aminobutyric acid (GABA) 








BAX BCL2-associated X protein -0.72 
690 208529_a
t 
BTF3L1 basic transcription factor 3, like 1 -0.7 
26582 208582_s
_at 
DUX3 double homeobox, 3 -0.75 
10075 208598_s
_at 





SNTB1 syntrophin, beta 1 (dystrophin-





VIL2 villin 2 (ezrin) -1.35 
1981 208625_s
_at 
EIF4G1 eukaryotic translation initiation 








ATPase, H+ transporting, 




PDIA6 protein disulfide isomerase family 




PARP1 poly (ADP-ribose) polymerase 




VCP valosin-containing protein 0.75 
10983 208656_s
_at 
CCNI cyclin I -0.81 
9601 208658_a
t 
PDIA4 protein disulfide isomerase family 




CLIC1 chloride intracellular channel 1 -0.98 
7267 208664_s
_at 
TTC3 tetratricopeptide repeat domain 3 0.61 
824 208683_a
t 
CAPN2 calpain 2, (m/II) large subunit -1.13 
10211 208748_s
_at 
FLOT1 flotillin 1 0.59 
8775 208751_a
t 
NAPA N-ethylmaleimide-sensitive factor 






































SRP72 signal recognition particle 72kDa 1.44 





PSMB6 proteasome (prosome, macropain) 




POLE3 polymerase (DNA directed), 































major histocompatibility complex, 




C1QBP complement component 1, q 




NADK NAD kinase 1.35 
65220 208919_s
_at 
NADK NAD kinase 1.14 
3958 208949_s
_at 





KLF6 Kruppel-like factor 6 -1.96 
1316 208961_s
_at 

















solute carrier family 25 
(mitochondrial carrier; oxoglutarate 




KRT7 keratin 7 -1.9 
9361 209017_s
_at 
LONP1 lon peptidase 1, mitochondrial 0.92 
65018 209018_s
_at 













AQP1 aquaporin 1 (Colton blood group) -3.11 
8202 209061_a
t 
NCOA3 nuclear receptor coactivator 3 -0.74 
182 209099_x
_at 
JAG1 jagged 1 (Alagille syndrome) -1.58 
7866 209100_a IFRD2 interferon-related developmental 1.07 
 212 
t regulator 2 
1490 209101_a
t 
CTGF connective tissue growth factor -3.67 
7353 209103_s
_at 





WBP2 WW domain binding protein 2 1.25 
7846 209118_s
_at 
TUBA1A tubulin, alpha 1a -1.57 
3535 209138_x
_at 
IGL@ immunoglobulin lambda locus -3.04 
9266 209158_s
_at 
PSCD2 pleckstrin homology, Sec7 and 




CYB561 cytochrome b-561 0.88 
1534 209164_s
_at 
CYB561 cytochrome b-561 0.93 
11067 209183_s
_at 





ATP2A2 ATPase, Ca++ transporting, cardiac 




ADCY6 adenylate cyclase 6 0.61 
7852 209201_x
_at 





RDBP RD RNA binding protein -0.69 
23095 209234_a
t 





KIAA0265 protein 0.9 
50814 209279_s
_at 










CDC42 effector protein (Rho 




NFIB nuclear factor I/B -1.08 
3400 209291_a
t 
ID4 inhibitor of DNA binding 4, 





NECAP1 NECAP endocytosis associated 1 0.79 
599 209311_a
t 





major histocompatibility complex, 




PSMD9 proteasome (prosome, macropain) 




DCN decorin -2.08 
55361 209345_s PI4K2A phosphatidylinositol 4-kinase type 0.96 
 213 
_at 2 alpha 
6452 209370_s
_at 







































CRAT carnitine acetyltransferase 1.37 
9373 209532_a
t 










MINPP1 multiple inositol polyphosphate 




PSCDBP pleckstrin homology, Sec7 and 





SLC1A4 solute carrier family 1 
(glutamate/neutral amino acid 




SLC1A4 solute carrier family 1 
(glutamate/neutral amino acid 




CD74 CD74 molecule, major 





PDLIM3 PDZ and LIM domain 3 -1.38 
64087 209624_s
_at 
MCCC2 methylcrotonoyl-Coenzyme A 











SLC19A2 solute carrier family 19 (thiamine 




CXCL12 chemokine (C-X-C motif) ligand 




NKX3-1 NK3 homeobox 1 0.55 
934 209771_x
_at 











CD69 CD69 molecule -2.65 
406 209824_s
_at 





PSME3 proteasome (prosome, macropain) 





FRAT2 frequently rearranged in advanced 




SPP1 secreted phosphoprotein 1 
(osteopontin, bone sialoprotein I, 






solute carrier family 25 
(mitochondrial carrier; Graves 









PIGO phosphatidylinositol glycan anchor 




SOCS1 suppressor of cytokine signaling 1 0.58 
2627 210002_a
t 
GATA6 GATA binding protein 6 -1.44 
84759 210022_a
t 
PCGF1 polycomb group ring finger 1 0.6 
3418 210045_a
t 










CCL19 chemokine (C-C motif) ligand 19 -2.76 
51257 210075_a
t 





ABCA4 ATP-binding cassette, sub-family 




INVS inversin 0.74 
5376 210139_s
_at 
PMP22 peripheral myelin protein 22 -1.38 
10211 210142_x
_at 
FLOT1 flotillin 1 0.72 
7763 210275_s
_at 
ZFAND5 zinc finger, AN1-type domain 5 -1.4 
2321 210287_s
_at 
FLT1 fms-related tyrosine kinase 1 
(vascular endothelial growth 





NAT8 N-acetyltransferase 8 -2.69 
10483 210293_s
_at 




KLHL25 kelch-like 25 (Drosophila) 0.72 
9356 210343_s
_at 
SLC22A6 solute carrier family 22 (organic 




ARTS-1 type 1 tumor necrosis factor 





DEFB1 defensin, beta 1 -3.64 
302 210427_x
_at 
ANXA2 annexin A2 -1.23 
10899 210434_x
_at 
JTB jumping translocation breakpoint 0.63 
11054 210443_x
_at 







hypothetical protein MGC31957 -1.56 
5987 210541_s
_at 
TRIM27 tripartite motif-containing 27 0.95 
3985 210582_s
_at 








SYNGR1 synaptogyrin 1 -0.63 
8558 210622_x
_at 





GCS1 glucosidase I 0.8 
6442 210632_s
_at 





KRT10 keratin 10 (epidermolytic 





ATG5 ATG5 autophagy related 5 









NRTN neurturin 1.2 
29015 210692_s
_at 
SLC43A3 solute carrier family 43, member 3 1.66 
10653 210715_s
_at 





MLX MAX-like protein X 0.37 
2047 210753_s
_at 
EPHB1 EPH receptor B1 0.65 
1601 210757_x
_at 






CYR61 cysteine-rich, angiogenic inducer, 
61 
-2.64 
28334 210822_a LOC2833 RPL13-2 pseudogene 0.53 
 216 
5 t 45 
1488 210835_s
_at 









ELOVL6 ELOVL family member 6, 













ASPH aspartate beta-hydroxylase 0.88 
3597 210904_s
_at 
IL13RA1 interleukin 13 receptor, alpha 1 1.57 
5204 210908_s
_at 
PFDN5 prefoldin subunit 5 -0.79 
28639 210915_x
_at 















GYG2 glycogenin 2 0.96 
8908 210964_s
_at 
GYG2 glycogenin 2 1.48 
406 210971_s
_at 












major histocompatibility complex, 
















FLJ30092 AF-1 specific protein phosphatase 0.61 
9601 211048_s
_at 
PDIA4 protein disulfide isomerase family 















CLPTM1 cleft lip and palate associated 




NAB1 NGFI-A binding protein 1 (EGR1 






acetyltransferase (E2 component of 




THPO thrombopoietin (myeloproliferative 
leukemia virus oncogene ligand, 





CSF2RA colony stimulating factor 2 










CASP1 caspase 1, apoptosis-related 





IGHG3 immunoglobulin heavy constant 






GABA(A) receptors associated 




ADRA1A adrenergic, alpha-1A-, receptor 1.84 
377 211622_s
_at 
ARF3 ADP-ribosylation factor 3 0.82 
 211642_a
t 
 NA -0.48 
 211645_x
_at 
 NA -2.7 
3912 211651_s
_at 
LAMB1 laminin, beta 1 -1.38 
3929 211652_s
_at 





major histocompatibility complex, 













ankyrin repeat domain 40 0.58 
5730 211748_x
_at 







methylmalonic aciduria (cobalamin 





ABI2 abl interactor 2 0.82 
28639 211796_s
_at 
TRBC1 T cell receptor beta constant 1 -1.59 
1634 211813_x
_at 
DCN decorin -2 
7066 211831_s
_at 
THPO thrombopoietin (myeloproliferative 
leukemia virus oncogene ligand, 







solute carrier family 25 






DCN decorin -1.96 
5141 211901_s
_at 
PDE4A phosphodiesterase 4A, cAMP-
specific (phosphodiesterase E2 









HSPA5 heat shock 70kDa protein 5 




COL4A2 collagen, type IV, alpha 2 -2.05 
3516 211974_x
_at 
RBPJ recombination signal binding 





COL4A1 collagen, type IV, alpha 1 -2.14 
79026 211986_a
t 





major histocompatibility complex, 






major histocompatibility complex, 






KIAA0220-like protein -1.62 
26099 212003_a
t 





UBXD2 UBX domain containing 2 0.98 
5411 212036_s
_at 







ATPase, H+ transporting, 









TBC1 domain family, member 9B 






TEX261 testis expressed 261 1.07 
2907 212090_a
t 
GRINA glutamate receptor, ionotropic, N-
methyl D-asparate-associated 






solute carrier family 39 (zinc 









PBX1 pre-B-cell leukemia homeobox 1 -1.04 
11260 212160_a
t 
XPOT exportin, tRNA (nuclear export 










AK2 adenylate kinase 2 0.89 
31 212186_a
t 












KCTD12 potassium channel tetramerisation 






KCTD12 potassium channel tetramerisation 











transmembrane protein 87A -0.94 
90411 212245_a
t 










MTDH metadherin 1.24 
92140 212250_a
t 
MTDH metadherin 1.34 
23175 212276_a
t 























ATP2A2 ATPase, Ca++ transporting, cardiac 




















ATPase, H+ transporting, 




TCF4 transcription factor 4 -1.54 
6925 212387_a
t 
TCF4 transcription factor 4 -1.63 
89910 212404_s
_at 























GRPEL1 GrpE-like 1, mitochondrial (E. coli) 0.89 
9807 212439_a
t 
IHPK1 inositol hexaphosphate kinase 1 0.8 
9645 212472_a
t 
MICAL2 microtubule associated 
monoxygenase, calponin and LIM 














DNA segment, Chr 15, Wayne 









LSM12 LSM12 homolog (S. cerevisiae) 0.92 
80308 212541_a
t 
FLAD1 FAD1 flavin adenine dinucleotide 









AIM1 absent in melanoma 1 -1.57 
10252 212558_a
t 
SPRY1 sprouty homolog 1, antagonist of 








acetyltransferase (E2 component of 




ENDOD1 endonuclease domain containing 1 -1.17 
23295 212576_a
t 
MGRN1 mahogunin, ring finger 1 1.04 
5788 212588_a
t 
PTPRC protein tyrosine phosphatase, 




IGJ immunoglobulin J polypeptide, 
linker protein for immunoglobulin 











transmembrane protein 41B 1.32 
8417 212631_a
t 
STX7 syntaxin 7 -0.6 
3097 212642_s
_at 
HIVEP2 human immunodeficiency virus 

















major histocompatibility complex, 






transmembrane protein 112B 0.64 
57460 212686_a
t 












TLN2 talin 2 0.64 
4239 212713_a
t 
MFAP4 microfibrillar-associated protein 4 -1.55 
390 212724_a
t 
RND3 Rho family GTPase 3 -1.08 
4833 212739_s
_at 












SLC1A4 solute carrier family 1 
(glutamate/neutral amino acid 




























KLHL18 kelch-like 18 (Drosophila) 0.43 
26112 212886_a
t 







hypothetical protein MGC15523 0.82 
7779 212907_a
t 
SLC30A1 solute carrier family 30 (zinc 



























 NA 1.89 
9875 212996_s
_at 
URB1 URB1 ribosome biogenesis 1 






angiopoietin-like 2 -0.58 










protein kinase, cAMP-dependent, 









DPT dermatopontin -2.2 
90121 213079_a
t 
TSR2 TSR2, 20S rRNA accumulation, 






ATG4A ATG4 autophagy related 4 














SNAPC5 small nuclear RNA activating 














ADCY1 adenylate cyclase 1 (brain) 1.05 
79987 213247_a
t 
SVEP1 sushi, von Willebrand factor type 





TRIM22 tripartite motif-containing 22 -2.16 
23264 213323_s
_at 





PVRL3 poliovirus receptor-related 3 1.35 
4191 213333_a
t 





ABCA5 ATP-binding cassette, sub-family 











 NA 1.16 
 213429_a
t 





similar to bK246H3.1 
(immunoglobulin lambda-like 




ANXA2 annexin A2 -1.28 
10980 213504_a
t 
COPS6 COP9 constitutive 
photomorphogenic homolog 





LAMA2 laminin, alpha 2 (merosin, 




LDHB lactate dehydrogenase B -2.5 
6039 213566_a
t 
RNASE6 ribonuclease, RNase A family, k6 -1.5 
65220 213607_x
_at 







similar to SRR1-like protein 0.74 
3384 213620_s
_at 










ZNF710 zinc finger protein 710 0.9 
7542 213740_s
_at 
ZFPL1 zinc finger protein-like 1 -1.38 
26156 213750_a
t 
RSL1D1 ribosomal L1 domain containing 1 0.98 
28996 213763_a
t 





STARD5 StAR-related lipid transfer 













transmembrane protein 110 0.87 
4673 213864_s
_at 





TCF4 transcription factor 4 -1.53 
633 213905_x
_at 
BGN biglycan -1.98 
 213929_a
t 
 NA 0.81 
23048 213940_s
_at 
FNBP1 formin binding protein 1 -0.95 
4069 213975_s
_at 
LYZ lysozyme (renal amyloidosis) -2.41 
6421 214016_s
_at 
SFPQ splicing factor proline/glutamine-








































FABP1 fatty acid binding protein 1, liver 0.45 
708 214214_s
_at 
C1QBP complement component 1, q 




GGA2 golgi associated, gamma adaptin 










MTMR4 myotubularin related protein 4 1.04 
3166 214386_a
t 
HMX1 H6 family homeobox 1 -0.65 
9814 214402_s
_at 










H2AFB2 H2A histone family, member B2 -0.41 
6472 214437_s
_at 





LBP lipopolysaccharide binding protein 1.49 
5005 214465_a
t 
ORM2 orosomucoid 2 0.8 
11212 214545_s
_at 










GPR37 G protein-coupled receptor 37 











IGKC immunoglobulin kappa constant -2.33 
28831 214677_x
_at 
IGLJ3 immunoglobulin lambda joining 3 -3.34 
6641 214708_a
t 
SNTB1 syntrophin, beta 1 (dystrophin-





YLPM1 YLP motif containing 1 0.59 
84124 214714_a
t 
ZNF394 zinc finger protein 394 -0.51 
54432 214733_s
_at 
YIPF1 Yip1 domain family, member 1 1.32 
 214769_a
t 
 NA 0.46 





ZNF75 zinc finger protein 75 (D8C6) 0.43 
3514 214836_x
_at 





KCTD20 potassium channel tetramerisation 














PRPF40A PRP40 pre-mRNA processing 




GTF3A general transcription factor IIIA 0.8 
3535 215121_x
_at 
IGL@ immunoglobulin lambda locus -3.01 
5937 215127_s
_at 
RBMS1 RNA binding motif, single stranded 






Rho guanine nucleotide exchange 




NTN2L netrin 2-like (chicken) -3.05 
 215185_a
t 





major histocompatibility complex, 





































PAPOLA poly(A) polymerase alpha 0.58 
3535 215379_x
_at 
IGL@ immunoglobulin lambda locus -3.13 
2260 215404_x
_at 
FGFR1 fibroblast growth factor receptor 1 










TRA@ T cell receptor alpha locus 0.68 
22888 215544_s
_at 





SWI/SNF related, matrix 
associated, actin dependent 
regulator of chromatin, subfamily 
0.83 
 226 















PLXNB1 plexin B1 0.98 
56928 215833_s
_at 





ADP-ribosylation factor guanine 







similar to omega protein -2.15 
10825 216083_s
_at 
NEU3 sialidase 3 (membrane sialidase) 0.56 
182 216268_s
_at 
JAG1 jagged 1 (Alagille syndrome) -2.09 
3183 216302_a
t 
HNRNPC heterogeneous nuclear 




HDAC3 histone deacetylase 3 0.63 
 216337_a
t 
 NA 0.38 
23223 216360_x
_at 
RRP12 ribosomal RNA processing 12 




 NA 0.95 
934 216379_x
_at 
CD24 CD24 molecule -2.15 
80344 216389_s
_at 
WDR23 WD repeat domain 23 1.08 
 216401_x
_at 
 NA -2.39 
3956 216405_a
t 
LGALS1 lectin, galactoside-binding, soluble, 











TMSB4X thymosin, beta 4, X-linked -0.74 
 216463_a
t 
 NA -0.33 
89795 216466_a
t 
NAV3 neuron navigator 3 -0.2 
56005 216483_s
_at 














 NA -1.02 
10130 216640_s PDIA6 protein disulfide isomerase family 1.35 
 227 
_at A, member 6 
6760 216684_s
_at 







Rho GTPase activating protein 1 0.88 
7204 216700_a
t 





RGS1 regulator of G-protein signaling 1 -4.23 
6648 216841_s
_at 










CDKN1C cyclin-dependent kinase inhibitor 




RRP12 ribosomal RNA processing 12 



















 NA 0.51 
9757 217069_a
t 
MLL4 myeloid/lymphoid or mixed-




SFXN3 sideroflexin 3 -1.19 
6208 217298_a
t 





KRT19P2 keratin 19 pseudogene 2 0.34 
 217423_a
t 
 NA 0.42 
 217458_a
t 





major histocompatibility complex, 









OR7E38P olfactory receptor, family 7, 












similar to olfactory receptor, family 









HP haptoglobin 1.84 





STMN1 stathmin 1/oncoprotein 18 -1.04 
29927 217716_s
_at 





VPS35 vacuolar protein sorting 35 




S100A6 S100 calcium binding protein A6 -1.96 
9168 217733_s
_at 
TMSB10 thymosin, beta 10 -1.23 
22820 217749_a
t 




















YPEL5 yippee-like 5 (Drosophila) -0.82 
10419 217786_a
t 



















NPLOC4 nuclear protein localization 4 






mitogen-activated protein kinase 




UBE2J1 ubiquitin-conjugating enzyme E2, 




VPS24 vacuolar protein sorting 24 




SDF4 stromal cell derived factor 4 0.71 
4282 217871_s
_at 











PTCD3 Pentatricopeptide repeat domain 3 0.76 
53826 217897_a
t 
FXYD6 FXYD domain containing ion 

























UQCC ubiquinol-cytochrome c reductase 












TOMM22 translocase of outer mitochondrial 






nerve growth factor receptor 








family with sequence similarity 









ribonuclease T2 -1.11 
8566 218019_s
_at 





VRK3 vaccinia related kinase 3 0.63 
55706 218073_s
_at 
TMEM48 transmembrane protein 48 0.53 
51304 218077_s
_at 





RRAGC Ras-related GTP binding C -0.83 
51073 218105_s
_at 
MRPL4 mitochondrial ribosomal protein L4 1.06 
55177 218126_a
t 















TRIB3 tribbles homolog 3 (Drosophila) 1.4 
56944 218162_a
t 
OLFML3 olfactomedin-like 3 -1.43 
56997 218168_s
_at 
CABC1 chaperone, ABC1 activity of bc1 









NANS N-acetylneuraminic acid synthase 









family with sequence similarity 

















MSTO1 misato homolog 1 (Drosophila) 0.99 
79447 218300_a
t 





TYW1 tRNA-yW synthesizing protein 1 











RWD domain containing 2B 1.1 
25796 218387_s
_at 
PGLS 6-phosphogluconolactonase 0.95 
11267 218391_a
t 
SNF8 SNF8, ESCRT-II complex subunit, 











FLJ11286 hypothetical protein FLJ11286 0.78 
79646 218433_a
t 
PANK3 pantothenate kinase 3 0.6 
26015 218441_s
_at 





TMEM33 transmembrane protein 33 1.09 
56915 218481_a
t 
EXOSC5 exosome component 5 0.56 
8891 218488_a
t 
EIF2B3 eukaryotic translation initiation 














PHF17 PHD finger protein 17 -1.47 
79178 218540_a
t 
THTPA thiamine triphosphatase 0.7 
63874 218581_a
t 
ABHD4 abhydrolase domain containing 4 0.69 
54662 218596_a
t 
TBC1D13 TBC1 domain family, member 13 0.7 
51696 218603_a
t 
HECA headcase homolog (Drosophila) -1.04 
51409 218620_s
_at 





LHFP lipoma HMGIC fusion partner -1.96 
8291 218660_a
t 
DYSF dysferlin, limb girdle muscular 




STX17 syntaxin 17 0.79 
57402 218677_a
t 




SDF2L1 stromal cell-derived factor 2-like 1 1.97 
2188 218689_a
t 





EXOSC4 exosome component 4 0.58 
28984 218723_s
_at 












transmembrane protein 161A 0.64 
80024 218749_s
_at 
SLC24A6 solute carrier family 24 
(sodium/potassium/calcium 




XKR8 XK, Kell blood group complex 






transmembrane protein 38B 1.33 
51205 218795_a
t 





SPCS3 signal peptidase complex subunit 3 













NAD synthetase 1 -1.11 
64838 218843_a
t 







tumor necrosis factor receptor 






Rho GTPase activating protein 15 -1.18 
54997 218872_a
t 
TESC tescalcin -1.11 
51069 218887_a
t 
MRPL2 mitochondrial ribosomal protein L2 0.73 
4771 218915_a
t 





CTBS chitobiase, di-N-acetyl- 1.39 
54925 218937_a
t 
ZNF434 zinc finger protein 434 0.65 
55278 218949_s
_at 












DnaJ (Hsp40) homolog, subfamily 




ACN9 ACN9 homolog (S. cerevisiae) 1.32 
64924 218989_x
_at 
SLC30A5 solute carrier family 30 (zinc 





MANEA mannosidase, endo-alpha 1.58 
55500 219017_a
t 
ETNK1 ethanolamine kinase 1 1.47 
51236 219071_x
_at 












ASPN asporin -2.47 
55661 219108_x
_at 















FAST kinase domains 3 1.12 
64218 219259_a
t 
SEMA4A sema domain, immunoglobulin 
domain (Ig), transmembrane 
domain (TM) and short 

















PDGFD platelet derived growth factor D -2.41 
55315 219344_a
t 
SLC29A3 solute carrier family 29 (nucleoside 




ATHL1 ATH1, acid trehalase-like 1 (yeast) -1.03 
57099 219366_a
t 





POLH polymerase (DNA directed), eta -1.41 
56833 219386_s
_at 
SLAMF8 SLAM family member 8 -1.16 
55128 219405_a
t 
TRIM68 tripartite motif-containing 68 0.72 
11264 219428_s
_at 










TMEM53 transmembrane protein 53 0.72 
55176 219499_a
t 












KCTD14 potassium channel tetramerisation 





KCNJ16 potassium inwardly-rectifying 




CADPS2 Ca2+-dependent activator protein 









PDZK1 interacting protein 1 -2.86 
24146 219640_a
t 
CLDN15 claudin 15 0.78 
6926 219682_s
_at 







transmembrane protein 149 1.28 
55277 219718_a
t 
FLJ10986 hypothetical protein FLJ10986 1.22 
79983 219756_s
_at 





TBC1 domain family, member 8B 




PRDM8 PR domain containing 8 -0.79 
7561 219854_a
t 





collectin sub-family member 11 -1.6 
11153 219910_a
t 
HYPE Huntingtin interacting protein E 1.4 
29925 219920_s
_at 





FLJ11850 hypothetical protein FLJ11850 0.53 
55034 219959_a
t 
MOCOS molybdenum cofactor sulfurase 1.93 
51377 219960_s
_at 










APBB1IP amyloid beta (A4) precursor 
protein-binding, family B, member 




ERO1LB ERO1-like beta (S. cerevisiae) 1.09 
93 220028_a
t 
ACVR2B activin A receptor, type IIB 0.83 
80235 220041_a
t 
PIGZ phosphatidylinositol glycan anchor 









coiled-coil domain containing 90A 1.06 
54875 220095_a
t 
C9orf39 chromosome 9 open reading frame 
39 
0.44 





CCDC68 coiled-coil domain containing 68 -1.19 
64924 220181_x
_at 
SLC30A5 solute carrier family 30 (zinc 



















OXCT2 3-oxoacid CoA transferase 2 -0.6 
55146 220261_s
_at 





EFCAB6 EF-hand calcium binding domain 6 0.45 
50624 220275_a
t 










TAF7L TAF7-like RNA polymerase II, 
TATA box binding protein (TBP)-





















GPR97 G protein-coupled receptor 97 0.41 
10164 220446_s
_at 
CHST4 carbohydrate (N-acetylglucosamine 






hypothetical protein MGC5566 0.46 
25897 220483_s
_at 
RNF19A ring finger protein 19A -1.08 
 220489_s
_at 
 NA -1.08 
64223 220587_s
_at 
GBL G protein beta subunit-like 0.67 
55179 220643_s
_at 
FAIM Fas apoptotic inhibitory molecule -1.38 
79978 220674_a
t 
FLJ22814 hypothetical protein FLJ22814 -0.56 
50854 220755_s
_at 





GPHN gephyrin 1.11 
80069 220904_a
t 











SFXN3 sideroflexin 3 -0.8 
81031 221024_s
_at 
SLC2A10 solute carrier family 2 (facilitated 









SLC17A5 solute carrier family 17 










methyltransferase like 2B 0.9 
10530 221127_s
_at 
RIG regulated in glioma -0.78 
 221159_a
t 




















GPR27 G protein-coupled receptor 27 0.62 
8385 221341_s
_at 
OR1D4 olfactory receptor, family 1, 




OR10J1 olfactory receptor, family 10, 




BNIP3L BCL2/adenovirus E1B 19kDa 









eukaryotic translation initiation 






cysteine-rich secretory protein 




SCLY selenocysteine lyase 1.83 
9501 221614_s
_at 










ZNF83 zinc finger protein 83 -1.6 
3514 221651_x
_at 
IGKC immunoglobulin kappa constant -2.56 
3514 221671_x
_at 
















AKAP13 A kinase (PRKA) anchor protein 13 -1.32 
1462 221731_x
_at 
VCAN versican -2.75 
3069 221767_x
_at 















KLHL22 kelch-like 22 (Drosophila) 0.38 
81570 221845_s
_at 
CLPB ClpB caseinolytic peptidase B 






NOMO3 NODAL modulator 3 1.52 
9683 221867_a
t 










 NA 0.66 
58986 221882_s
_at 

















TXNRD3 thioredoxin reductase 3 0.77 
27079 221940_a
t 
RPUSD2 RNA pseudouridylate synthase 






TMEM80 transmembrane protein 80 -0.85 
5165 221957_a
t 





GPR137 G protein-coupled receptor 137 0.76 
51150 221972_s
_at 










AKAP13 A kinase (PRKA) anchor protein 13 -1.35 
10399 222034_a
t 
GNB2L1 guanine nucleotide binding protein 












TBC1D16 TBC1 domain family, member 16 1.04 
3268 222126_a
t 




TCF4 transcription factor 4 -1.89 
9236 222156_x
_at 
CCPG1 cell cycle progression 1 1.19 
60526 222192_s
_at 





NCLN nicalin homolog (zebrafish) 0.75 
29956 222212_s
_at 





LRRC59 leucine rich repeat containing 59 1.28 
55000 222244_s
_at 
TUG1 taurine upregulated gene 1 -1.13 
25896 222250_s
_at 
INTS7 integrator complex subunit 7 0.98 
79939 222263_a
t 














olfactory receptor, family 7, 












hypothetical LOC646808 0.59 
79791 222352_a
t 
FBXO31 F-box protein 31 0.56 





immunoglobulin mu binding 
protein 2 
0.66 
23625 32209_at FAM89B family with sequence similarity 89, 
member B 
0.57 
10554 32836_at AGPAT1 1-acylglycerol-3-phosphate O-
acyltransferase 1 (lysophosphatidic 




GALR3 galanin receptor 3 0.68 
10298 33814_at PAK4 p21(CDKN1A)-activated kinase 4 0.57 
1043 34210_at CD52 CD52 molecule -1.55 
9894 34260_at TELO2 TEL2, telomere maintenance 2, 
homolog (S. cerevisiae) 
-0.75 
8517 36004_at IKBKG inhibitor of kappa light polypeptide 
gene enhancer in B-cells, kinase 
gamma 
0.69 







ZNF710 zinc finger protein 710 0.98 
23549 38703_at DNPEP aspartyl aminopeptidase 0.5 
4862 39549_at NPAS2 neuronal PAS domain protein 2 1.27 
 238 
6305 39835_at SBF1 SET binding factor 1 0.51 
37465
5 
39891_at ZNF710 zinc finger protein 710 0.4 
55794 40255_at DDX28 DEAD (Asp-Glu-Ala-Asp) box 
polypeptide 28 
0.53 
8045 40359_at RASSF7 Ras association (RalGDS/AF-6) 
domain family 7 
0.68 
53615 41160_at MBD3 methyl-CpG binding domain 
protein 3 
0.88 
79676 44617_at OGFOD2 2-oxoglutarate and iron-dependent 




FLJ14154 hypothetical protein FLJ14154 0.75 
54985 45714_at HCFC1R
1 
host cell factor C1 regulator 1 
(XPO1 dependent) 
-0.74 
55615 47069_at PRR5 proline rich 5 (renal) 0.73 





invasion inhibitory protein 45 0.8 
23410 49327_at SIRT3 sirtuin (silent mating type 
information regulation 2 homolog) 
3 (S. cerevisiae) 
0.55 
9409 49878_at PEX16 peroxisomal biogenesis factor 16 0.51 
58525 52005_at WIZ widely interspaced zinc finger 
motifs 
0.7 
84065 52078_at C1orf160 chromosome 1 open reading frame 
160 
0.6 
80789 53968_at INTS5 integrator complex subunit 5 0.96 






57473 55872_at ZNF512B zinc finger protein 512B 1.11 





low density lipoprotein receptor 
adaptor protein 1 
0.6 
4718 58916_at NDUFC2 NADH dehydrogenase 
(ubiquinone) 1, subcomplex 




59631_at TXNRD3 thioredoxin reductase 3 0.5 
37626
7 





phospholipase A2, group IVB 
(cytosolic) 
0.82 
11094 61874_at C9orf7 chromosome 9 open reading frame 
7 
0.73 
57175 64486_at CORO1B coronin, actin binding protein, 1B 1.14 
78992 65086_at YIPF2 Yip1 domain family, member 2 0.78 




79939 79005_at SLC35E1 solute carrier family 35, member 
E1 
0.4 
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